<?xml version="1.0"?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2014//EN" "http://www.ncbi.nlm.nih.gov/corehtml/query/DTD/pubmed_140101.dtd">
<PubmedArticleSet>
<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132496</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-3686</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cancer cell</Title>
                <ISOAbbreviation>Cancer Cell</ISOAbbreviation>
            </Journal>
            <ArticleTitle>ER Stress Cooperates with Hypernutrition to Trigger TNF-Dependent Spontaneous HCC Development.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1535-6108(14)00277-3</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.ccr.2014.07.001</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Endoplasmic reticulum (ER) stress has been implicated in the pathogenesis of viral hepatitis, insulin resistance, hepatosteatosis, and nonalcoholic steatohepatitis (NASH), disorders that increase risk of hepatocellular carcinoma (HCC). To determine whether and how ER stress contributes to obesity-driven hepatic tumorigenesis we fed wild-type (WT) and MUP-uPA mice, in which hepatocyte ER stress is induced by plasminogen activator expression, with high-fat diet. Although both strains were equally insulin resistant, the MUP-uPA mice exhibited more liver damage, more immune infiltration, and increased lipogenesis and, as a result, displayed classical NASH signs and developed typical steatohepatitic HCC. Both NASH and HCC development were dependent on TNF produced by inflammatory macrophages that accumulate in the MUP-uPA liver in response to hepatocyte ER stress.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Nakagawa</LastName>
                    <ForeName>Hayato</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, San Diego, CA 92093, USA; Department of Gastroenterology, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Umemura</LastName>
                    <ForeName>Atsushi</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, San Diego, CA 92093, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Taniguchi</LastName>
                    <ForeName>Koji</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, San Diego, CA 92093, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Font-Burgada</LastName>
                    <ForeName>Joan</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, San Diego, CA 92093, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dhar</LastName>
                    <ForeName>Debanjan</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, San Diego, CA 92093, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ogata</LastName>
                    <ForeName>Hisanobu</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, San Diego, CA 92093, USA; Department of Medicine and Clinical Science, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-8582, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhong</LastName>
                    <ForeName>Zhenyu</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, San Diego, CA 92093, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Valasek</LastName>
                    <ForeName>Mark A</ForeName>
                    <Initials>MA</Initials>
                    <Affiliation>Department of Pathology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, San Diego, CA 92093, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Seki</LastName>
                    <ForeName>Ekihiro</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Department of Medicine, School of Medicine, University of California, San Diego, 9500 Gilman Drive, San Diego, CA 92093, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hidalgo</LastName>
                    <ForeName>Juan</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Cell Biology, Physiology and Immunology, Institute of Neurosciences, Universitat Autonoma de Barcelona, Bellaterra, 08193 Barcelona, Spain.</Affiliation>
                </Author>
                <Author>
                    <LastName>Koike</LastName>
                    <ForeName>Kazuhiko</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Gastroenterology, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kaufman</LastName>
                    <ForeName>Randal J</ForeName>
                    <Initials>RJ</Initials>
                    <Affiliation>Program in Degenerative Diseases, Sanford-Burnham Medical Research Institute, 10901 North Torrey Pines Road, La Jolla, CA 92037, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Karin</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Laboratory of Gene Regulation and Signal Transduction, Department of Pharmacology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, San Diego, CA 92093, USA; Department of Pathology, School of Medicine, University of California, San Diego, 9500 Gilman Drive, San Diego, CA 92093, USA. Electronic address: karinoffice@ucsd.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cancer Cell</MedlineTA>
            <NlmUniqueID>101130617</NlmUniqueID>
            <ISSNLinking>1535-6108</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1535-6108(14)00277-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ccr.2014.07.001</ArticleId>
            <ArticleId IdType="pubmed">25132496</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132457</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-1220</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of steroid biochemistry and molecular biology</Title>
                <ISOAbbreviation>J. Steroid Biochem. Mol. Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Vitamin D deficiency decreases adiposity in rats and causes altered expression of uncoupling proteins and steroid receptor coactivator3.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0960-0760(14)00184-8</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.jsbmb.2014.08.005</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The vitamin D endocrine system is functional in the adipose tissue, as demonstrated in vitro, in cultured adipocytes, and in vivo in mutant mice that developed altered lipid metabolism and fat storage in the absence of either 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] or the vitamin D receptor. The aim of the present study was to examine the role of vitamin D and calcium on body adiposity in a diet-induced vitamin D deficient rat model. Vitamin D-deficient rats gained less weight and had lower amounts of visceral fat. Consistent with reduced adipose tissue mass, the vitamin D-deficient rats had low circulating levels of leptin, which reflects body fat stores. Expression of vitamin D and calcium sensing receptors, and that of genes involved in adipogenesis such as peroxisome proliferator-activated receptor, fatty acid synthase and leptin were significantly reduced in white adipose tissue of deficient rats compared to vitamin D-sufficient rats. Furthermore, the expression of uncoupling proteins (Ucp1 and Ucp2) was elevated in the white adipose tissue of the deficient rat indicative of higher energy expenditure, thereby leading to a lean phenotype. Expression of the p160 steroid receptor coactivator3 (SRC3), a key regulator of adipogenesis in white adipose tissue was decreased in vitamin D-deficient state. Interestingly, most of the changes observed in vitamin D deficient rats were corrected by calcium supplementation alone. Our data demonstrates that dietary vitamin D and calcium regulate adipose tissue function and metabolism.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Bhat</LastName>
                    <ForeName>Mehrajuddin</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Endocrinology and Metabolism, Hyderabad, India.</Affiliation>
                </Author>
                <Author>
                    <LastName>Noolu</LastName>
                    <ForeName>Bindu</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Department of Endocrinology and Metabolism, Hyderabad, India.</Affiliation>
                </Author>
                <Author>
                    <LastName>Qadri</LastName>
                    <ForeName>Syed Syh</ForeName>
                    <Initials>SS</Initials>
                    <Affiliation>Department of Pathology, National Institute of Nutrition, Hyderabad, India.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ismail</LastName>
                    <ForeName>Ayesha</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Endocrinology and Metabolism, Hyderabad, India. Electronic address: ayesha.ismail@ninindia.org.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Steroid Biochem Mol Biol</MedlineTA>
            <NlmUniqueID>9015483</NlmUniqueID>
            <ISSNLinking>0960-0760</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Adiposity</Keyword>
            <Keyword MajorTopicYN="N">Calcium</Keyword>
            <Keyword MajorTopicYN="N">Steroid receptor coactivator</Keyword>
            <Keyword MajorTopicYN="N">Uncoupling proteins</Keyword>
            <Keyword MajorTopicYN="N">Vitamin D</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25132457</ArticleId>
            <ArticleId IdType="pii">S0960-0760(14)00184-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.jsbmb.2014.08.005</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132452</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2042-0226</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cellular &amp; molecular immunology</Title>
                <ISOAbbreviation>Cell. Mol. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A B-1a cell subset induces Foxp3(-) T cells with regulatory activity through an IL-10-independent pathway.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/cmi.2014.56</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Regulatory T (Treg) cells play a critical role in the maintenance of tolerance. B-1a cells belong to a specific and functionally important B-cell subset that exerts its regulatory role through the production of IL-10. While IL-10 has been correlated with the induction of type 1 Treg (Tr1) cells or Tr1-like cells, whether IL-10-producing B-1a cells are able to induce Treg cells, especially the Tr1 lineage, is poorly understood. We have demonstrated that, similar to the reported B-2 cells, B-1a cells are able to convert na??ve CD4(+)CD25(-) T cells into a subset of T cells with suppressive function, which we called 'Treg-of-B1a' cells. Treg-of-B1a cells do not express Foxp3, but upregulate the Treg markers OX40, programmed death 1 (PD-1), inducible costimulator (ICOS) and IL-10R. Moreover, Treg-of-B1a cells do not express Foxp3 and produce high levels of IFN-?? and IL-10, but minimal amounts of IL-4; therefore, they resemble Tr1 cells. However, utilizing IL-10(-/-) mice, we showed that IL-10 was not involved in the induction of Treg-of-B1a cells. On the contrary, CD86-mediated costimulation was essential for B-1a cells to drive the induction of Treg-of-B1a cells. Finally, we demonstrated that, in contrast to the Treg cells generated by B-2 cells that mediate contact-dependent suppression, Treg-of-B1a cells suppress through secreting soluble factors. While Tr1 cells mediate suppression mainly through IL-10 or TGF-?? secretion, Treg-of-B1a cells mediate suppression through an IL-10- and TGF-??-independent pathway. Together, these findings suggest that B-1a cells induce a functionally and phenotypically distinct Treg population that is dissimilar to the reported Foxp3(+) Treg or Tr1 cells.Cellular &amp; Molecular Immunology advance online publication, 18 August 2014; doi:10.1038/cmi.2014.56.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Hsu</LastName>
                    <ForeName>Ling-Hui</ForeName>
                    <Initials>LH</Initials>
                    <Affiliation>Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Kun-Po</ForeName>
                    <Initials>KP</Initials>
                    <Affiliation>Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chu</LastName>
                    <ForeName>Kuan-Hua</ForeName>
                    <Initials>KH</Initials>
                    <Affiliation>Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chiang</LastName>
                    <ForeName>Bor-Luen</ForeName>
                    <Initials>BL</Initials>
                    <Affiliation>1] Graduate Institute of Immunology, College of Medicine, National Taiwan University, Taipei, Taiwan, China [2] Department of Medical Research, National Taiwan University Hospital, Taipei, Taiwan, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cell Mol Immunol</MedlineTA>
            <NlmUniqueID>101242872</NlmUniqueID>
            <ISSNLinking>1672-7681</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">cmi201456</ArticleId>
            <ArticleId IdType="doi">10.1038/cmi.2014.56</ArticleId>
            <ArticleId IdType="pubmed">25132452</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132448</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1537-6605</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>American journal of human genetics</Title>
                <ISOAbbreviation>Am. J. Hum. Genet.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mutations in NOTCH1 Cause Adams-Oliver Syndrome.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0002-9297(14)00320-6</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.ajhg.2014.07.011</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Notch signaling determines and reinforces cell fate in bilaterally symmetric multicellular eukaryotes. Despite the involvement of Notch in many key developmental systems, human mutations in Notch signaling components have mainly been described in disorders with vascular and bone effects. Here, we report five heterozygous NOTCH1 variants in unrelated individuals with Adams-Oliver syndrome (AOS), a rare disease with major features of aplasia cutis of the scalp and terminal transverse limb defects. Using whole-genome sequencing in a cohort of 11??families lacking mutations in the four genes with known roles in AOS pathology (ARHGAP31, RBPJ, DOCK6, and EOGT), we found a heterozygous de novo 85 kb deletion spanning the NOTCH1 5' region and three coding variants (c.1285T&gt;C [p.Cys429Arg], c.4487G&gt;A [p.Cys1496Tyr], and c.5965G&gt;A [p.Asp1989Asn]), two of which are de novo, in four unrelated probands. In a fifth family, we identified a heterozygous canonical splice-site variant (c.743-1 G&gt;T) in an affected father and daughter. These variants were not present in 5,077 in-house control genomes or in public databases. In keeping with the prominent developmental role described for Notch1 in mouse vasculature, we observed cardiac and multiple vascular defects in four of the five families. We propose that the limb and scalp defects might also be due to a vasculopathy in NOTCH1-related AOS. Our results suggest that mutations in NOTCH1 are the most common cause of AOS and add to a growing list of human diseases that have a vascular and/or bony component and are caused by alterations in the Notch signaling pathway.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Stittrich</LastName>
                    <ForeName>Anna-Barbara</ForeName>
                    <Initials>AB</Initials>
                    <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lehman</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Medical Genetics and Child and Family Research Institute, University of British Columbia, Vancouver, BC V6H 3N1, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bodian</LastName>
                    <ForeName>Dale L</ForeName>
                    <Initials>DL</Initials>
                    <Affiliation>Inova Translational Medicine Institute, Inova Health System, Falls Church, VA 22042, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ashworth</LastName>
                    <ForeName>Justin</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zong</LastName>
                    <ForeName>Zheyuan</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Department of Medical Genetics and Child and Family Research Institute, University of British Columbia, Vancouver, BC V6H 3N1, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Hong</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lam</LastName>
                    <ForeName>Patricia</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Medical Genetics and Child and Family Research Institute, University of British Columbia, Vancouver, BC V6H 3N1, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Khromykh</LastName>
                    <ForeName>Alina</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Inova Translational Medicine Institute, Inova Health System, Falls Church, VA 22042, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Iyer</LastName>
                    <ForeName>Ramaswamy K</ForeName>
                    <Initials>RK</Initials>
                    <Affiliation>Inova Translational Medicine Institute, Inova Health System, Falls Church, VA 22042, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Vockley</LastName>
                    <ForeName>Joseph G</ForeName>
                    <Initials>JG</Initials>
                    <Affiliation>Inova Translational Medicine Institute, Inova Health System, Falls Church, VA 22042, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Baveja</LastName>
                    <ForeName>Rajiv</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Fairfax Neonatal Associates, Inova Health System, Falls Church, VA 22042, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Silva</LastName>
                    <ForeName>Ermelinda Santos</ForeName>
                    <Initials>ES</Initials>
                    <Affiliation>Pediatric Gastroenterology Service, Centro Hospitalar do Porto, Porto 4050-111, Portugal.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dixon</LastName>
                    <ForeName>Joanne</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Genetic Services, Wellington Hospital, Capital &amp; Coast District Health Board, Wellington 6242, New Zealand.</Affiliation>
                </Author>
                <Author>
                    <LastName>Leon</LastName>
                    <ForeName>Eyby L</ForeName>
                    <Initials>EL</Initials>
                    <Affiliation>Division of Genetics and Metabolism, Children's National Medical Center, Washington, DC 20010, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Solomon</LastName>
                    <ForeName>Benjamin D</ForeName>
                    <Initials>BD</Initials>
                    <Affiliation>Inova Translational Medicine Institute, Inova Health System, Falls Church, VA 22042, USA; Department of Pediatrics, Inova Children's Hospital, Inova Health System, Falls Church, VA 22042, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Glusman</LastName>
                    <ForeName>Gustavo</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Niederhuber</LastName>
                    <ForeName>John E</ForeName>
                    <Initials>JE</Initials>
                    <Affiliation>Inova Translational Medicine Institute, Inova Health System, Falls Church, VA 22042, USA. Electronic address: john.niederhuber@inova.org.</Affiliation>
                </Author>
                <Author>
                    <LastName>Roach</LastName>
                    <ForeName>Jared C</ForeName>
                    <Initials>JC</Initials>
                    <Affiliation>Institute for Systems Biology, Seattle, WA 98109, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Patel</LastName>
                    <ForeName>Millan S</ForeName>
                    <Initials>MS</Initials>
                    <Affiliation>Department of Medical Genetics and Child and Family Research Institute, University of British Columbia, Vancouver, BC V6H 3N1, Canada. Electronic address: mpatel@cw.bc.ca.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Am J Hum Genet</MedlineTA>
            <NlmUniqueID>0370475</NlmUniqueID>
            <ISSNLinking>0002-9297</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0002-9297(14)00320-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ajhg.2014.07.011</ArticleId>
            <ArticleId IdType="pubmed">25132448</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132376</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1880-3873</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of atherosclerosis and thrombosis</Title>
                <ISOAbbreviation>J. Atheroscler. Thromb.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Percutaneous Carbon Dioxide Treatment using a Gas Mist Generator Enhances the Collateral Blood Flow in the Ischemic Hindlimb.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Aim: Highly concentrated carbon dioxide (CO2) is thought to be useful for ischemic diseases. We investigated whether treatment with a few micrometers of CO2 molecules atomized via two fluidnozzles (CO2 mist) exerts an angiogenic effect in a mouse ischemic hindlimb model. Methods: Mice with unilateral hindlimb ischemia were divided into untreated (UT), 100% CO2 gas alone-treated (CG), mixed air (O2; 20%, N2; 80%) mist-treated (AM) and 100% CO2 mist-treated (CM) groups. The lower body of the mice was encased in a polyethylene bag filled with each gaseous agent using a gas mist generator for 10 minutes daily. Results: According to a laser Doppler analysis, the ischemic hindlimb blood flow was persistently higher after the seventh day of induction of ischemia in the CM group than in the UT group. The capillary density was also greater in the CM group on day 28 compared with that observed in the UT group. In addition, the parameters in the AM and CG groups were similar to those obtained in the UT group. The observed effects were abolished by the administration of an inhibitor of nitric oxide synthase (NOS). The vascular endothelial growth factor mRNA expression and protein levels and the phosphorylated endothelial NOS level were increased in the CM group compared with that observed in the UT group. A proteomic analysis using liquid chromatography-tandem mass spectrometry identified novel protein candidates regulated by CO2 mist. Conclusion: Percutaneous CO2 mist therapy may be useful for treating ischemia-induced angiogenesis.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Izumi</LastName>
                    <ForeName>Yasukatsu</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Pharmacology, Osaka City University Medical School.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yamaguchi</LastName>
                    <ForeName>Takehiro</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Yamazaki</LastName>
                    <ForeName>Takanori</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Yamashita</LastName>
                    <ForeName>Naoto</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author>
                    <LastName>Nakamura</LastName>
                    <ForeName>Yasuhiro</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Shiota</LastName>
                    <ForeName>Masayuki</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Tanaka</LastName>
                    <ForeName>Masako</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Sano</LastName>
                    <ForeName>Soichi</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Osada-Oka</LastName>
                    <ForeName>Mayuko</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Shimada</LastName>
                    <ForeName>Kenei</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Wanibuchi</LastName>
                    <ForeName>Hideki</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Miura</LastName>
                    <ForeName>Katsuyuki</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Yoshiyama</LastName>
                    <ForeName>Minoru</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Iwao</LastName>
                    <ForeName>Hiroshi</ForeName>
                    <Initials>H</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Atheroscler Thromb</MedlineTA>
            <NlmUniqueID>9506298</NlmUniqueID>
            <ISSNLinking>1340-3478</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">DN/JST.JSTAGE/jat/23770</ArticleId>
            <ArticleId IdType="pubmed">25132376</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132361</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>24</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-0631</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Life sciences</Title>
                <ISOAbbreviation>Life Sci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Gastrodin prevents motor deficits and oxidative stress in the MPTP mouse model of Parkinson's disease: Involvement of ERK1/2-Nrf2 signaling pathway.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0024-3205(14)00676-6</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.lfs.2014.08.004</ELocationID>
            <Abstract>
                <AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Current no effective therapy is available to halt the progression of Parkinson's disease (PD). Oxidative stress has been implicated in the etiology of PD. The present study evaluates the hypothesis that prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced motor deficits by gastrodin might mainly result from its antioxidant property via interrupting extracellular signal regulated protein kinases (ERK) 1/2-nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway.</AbstractText>
                <AbstractText Label="MAIN METHODS" NlmCategory="METHODS">Pretreatment of mouse model of PD is established by treating C57BL/6 mice with 4 doses of MPTP (30mg/kg per day, i.p.), with gastrodin (60mg/kg per day) administered by daily intraperitoneal injection for 2weeks. Motor behavior of mice was monitored by open-field test and rotarod test. Real-time polymerase chain reaction and Western blotting were used to analyze the expression of genes.</AbstractText>
                <AbstractText Label="KEY FINDINGS" NlmCategory="RESULTS">MPTP-induced motor deficits were partially and significantly forestalled by gastrodin. Gastrodin treatment prevented MPTP-induced oxidative stress, as measured by malondialdehyde in midbrain. Interestingly, MPTP-intoxicated mice treated with gastrodin robustly increased heme oxygenase 1, superoxide dismutase, glutathione levels, and Nrf2 nuclear translocation in striatum of MPTP-intoxicated mice. Furthermore, results herein suggest that the antioxidant pathway activated by gastrodin involves ERK1/2 phosphorylation.</AbstractText>
                <AbstractText Label="SIGNIFICANCE" NlmCategory="CONCLUSIONS">Gastrodin protects midbrain of MPTP-intoxicated mice against oxidative stress, in part, through interrupting ERK1/2-Nrf2 pathway mechanism, which will give us an insight into the potential of gastrodin in terms of opening up new therapeutic avenues for PD.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Xiao-Li</ForeName>
                    <Initials>XL</Initials>
                    <Affiliation>The Institute of Medicine, Qiqihar Medical University, Qiqihar 161006, Heilongjiang, Peoples' Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Xing</LastName>
                    <ForeName>Gui-Hua</ForeName>
                    <Initials>GH</Initials>
                    <Affiliation>The Institute of Medicine, Qiqihar Medical University, Qiqihar 161006, Heilongjiang, Peoples' Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hong</LastName>
                    <ForeName>Bo</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>The Institute of Medicine, Qiqihar Medical University, Qiqihar 161006, Heilongjiang, Peoples' Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Xiao-Ming</ForeName>
                    <Initials>XM</Initials>
                    <Affiliation>The Institute of Medicine, Qiqihar Medical University, Qiqihar 161006, Heilongjiang, Peoples' Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zou</LastName>
                    <ForeName>Yu</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>The Institute of Medicine, Qiqihar Medical University, Qiqihar 161006, Heilongjiang, Peoples' Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Xiao-Jie</ForeName>
                    <Initials>XJ</Initials>
                    <Affiliation>The Institute of Medicine, Qiqihar Medical University, Qiqihar 161006, Heilongjiang, Peoples' Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dong</LastName>
                    <ForeName>Miao-Xian</ForeName>
                    <Initials>MX</Initials>
                    <Affiliation>The Institute of Medicine, Qiqihar Medical University, Qiqihar 161006, Heilongjiang, Peoples' Republic of China. Electronic address: dmx1969@126.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Life Sci</MedlineTA>
            <NlmUniqueID>0375521</NlmUniqueID>
            <ISSNLinking>0024-3205</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (PubChem CID: 1388)</Keyword>
            <Keyword MajorTopicYN="N">Curcumol (PubChem CID: 115067)</Keyword>
            <Keyword MajorTopicYN="N">Gastrodin</Keyword>
            <Keyword MajorTopicYN="N">Glutathione</Keyword>
            <Keyword MajorTopicYN="N">Oxidative stress</Keyword>
            <Keyword MajorTopicYN="N">Parkinson's disease</Keyword>
            <Keyword MajorTopicYN="N">Rotarod test</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>5</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25132361</ArticleId>
            <ArticleId IdType="pii">S0024-3205(14)00676-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.lfs.2014.08.004</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132354</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1527-3350</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Hepatology (Baltimore, Md.)</Title>
                <ISOAbbreviation>Hepatology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/hep.27383</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Alcoholic hepatitis (AH) is a distinct spectrum of alcoholic liver disease (ALD) with intense neutrophilic (PMN) inflammation and high mortality. Although a recent study implicates osteopontin (SPP1) in AH, SPP1 is also shown to have protective effects on experimental ALD. To address this unsettled question, we examined the effects of SPP1 deficiency in male mice given 40% calories derived from ad libitum consumption of the Western diet high in cholesterol and saturated fat (HCFD) and the rest from intragastric feeding (iG) of alcohol diet without or with weekly alcohol binge. Weekly binge in this new hybrid feeding model shifts chronic ASH with macrophage inflammation and perisinusoidal and pericelluar fibrosis to AH in 57% (15/26) of the mice, accompanied by inductions of chemokines (Spp1, Cxcl1, Il-17a), progenitor genes (Cd133, Cd24, Nanog, Epcam), PMN infiltration, and clinical features of AH such as hypoalbuminemia, bilirubinemia, and splenomegaly. SPP1 deficiency does not reduce the AH incidence and inductions of progenitor and fibrogenic genes but rather enhances the Il-17a induction and PMN infiltration in some mice. Further, in the absence of SPP1, chronic ASH mice without weekly binge begin to develop AH. In conclusion, these results suggest SPP1 has a protective rather than causal role for experimental AH reproduced in our model. (Hepatology 2014).</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American Association for the Study of Liver Diseases.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lazaro</LastName>
                    <ForeName>Raul</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Southern California Research Center for ALPD and Cirrhosis, Keck School of Medicine of the University of Southern California; Departments of Pathology, Keck School of Medicine of the University of Southern California.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wu</LastName>
                    <ForeName>Raymond</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Sunyoung</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Zhu</LastName>
                    <ForeName>Nian-Ling</ForeName>
                    <Initials>NL</Initials>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Chia-Lin</ForeName>
                    <Initials>CL</Initials>
                </Author>
                <Author>
                    <LastName>French</LastName>
                    <ForeName>Samuel W</ForeName>
                    <Initials>SW</Initials>
                </Author>
                <Author>
                    <LastName>Xu</LastName>
                    <ForeName>Jun</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Machida</LastName>
                    <ForeName>Keigo</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Tsukamoto</LastName>
                    <ForeName>Hidekazu</ForeName>
                    <Initials>H</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Hepatology</MedlineTA>
            <NlmUniqueID>8302946</NlmUniqueID>
            <ISSNLinking>0270-9139</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">IL-17a</Keyword>
            <Keyword MajorTopicYN="N">IL-22</Keyword>
            <Keyword MajorTopicYN="N">NANOG</Keyword>
            <Keyword MajorTopicYN="N">Spp1</Keyword>
            <Keyword MajorTopicYN="N">TLR4</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.27383</ArticleId>
            <ArticleId IdType="pubmed">25132354</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132335</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Protective properties of a fusion pneumococcal surface protein A (PspA) vaccine against pneumococcal challenge by five different PspA clades in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0264-410X(14)01090-1</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.vaccine.2014.07.108</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">An increase in the appearance of nonvaccine serotypes in both children and adults with invasive pneumococcal disease (IPD) after introduction of pneumococcal conjugate vaccine represents a limitation of this vaccine. In this study, we generated three recombinant pneumococcal surface protein A (PspA) proteins comprising PspA families 1 and 2, and we examined the reactivity of antisera raised in mice immunized with a PspA fusion protein in combination with CpG oligonucleotides plus aluminum hydroxide gel. The protective effects of immunization with PspA fusion proteins against pneumococcal challenge by strains with five different PspA clades were also examined in mice. Flow cytometry demonstrated that PspA3+2-induced antiserum showed the greatest binding of PspA-specific IgG to all five challenge strains with different clades. PspA2+4- or PspA2+5-induced antiserum showed the lowest binding of PspA-specific IgG to clade 3. Immunization with PspA3+2 afforded significant protection against pneumococcal challenge by five strains with different clades in mice, but immunization with PspA2+4 or PspA2+5 failed to protect mice from pneumococcal challenge by strains with clades 1 and 3. The binding of PspA-specific IgG in antisera raised by three PspA fusion proteins was examined in 68 clinical isolates from adult patients with IPD. Immunization of mice with PspA3+2-induced antiserum with a high binding capacity for clinical isolates expressing clades 1-4, but not clade 5. Our results suggest that the PspA3+2 vaccine has an advantage over the PspA2+4 or PspA2+5 vaccine in terms of a broad range of cross-reactivity with clinical isolates and cross-protection against pneumococcal challenge in mice.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Piao</LastName>
                    <ForeName>Zhenyu</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Laboratory for Clinical Research on Infectious Disease, International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Japan; Division of Infection Control and Prevention, Osaka University Graduate School of Medicine, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Akeda</LastName>
                    <ForeName>Yukihiro</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Laboratory for Clinical Research on Infectious Disease, International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Takeuchi</LastName>
                    <ForeName>Dan</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Laboratory for Clinical Research on Infectious Disease, International Research Center for Infectious Diseases, Research Institute for Microbial Diseases, Osaka University, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ishii</LastName>
                    <ForeName>Ken J</ForeName>
                    <Initials>KJ</Initials>
                    <Affiliation>National Institute of Biomedical Innovation, Japan; Laboratory of Vaccine Science, WPI Immunology Frontier Research Center, Osaka University, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ubukata</LastName>
                    <ForeName>Kimiko</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Department of Infectious Diseases, Keio University School of Medicine, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Briles</LastName>
                    <ForeName>David E</ForeName>
                    <Initials>DE</Initials>
                    <Affiliation>Department of Microbiology, University of Alabama at Birmingham, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tomono</LastName>
                    <ForeName>Kazunori</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Division of Infection Control and Prevention, Osaka University Graduate School of Medicine, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Oishi</LastName>
                    <ForeName>Kazunori</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Infectious Disease Surveillance Center, National Institute of Infectious Diseases, Japan. Electronic address: oishik@nih.go.jp.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Binding of PspA-specific IgG</Keyword>
            <Keyword MajorTopicYN="N">Cross-protection</Keyword>
            <Keyword MajorTopicYN="N">PspA fusion protein</Keyword>
            <Keyword MajorTopicYN="N">PspA vaccine</Keyword>
            <Keyword MajorTopicYN="N">Streptococcus pneumoniae</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25132335</ArticleId>
            <ArticleId IdType="pii">S0264-410X(14)01090-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2014.07.108</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132285</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-2825</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>17</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of clinical laboratory analysis</Title>
                <ISOAbbreviation>J. Clin. Lab. Anal.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Comparison of Chromogenic In Situ Hybridization and Fluorescence In Situ Hybridization for the Evaluation of MDM2 Amplification in Adipocytic Tumors.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/jcla.21794</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Atypical lipomatous tumor/well-differentiated liposarcoma (ALT-WDLPS) and dedifferentiated liposarcoma (DDLPS) are characterized cytogenetically by a 12q13-15 amplification involving the mouse double minute 2 (MDM2) oncogene. Fluorescence in situ hybridization (FISH) is used frequently to detect this amplification and aid with the diagnosis of these entities, which is difficult by morphology alone. Recently, bright-field in situ hybridization techniques such as chromogenic in situ hybridization (CISH) have been introduced for the determination of MDM2 amplification status.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">The present study compared the results of FISH and CISH for detecting MDM2 amplification in 41 cases of adipocytic tumors. Amplification was defined in both techniques as a MDM2/CEN12 ratio of 2 or greater.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Eleven cases showed amplification with both FISH and CISH, and 26 cases showed no amplification with both methods. Two cases had discordant results between CISH and FISH, and two cases were not interpretable by CISH.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">CISH is advantageous for allowing pathologists to evaluate the histologic and molecular alterations occurring simultaneously in a specimen. Moreover, CISH is found to be more cost- and time-efficient when used with automation, and the signals do not quench over time. CISH technique is a reliable alternative to FISH in the evaluation of adipocytic tumors for MDM2 amplification.</AbstractText>
                <CopyrightInformation>?? 2014 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Mardekian</LastName>
                    <ForeName>Stacey K</ForeName>
                    <Initials>SK</Initials>
                    <Affiliation>Department of Pathology, Anatomy and Cell Biology, Thomas Jefferson University, Philadelphia, Pennsylvania.</Affiliation>
                </Author>
                <Author>
                    <LastName>Solomides</LastName>
                    <ForeName>Charalambos C</ForeName>
                    <Initials>CC</Initials>
                </Author>
                <Author>
                    <LastName>Gong</LastName>
                    <ForeName>Jerald Z</ForeName>
                    <Initials>JZ</Initials>
                </Author>
                <Author>
                    <LastName>Peiper</LastName>
                    <ForeName>Stephen C</ForeName>
                    <Initials>SC</Initials>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Zi-Xuan</ForeName>
                    <Initials>ZX</Initials>
                </Author>
                <Author>
                    <LastName>Bajaj</LastName>
                    <ForeName>Renu</ForeName>
                    <Initials>R</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Clin Lab Anal</MedlineTA>
            <NlmUniqueID>8801384</NlmUniqueID>
            <ISSNLinking>0887-8013</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">MDM2 protein</Keyword>
            <Keyword MajorTopicYN="N">adipose tissue</Keyword>
            <Keyword MajorTopicYN="N">human gene amplification in situ hybridization chromogenic compounds</Keyword>
            <Keyword MajorTopicYN="N">neoplasms</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jcla.21794</ArticleId>
            <ArticleId IdType="pubmed">25132285</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132272</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-5594</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>0</Volume>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Oncogene</Title>
                <ISOAbbreviation>Oncogene</ISOAbbreviation>
            </Journal>
            <ArticleTitle>TGF-?? signaling alters the pattern of liver tumorigenesis induced by Pten inactivation.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/onc.2014.258</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Hepatocarcinogenesis results from the accumulation of genetic and epigenetic changes in liver cells. A common mechanism through which these alterations induce liver cancer is by deregulating signaling pathways. A number of signaling pathways, including the PI3K/PTEN/AKT and transforming growth factor ?? (TGF-??) pathways have been implicated in normal liver development as well as in cancer formation. In this study, we assessed the effect of the TGF-?? signaling pathway on liver tumors induced by phosphatase and tensin homolog (Pten) loss. Inactivation of only the TGF-?? receptor type II, Tgfbr2, in the mouse liver (Tgfbr2(LKO)) had no overt phenotype, while inactivation of Pten alone (Pten(LKO)), resulted in the formation of both hepatocellular carcinomas and cholangiocarcinomas (CC). Interestingly, deletion of both Pten and Tgfbr2 (Pten(LKO);Tgfbr2(LKO)) in the mouse liver resulted in a dramatic shift in tumor type to predominantly CC. Assessment of the PI3K/PTEN/AKT pathway revealed increased phosphorylation of AKT and glycogen synthase kinase 3 beta (GSK-3??) in both the Pten(LKO) and Pten(LKO);Tgfbr2(LKO) mice, suggesting that this pathway is constitutively active regardless of the status of the TGF-?? signaling pathway. However, phosphorylation of p70 S6 kinase was observed in the liver of all three phenotypes (Tgfbr2(LKO), Pten(LKO), Pten(LKO);Tgfbr2(LKO)) indicating that the loss of Tgfbr2 and/or Pten leads to an increase in this signaling pathway. Analysis of markers of liver progenitor/stem cells revealed that the loss of TGF-?? signaling resulted in increased expression of c-Kit and CD133. Furthermore, in addition to increased c-Kit and CD133, Scf and EpCam expression were also increased in the double knock-out mice. These results suggest that the alteration in tumor types between the Pten(LKO) mice and Pten(LKO);Tgfbr2(LKO) mice is secondary to the altered regulation of stem-cell features induced by the loss of TGF-?? signaling.Oncogene advance online publication, 18 August 2014; doi:10.1038/onc.2014.258.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Morris</LastName>
                    <ForeName>S M</ForeName>
                    <Initials>SM</Initials>
                    <Affiliation>Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Carter</LastName>
                    <ForeName>K T</ForeName>
                    <Initials>KT</Initials>
                    <Affiliation>Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Baek</LastName>
                    <ForeName>J Y</ForeName>
                    <Initials>JY</Initials>
                    <Affiliation>Center for Colorectal Cancer, Research Institute and Hospital, National Cancer Center, Goyang, Republic of Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Koszarek</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yeh</LastName>
                    <ForeName>M M</ForeName>
                    <Initials>MM</Initials>
                    <Affiliation>Department of Pathology, University of Washington Medical School, Seattle, WA, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Knoblaugh</LastName>
                    <ForeName>S E</ForeName>
                    <Initials>SE</Initials>
                    <Affiliation>Comparative Medicine, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Grady</LastName>
                    <ForeName>W M</ForeName>
                    <Initials>WM</Initials>
                    <Affiliation>1] Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Department of Medicine, University of Washington Medical School, Seattle, WA, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <GrantList>
                <Grant>
                    <GrantID>P30 CA015704</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 DK060669</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>T32 CA080416</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Oncogene</MedlineTA>
            <NlmUniqueID>8711562</NlmUniqueID>
            <ISSNLinking>0950-9232</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">onc2014258</ArticleId>
            <ArticleId IdType="doi">10.1038/onc.2014.258</ArticleId>
            <ArticleId IdType="pubmed">25132272</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132271</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-5594</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>0</Volume>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Oncogene</Title>
                <ISOAbbreviation>Oncogene</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The dual-acting chemotherapeutic agent Alchemix induces cell death independently of ATM and p53.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/onc.2014.266</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Topoisomerase inhibitors are in common use as chemotherapeutic agents although they can display reduced efficacy in chemotherapy-resistant tumours, which have inactivated DNA damage response (DDR) genes, such as ATM and TP53. Here, we characterise the cellular response to the dual-acting agent, Alchemix (ALX), which is a modified anthraquinone that functions as a topoisomerase inhibitor as well as an alkylating agent. We show that ALX induces a robust DDR at nano-molar concentrations and this is mediated primarily through ATR- and DNA-PK- but not ATM-dependent pathways, despite DNA double strand breaks being generated after prolonged exposure to the drug. Interestingly, exposure of epithelial tumour cell lines to ALX in vitro resulted in potent activation of the G2/M checkpoint, which after a prolonged arrest, was bypassed allowing cells to progress into mitosis where they ultimately died by mitotic catastrophe. We also observed effective killing of lymphoid tumour cell lines in vitro following exposure to ALX, although, in contrast, this tended to occur via activation of a p53-independent apoptotic pathway. Lastly, we validate the effectiveness of ALX as a chemotherapeutic agent in vivo by demonstrating its ability to cause a significant reduction in tumour cell growth, irrespective of TP53 status, using a mouse leukaemia xenograft model. Taken together, these data demonstrate that ALX, through its dual action as an alkylating agent and topoisomerase inhibitor, represents a novel anti-cancer agent that could be potentially used clinically to treat refractory or relapsed tumours, particularly those harbouring mutations in DDR genes.Oncogene advance online publication, 18 August 2014; doi:10.1038/onc.2014.266.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Thomas</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>IBR West Extension, School of Cancer Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Perry</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>IBR West Extension, School of Cancer Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Berhane</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>IBR West Extension, School of Cancer Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Oldreive</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>IBR West Extension, School of Cancer Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zlatanou</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>IBR West Extension, School of Cancer Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Williams</LastName>
                    <ForeName>L R</ForeName>
                    <Initials>LR</Initials>
                    <Affiliation>IBR West Extension, School of Cancer Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Weston</LastName>
                    <ForeName>V J</ForeName>
                    <Initials>VJ</Initials>
                    <Affiliation>IBR West Extension, School of Cancer Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Stankovic</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>IBR West Extension, School of Cancer Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kearns</LastName>
                    <ForeName>P</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>IBR West Extension, School of Cancer Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Pors</LastName>
                    <ForeName>K</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Institute of Cancer Therapeutics, School of Life Sciences, University of Bradford, West Yorkshire, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Grand</LastName>
                    <ForeName>R J</ForeName>
                    <Initials>RJ</Initials>
                    <Affiliation>IBR West Extension, School of Cancer Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Stewart</LastName>
                    <ForeName>G S</ForeName>
                    <Initials>GS</Initials>
                    <Affiliation>IBR West Extension, School of Cancer Sciences, College of Medicine and Dentistry, University of Birmingham, Birmingham, UK.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Oncogene</MedlineTA>
            <NlmUniqueID>8711562</NlmUniqueID>
            <ISSNLinking>0950-9232</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">onc2014266</ArticleId>
            <ArticleId IdType="doi">10.1038/onc.2014.266</ArticleId>
            <ArticleId IdType="pubmed">25132271</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132267</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-5594</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>0</Volume>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Oncogene</Title>
                <ISOAbbreviation>Oncogene</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Anoikis resistance is a critical feature of highly aggressive ovarian cancer cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/onc.2014.264</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">High-grade serous ovarian cancer is an aggressive form of epithelial ovarian cancer (EOC), and accounts for the majority of deaths due to EOC. The critical cellular processes and underlying molecular mechanisms that define this malignancy remain poorly understood. Using a syngeneic murine model, we investigated the changes that accompanied the progression to increased aggressiveness induced by in vivo passage of mouse EOC cells. We found that enhanced anoikis resistance was a key cellular process associated with greater aggressiveness and tumorigenicity in vivo. Biochemical studies revealed that the enhanced anoikis resistance was associated with the activation of the Src/Akt/Erk signaling pathway. A higher rate of metabolism and autophagy were also associated with increased anoikis resistance. Blocking these pathways with specific inhibitors and/or genetic modifications significantly increased anoikis in vitro and inhibited tumor development in vivo. In addition, we demonstrated that similar signaling pathways were also involved in a human EOC cell line model. Collectively, our data suggest that anoikis resistance represents a critical and a distinguishing feature underlying the aggressiveness of ovarian cancer cells.Oncogene advance online publication, 18 August 2014; doi:10.1038/onc.2014.264.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Cai</LastName>
                    <ForeName>Q</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yan</LastName>
                    <ForeName>L</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Xu</LastName>
                    <ForeName>Y</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Obstetrics and Gynecology, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <GrantList>
                <Grant>
                    <GrantID>R01 CA155145</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Oncogene</MedlineTA>
            <NlmUniqueID>8711562</NlmUniqueID>
            <ISSNLinking>0950-9232</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>11</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">onc2014264</ArticleId>
            <ArticleId IdType="doi">10.1038/onc.2014.264</ArticleId>
            <ArticleId IdType="pubmed">25132267</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132263</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-5594</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Oncogene</Title>
                <ISOAbbreviation>Oncogene</ISOAbbreviation>
            </Journal>
            <ArticleTitle>BRCA1-IRIS inactivation sensitizes ovarian tumors to cisplatin.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/onc.2014.237</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Ovarian cancer is the first in mortalities among gynecologic cancers in the United States, often due to late diagnosis and/or acquired platinum-resistant recurrences. This study investigates whether BRCA1-IRIS is a novel treatment target for ovarian cancers and in platinum-resistant recurrences. Here we show that more than half of the ovarian cancer samples analyzed showed BRCA1-IRIS and survivin overexpression and lacked nuclear FOXO3a expression. Normal ovarian epithelial cells overexpressing BRCA1-IRIS formed metastasis in mice when injected in the peritoneal cavity, whereas aggressive ovarian cancer cell lines failed to form tumors or metastases in mice when BRCA1-IRIS was silenced in them. We show that BRCA1-IRIS activates two autocrine signaling loops, brain-derived neurotrophic factor/tyrosine kinase B receptor (BDNF/TrkB) and neuregulin 1 (NRG1)/ErbB2. These loops are involved in anoikis resistance and metastasis promotion. These loops operate in several ovarian cancer cell lines, and BRCA1-IRIS silencing or inactivation using a novel inhibitory peptide renders both non-functional and promoted cell death. In a mouse xenograft model, BRCA1-IRIS inactivation using this novel inhibitory peptide resulted in significant reduction in ovarian tumor growth. More importantly, this treatment sensitized ovarian tumors to low cisplatin concentrations. Taken together, these data strongly suggest that BRCA1-IRIS and/or BDNF/TrkB and NRG1/ErbB2 could serve as rational therapeutic targets for advanced ovarian cancers.Oncogene advance online publication, 18 August 2014; doi:10.1038/onc.2014.237.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Paul</LastName>
                    <ForeName>B T</ForeName>
                    <Initials>BT</Initials>
                    <Affiliation>Cancer Institute and Department of Biochemistry, University of Mississippi Medical Center, Jackson, MS, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Blanchard</LastName>
                    <ForeName>Z</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Cancer Institute and Department of Biochemistry, University of Mississippi Medical Center, Jackson, MS, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ridgway</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Obstetrics and Gynecology, University of Mississippi Medical Center, Jackson, MS, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>ElShamy</LastName>
                    <ForeName>W M</ForeName>
                    <Initials>WM</Initials>
                    <Affiliation>Cancer Institute and Department of Biochemistry, University of Mississippi Medical Center, Jackson, MS, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Oncogene</MedlineTA>
            <NlmUniqueID>8711562</NlmUniqueID>
            <ISSNLinking>0950-9232</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">onc2014237</ArticleId>
            <ArticleId IdType="doi">10.1038/onc.2014.237</ArticleId>
            <ArticleId IdType="pubmed">25132263</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132262</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-5594</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Oncogene</Title>
                <ISOAbbreviation>Oncogene</ISOAbbreviation>
            </Journal>
            <ArticleTitle>N-terminus-modified Hec1 suppresses tumour growth by interfering with kinetochore-microtubule dynamics.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1038/onc.2014.265</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Mitotic proteins are attractive targets to develop molecular cancer therapeutics due to the intimate interdependence between cell proliferation and mitosis. In this work, we have explored the therapeutic potential of the kinetochore (KT) protein Hec1 (Highly Expressed in Cancer protein 1) as a molecular target to produce massive chromosome missegregation and cell death in cancer cells. Hec1 is a constituent of the Ndc80 complex, which mediates KT-microtubule (MT) attachments at mitosis and is upregulated in various cancer types. We expressed Hec1 fused with enhanced green fluorescent protein (EGFP) at its N-terminus MT-interaction domain in HeLa cells and showed that expression of this modified Hec1, which localized at KTs, blocked cell proliferation and promoted apoptosis in tumour cells. EGFP-Hec1 was extremely potent in tumour cell killing and more efficient than siRNA-induced Hec1 depletion. In striking contrast, normal cells showed no apparent cell proliferation defects or cell death following EGFP-Hec1 expression. Live-cell imaging demonstrated that cancer cell death was associated with massive chromosome missegregation within multipolar spindles after a prolonged mitotic arrest. Moreover, EGFP-Hec1 expression was found to increase KT-MT attachment stability, providing a molecular explanation for the abnormal spindle architecture and the cytotoxic activity of this modified protein. Consistent with cell culture data, EGFP-Hec1 expression was found to strongly inhibit tumour growth in a mouse xenograft model by disrupting mitosis and inducing multipolar spindles. Taken together, these findings demonstrate that stimulation of massive chromosome segregation defects can be used as an anti-cancer strategy through the activation of mitotic catastrophe after a multipolar mitosis. Importantly, this study represents a clear proof of concept that targeting KT proteins required for proper KT-MT attachment dynamics constitutes a powerful approach in cancer therapy.Oncogene advance online publication, 18 August 2014; doi:10.1038/onc.2014.265.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Orticello</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Institute of Biology, Molecular Medicine and Nanobiotechnology, CNR National Research Council, Rome, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Fiore</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Institute of Biology, Molecular Medicine and Nanobiotechnology, CNR National Research Council, Rome, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Totta</LastName>
                    <ForeName>P</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Institute of Biology, Molecular Medicine and Nanobiotechnology, CNR National Research Council, Rome, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Desideri</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Rome, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Barisic</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Chromosome Instability and Dynamics Laboratory, Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.</Affiliation>
                </Author>
                <Author>
                    <LastName>Passeri</LastName>
                    <ForeName>D</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Anatomic Pathology Institute, Tor Vergata University, Rome, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lenzi</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Biology and Biotechnology 'Charles Darwin', Sapienza University, Rome, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Rosa</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Biology and Biotechnology 'Charles Darwin', Sapienza University, Rome, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Orlandi</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Anatomic Pathology Institute, Tor Vergata University, Rome, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Maiato</LastName>
                    <ForeName>H</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>1] Chromosome Instability and Dynamics Laboratory, Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal [2] Cell Division Unit, Department of Experimental Biology, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bufalo</LastName>
                    <ForeName>D Del</ForeName>
                    <Initials>DD</Initials>
                    <Affiliation>Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Rome, Italy.</Affiliation>
                </Author>
                <Author>
                    <LastName>Degrassi</LastName>
                    <ForeName>F</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Institute of Biology, Molecular Medicine and Nanobiotechnology, CNR National Research Council, Rome, Italy.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Oncogene</MedlineTA>
            <NlmUniqueID>8711562</NlmUniqueID>
            <ISSNLinking>0950-9232</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">onc2014265</ArticleId>
            <ArticleId IdType="doi">10.1038/onc.2014.265</ArticleId>
            <ArticleId IdType="pubmed">25132262</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132229</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>19</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Print">0006-3002</ISSN>
                <JournalIssue CitedMedium="Print">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Biochimica et biophysica acta</Title>
                <ISOAbbreviation>Biochim. Biophys. Acta</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Excessive microglial activation aggravates olfactory dysfunction by impeding the survival of newborn neurons in the olfactory bulb of Niemann-Pick disease type C1 mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0925-4439(14)00258-0</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.bbadis.2014.08.005</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Progressive olfactory impairment is one of the earliest markers of neurodegeneration. However, the underlying mechanism for this dysfunction remains unclear. The present study investigated the possible role of microgliosis in olfactory deficits using a mouse model of Niemann-Pick disease type C1 (NPC1), which is an incurable neurodegenerative disorder with disrupted lipid trafficking. At 7weeks of age, NPC1 mutants showed a distinct olfactory impairment in an olfactory test compared with age-matched wild-type controls (WT). The marked loss of olfactory sensory neurons within the NPC1 affected olfactory bulb (NPC1-OB) suggests that NPC1 dysfunction impairs olfactory structure. Furthermore, the pool of neuroblasts in the OB was diminished in NPC1 mice despite the intact proliferative capacity of neural stem/progenitor cells in the subventricular zone. Instead, pro-inflammatory proliferating microglia accumulated extensively in the NPC1-OB as the disease progressed. To evaluate the impact of abnormal microglial activation on olfaction in NPC1 mice, a microglial inhibition study was performed using the anti-inflammatory agent Cyclosporin A (CsA). Importantly, long-term CsA treatment in NPC1 mice reduced reactive microgliosis, restored the survival of newly generated neurons in the OB and improved overall performance on the olfactory test. Therefore, our study highlights the possible role of microglia in the regulation of neuronal turnover in the OB and provides insight into the possible therapeutic applications of microglial inhibition in the attenuation or reversal of olfactory impairment.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Seo</LastName>
                    <ForeName>Yoojin</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Adult Stem Cell Research Center, College of Veterinary Medicine, Seoul National University, Seoul 151-742, South Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Hyung-Sik</ForeName>
                    <Initials>HS</Initials>
                    <Affiliation>Adult Stem Cell Research Center, College of Veterinary Medicine, Seoul National University, Seoul 151-742, South Korea; Institute for Stem Cell and Regenerative Medicine at Kangstem Biotech, Biotechnology Incubating Center, Seoul National University, Seoul 151-742, South Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shin</LastName>
                    <ForeName>Yooyoung</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Adult Stem Cell Research Center, College of Veterinary Medicine, Seoul National University, Seoul 151-742, South Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kang</LastName>
                    <ForeName>Insung</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Adult Stem Cell Research Center, College of Veterinary Medicine, Seoul National University, Seoul 151-742, South Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Choi</LastName>
                    <ForeName>Soon Won</ForeName>
                    <Initials>SW</Initials>
                    <Affiliation>Adult Stem Cell Research Center, College of Veterinary Medicine, Seoul National University, Seoul 151-742, South Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yu</LastName>
                    <ForeName>Kyung-Rok</ForeName>
                    <Initials>KR</Initials>
                    <Affiliation>Adult Stem Cell Research Center, College of Veterinary Medicine, Seoul National University, Seoul 151-742, South Korea; Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul 151-742, South Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Seo</LastName>
                    <ForeName>Kwang-Won</ForeName>
                    <Initials>KW</Initials>
                    <Affiliation>Adult Stem Cell Research Center, College of Veterinary Medicine, Seoul National University, Seoul 151-742, South Korea; Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul 151-742, South Korea; Institute for Stem Cell and Regenerative Medicine at Kangstem Biotech, Biotechnology Incubating Center, Seoul National University, Seoul 151-742, South Korea. Electronic address: kwseo@kangstem.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kang</LastName>
                    <ForeName>Kyung-Sun</ForeName>
                    <Initials>KS</Initials>
                    <Affiliation>Adult Stem Cell Research Center, College of Veterinary Medicine, Seoul National University, Seoul 151-742, South Korea; Research Institute for Veterinary Science, College of Veterinary Medicine, Seoul National University, Seoul 151-742, South Korea. Electronic address: kangpub@snu.ac.kr.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Biochim Biophys Acta</MedlineTA>
            <NlmUniqueID>0217513</NlmUniqueID>
            <ISSNLinking>0006-3002</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cyclosporin A</Keyword>
            <Keyword MajorTopicYN="N">Microglia</Keyword>
            <Keyword MajorTopicYN="N">Neurodegeneration</Keyword>
            <Keyword MajorTopicYN="N">Niemann???Pick disease type C1</Keyword>
            <Keyword MajorTopicYN="N">Olfaction</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25132229</ArticleId>
            <ArticleId IdType="pii">S0925-4439(14)00258-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbadis.2014.08.005</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132193</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1742-4658</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The FEBS journal</Title>
                <ISOAbbreviation>FEBS J.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>PAX2 upregulates androgen receptor gene expression in androgen-independent prostate cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/febs.12959</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Androgen-independent prostate cancer is known as a hormone-refractory disease. Though the androgen receptor (AR) is considered to be a key regulator of androgen-independent prostate cancer progression, the mechanism through which AR gene expression is regulated is not well understood. Here, we showed that the AR gene was upregulated by paired box 2 (PAX2) in androgen-independent prostate cancer. When PAX2 upregulated AR gene expression, a decrease in DNA methylation of the AR gene locus was also observed. PAX2 was highly expressed and promoted cell growth in an androgen-independent prostate cancer cell line (22Rv1). The cell growth inhibition by PAX2 knockdown was rescued by AR overexpression in 22Rv1 cells. In a mouse xenograft model of androgen-independent prostate cancer, PAX2 knockdown inhibited tumor growth and AR gene expression and increased DNA methylation of the AR gene. Consistent with this, AR and PAX2 expression levels were positively correlated in prostate cancer patients. These findings suggested that PAX2 promoted cancer cell growth in androgen-independent prostate cancer by regulating AR gene expression through an epigenetic mechanism. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ito</LastName>
                    <ForeName>Saya</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Urology, Kyoto Prefectural University of Medicine, Kyoto, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ueda</LastName>
                    <ForeName>Takashi</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Ueno</LastName>
                    <ForeName>Akihisa</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Nakagawa</LastName>
                    <ForeName>Hideo</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Taniguchi</LastName>
                    <ForeName>Hidefumi</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Hongo</LastName>
                    <ForeName>Fumiya</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Kamoi</LastName>
                    <ForeName>Kazumi</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Okihara</LastName>
                    <ForeName>Koji</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Kawauchi</LastName>
                    <ForeName>Akihiro</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Miki</LastName>
                    <ForeName>Tsuneharu</ForeName>
                    <Initials>T</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>FEBS J</MedlineTA>
            <NlmUniqueID>101229646</NlmUniqueID>
            <ISSNLinking>1742-464X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">DNA methylation</Keyword>
            <Keyword MajorTopicYN="N">PAX2</Keyword>
            <Keyword MajorTopicYN="N">androgen receptor</Keyword>
            <Keyword MajorTopicYN="N">gene expression</Keyword>
            <Keyword MajorTopicYN="N">prostate cancer</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/febs.12959</ArticleId>
            <ArticleId IdType="pubmed">25132193</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132189</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1549-4918</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>5</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Stem cells (Dayton, Ohio)</Title>
                <ISOAbbreviation>Stem Cells</ISOAbbreviation>
            </Journal>
            <ArticleTitle>iPS Cell Transplantation Increases Regeneration and Functional Recovery after Ischemic Stroke in Neonatal Rats.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/stem.1802</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Limited treatments are available for perinatal/neonatal stroke. Induced pluripotent stem cells (iPSCs) hold therapeutic promise for stroke treatment, but the benefits of iPSC transplantation in neonates are relatively unknown. We hypothesized that transplanted iPS cell-derived neural progenitors (iPSC-NPCs) would increase regeneration after stroke. Mouse pluripotent iPSCs were differentiated into neural progenitors using a retinoic acid protocol. Differentiated neural cells were characterized by using multiple criteria and assessments. Ischemic stroke was induced in postnatal day 7 (P7) rats by occluding the right middle cerebral artery and right common carotid artery. iPSC-NPCs (400,000 in 4 ??l) were transplanted into the penumbra via intracranial injection 7d after stroke. Trophic factor expression in the peri-infarct tissue was measured using Western blot analysis. Animals received daily BrdU injections and were sacrificed 21d after stroke for immunohistochemistry. The vibrissae-elicited forelimb placement test was used to evaluate functional recovery. Differentiated iPSCs expressed mature neuronal markers, functional sodium and potassium channels, and fired action potentials. Several angiogenic and neurogenic trophic factors were identified in iPSC-NPCs. Animals that received iPSC-NPC transplantation had greater expression of SDF-1?? and VEGF in the peri-infarct region. iPSC-NPCs stained positive for NeuN or GFAP 14 days after transplantation. iPSC-NPC-transplanted animals showed greater numbers of BrdU/NeuN and BrdU/Collagen IV co-labeled cells in the peri-infarct area compared to stroke controls, and performed better in a sensorimotor functional test after stroke. iPSC-NPC therapy may play multiple therapeutic roles after stroke by providing trophic factors, increasing angiogenesis and neurogenesis, and providing new cells for tissue repair. Stem Cells 2014.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 AlphaMed Press.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Chau</LastName>
                    <ForeName>Monica</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Anesthesiology, Emory University School of Medicine, Atlanta, GA, 30322.</Affiliation>
                </Author>
                <Author>
                    <LastName>Deveau</LastName>
                    <ForeName>Todd C</ForeName>
                    <Initials>TC</Initials>
                </Author>
                <Author>
                    <LastName>Song</LastName>
                    <ForeName>Mingke</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Gu</LastName>
                    <ForeName>Xiaohuan</ForeName>
                    <Initials>X</Initials>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Dongdong</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Wei</LastName>
                    <ForeName>Ling</ForeName>
                    <Initials>L</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>5</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Stem Cells</MedlineTA>
            <NlmUniqueID>9304532</NlmUniqueID>
            <ISSNLinking>1066-5099</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">iPS cells</Keyword>
            <Keyword MajorTopicYN="N">ischemic stroke</Keyword>
            <Keyword MajorTopicYN="N">neuronal differentiation</Keyword>
            <Keyword MajorTopicYN="N">trophic factors</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/stem.1802</ArticleId>
            <ArticleId IdType="pubmed">25132189</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132144</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1365-2362</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>European journal of clinical investigation</Title>
                <ISOAbbreviation>Eur. J. Clin. Invest.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Treatment with Evasin-3 abrogates neutrophil-mediated inflammation in mouse acute pancreatitis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/eci.12327</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Acute pancreatitis is characterized by inflammatory processes affecting not only the pancreas, but also the lung. Here, we investigated timing of leukocyte infiltration and chemokine expression within lung and pancreas during pancreatitis and whether treatments selectively inhibiting chemokines (using Evasins) could improve organ injury.</AbstractText>
                <AbstractText Label="MATERIAL AND METHODS" NlmCategory="METHODS">C57Bl/6 mice were submitted in vivo to 10-hourly intraperitoneal injections of cerulein and followed for up to 168 hours. Five minutes after the first cerulein injection, a single intraperitoneal injection of 10 ??g Evasin-3, 1 ??g Evasin-4 or an equal volume of vehicle (PBS) was performed. Leukocytes, reactive oxygen species (ROS), necrosis and chemokine/cytokine mRNA expression were assessed in different organs by immunohistology and Real time RT-PCR, respectively.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">In the lung, neutrophil and macrophage infiltration peaked at 12 hours and was accompanied by increased CXCL2 mRNA expression. CCL2, CXCL1 and TNF-alpha significantly increased after 24 hours as compared to baseline. No increase in CCL3 and CCL5 was observed. In the pancreas, neutrophil infiltration peaked at 6 hours, while macrophages increased only after 72 hours. Treatment with Evasin-3 decreased neutrophil infiltration, ROS production and apoptosis in the lung and reduced neutrophils, macrophages apoptosis and necrosis in the pancreas. Evasin-4 only reduced macrophage content in the lung and did not provide any benefit at the pancreas level.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Chemokine production and leukocyte infiltration are timely regulated in lung and pancreas during pancreatitis. CXC chemokine inhibition with Evasin-3 improved neutrophil inflammation and injury, potentially interfering with damages in acute pancreatitis and related pulmonary complications. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Montecucco</LastName>
                    <ForeName>Fabrizio</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Division of Cardiology, Foundation for Medical Researches, University of Geneva, 64, avenue de la Roseraie, 1211, Geneva, Switzerland; First Clinic of Internal Medicine, Department of Internal Medicine, University of Genoa School of Medicine. IRCCS Azienda Ospedaliera Universitaria San Martino-IST Istituto Nazionale per la Ricerca sul Cancro, viale Benedetto XV, 16132, Genoa, Italy; Division of Laboratory Medicine, Department of Genetics and Laboratory Medicine, Geneva University Hospitals, n4, Gabrielle-Perret-Gentil, 1205, Geneva, Switzerland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mach</LastName>
                    <ForeName>Fran??ois</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Lenglet</LastName>
                    <ForeName>S??bastien</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Vonlaufen</LastName>
                    <ForeName>Alain</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Quinder??</LastName>
                    <ForeName>Ana Lu??za Gomes</ForeName>
                    <Initials>AL</Initials>
                </Author>
                <Author>
                    <LastName>Pelli</LastName>
                    <ForeName>Graziano</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Burger</LastName>
                    <ForeName>Fabienne</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Galan</LastName>
                    <ForeName>Katia</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Dallegri</LastName>
                    <ForeName>Franco</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Carbone</LastName>
                    <ForeName>Federico</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Proudfoot</LastName>
                    <ForeName>Amanda E</ForeName>
                    <Initials>AE</Initials>
                </Author>
                <Author>
                    <LastName>Vuilleumier</LastName>
                    <ForeName>Nicolas</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author>
                    <LastName>Frossard</LastName>
                    <ForeName>Jean-Louis</ForeName>
                    <Initials>JL</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Eur J Clin Invest</MedlineTA>
            <NlmUniqueID>0245331</NlmUniqueID>
            <ISSNLinking>0014-2972</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Inflammation</Keyword>
            <Keyword MajorTopicYN="N">Lung</Keyword>
            <Keyword MajorTopicYN="N">Pancreas</Keyword>
            <Keyword MajorTopicYN="N">Pancreatitis</Keyword>
            <Keyword MajorTopicYN="N">pancreatic damage.</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/eci.12327</ArticleId>
            <ArticleId IdType="pubmed">25132144</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132107</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1742-4658</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>6</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The FEBS journal</Title>
                <ISOAbbreviation>FEBS J.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>FrxA is a GSNO reductase enzyme that contributes to Helicobacter pylori pathogenicity.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/febs.12958</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Helicobacter pylori is a worldwide spread pathogen that infects the gastric mucosa of a large percentage of the human population and predisposes to peptic ulceration and gastric cancer. Persistent colonization of humans by H. pylori triggers an inflammatory response that leads to the production of reactive nitrogen species. However, the H. pylori defences against nitrosative stress remain largely unknown. In this work, we show that the NADH-flavin oxidoreductase FrxA of H. pylori besides metabolizing nitrofurans and metronidazole has S-nitrosoglutathione (GSNO) reductase activity. In agreement, inactivation of the FrxA encoding gene resulted in a strain more sensitive to GSNO. FrxA also proved to contribute to the proliferation of H. pylori in macrophages, which are key phagocytic cells of the mammalian innate immune system. Moreover, FrxA is shown to support the virulence of the pathogen upon mice infection. Altogether, we provide evidence for a new function of FrxA that contributes to the successful chronic colonization ability that characterizes H. pylori. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Justino</LastName>
                    <ForeName>Marta C</ForeName>
                    <Initials>MC</Initials>
                    <Affiliation>Instituto de Tecnologia Qu??mica e Biol??gica Ant??nio Xavier, Universidade Nova de Lisboa, Oeiras, Portugal; Escola Superior de Tecnologia do Barreiro, Instituto Polit??cnico de Set??bal, Barreiro, Portugal.</Affiliation>
                </Author>
                <Author>
                    <LastName>Parente</LastName>
                    <ForeName>Margarida R</ForeName>
                    <Initials>MR</Initials>
                </Author>
                <Author>
                    <LastName>Boneca</LastName>
                    <ForeName>Ivo G</ForeName>
                    <Initials>IG</Initials>
                </Author>
                <Author>
                    <LastName>Saraiva</LastName>
                    <ForeName>L??gia M</ForeName>
                    <Initials>LM</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>FEBS J</MedlineTA>
            <NlmUniqueID>101229646</NlmUniqueID>
            <ISSNLinking>1742-464X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Helicobacter pylori</Keyword>
            <Keyword MajorTopicYN="N">GSNO reductase</Keyword>
            <Keyword MajorTopicYN="N">Nitroreductase</Keyword>
            <Keyword MajorTopicYN="N">nitrosative stress</Keyword>
            <Keyword MajorTopicYN="N">nitrosoglutathione</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/febs.12958</ArticleId>
            <ArticleId IdType="pubmed">25132107</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132091</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1559-1182</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>19</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular neurobiology</Title>
                <ISOAbbreviation>Mol. Neurobiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Inhibition of H3K4me2 Demethylation Protects Auditory Hair Cells from Neomycin-Induced Apoptosis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Aminoglycoside-induced hair cell loss is a major cause of hearing impairment in children and deserves more attention in medical research. Epigenetic mechanisms have been shown to protect hair cells from ototoxic drugs. In this study, we focused on the role of dimethylated histone H3K4 (H3K4me2) in hair cell survival. To investigate the effects of lysine-specific demethylase 1 (LSD1)-the histone demethylase primarily responsible for demethylating H3K4me2-on neomycin-induced hair cell loss, isolated cochleae were pretreated with LSD1 inhibitors followed by neomycin exposure. There was a severe loss of hair cells in the organ of Corti after neomycin exposure, and inhibition of LSD1 significantly protected against neomycin-induced hair cell loss. H3K4me2 expression in the nuclei of hair cells decreased after exposure to neomycin, and blocking the decreased expression of H3K4me2 with LSD1 inhibitors prevented hair cell loss. Local delivery of these inhibitors in vivo also protected hair cells from neomycin-induced ototoxicity and maintained the hearing threshold in mice as determined by auditory brain stem response. This inhibition of neomycin-induced apoptosis occurs via reduced caspase-3 activation. Together, our findings demonstrate the protective role for H3K4me2 against neomycin-induced hair cell loss and hearing loss.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>He</LastName>
                    <ForeName>Yingzi</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Otolaryngology, Affiliated Eye and ENT Hospital, Fudan University, Shanghai, 200031, People's Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yu</LastName>
                    <ForeName>Huiqian</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Cai</LastName>
                    <ForeName>Chengfu</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Sun</LastName>
                    <ForeName>Shan</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Chai</LastName>
                    <ForeName>Renjie</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Huawei</ForeName>
                    <Initials>H</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Mol Neurobiol</MedlineTA>
            <NlmUniqueID>8900963</NlmUniqueID>
            <ISSNLinking>0893-7648</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s12035-014-8841-3</ArticleId>
            <ArticleId IdType="pubmed">25132091</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132073</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1440-1681</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical and experimental pharmacology &amp; physiology</Title>
                <ISOAbbreviation>Clin. Exp. Pharmacol. Physiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>TGF-??1 mediates psoriasis-like lesions via a Smad3-dependent mechanism in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/1440-1681.12294</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">TGF-??1 signals through downstream Smad-dependent and independent pathways to exert its biological activities. It is reported that overexpression of TGF-??1 results in the development of psoriasis-like lesions in a mouse model of K5.TGF-?? (WT) transgenic mice. However, signaling mechanisms by which TGF-??1 mediates psoriasis-like lesions remain undefined. In the present study, we hypothesized that TGF-??1 may mediate psoriasis-like lesions via a Smad3-dependent mechanism. This was tested in a mouse model of K5.TGF-?? (WT) transgenic mice by blocking TGF-?? signaling with a specific Smad3 inhibitor. Results showed that topical treatment with a Smad3 inhibitor markedly blocked TGF-??/Smad3 signaling and progressive psoriasis-like lesions in K5.TGF-?? (WT) transgenic mice by reducing the skin severity score, DSFT score, infiltration of CD3(+) T cells and F4/80(+) macrophages, and degree of fibrosis in the dermis. This was associated with a marked reduction in TGF-??1, IL-6, IL-23, and IL-17A both locally in the skin plaque lesions and systemically in plasma, resulting in inhibition of a Th17 transcriptional factor ROR??t and CD4(+) IL-17A(+) cells accumulation within the skin plaque lesions. In conclusion, TGF-??1 mediates psoriasis-like lesions via a Smad3-dependent, Th17-mediated mechanism. Targeting TGF ??/Smad3 signaling with a Smad3 inhibitor may represent a novel and effective therapy for psoriasis. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Yun</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Li Ka Shing Institute of Health Sciences and Department of Medicine and Therapeutics, the Chinese University of Hong Kong, Hong Kong, China; School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Meng</LastName>
                    <ForeName>Xiao-Ming</ForeName>
                    <Initials>XM</Initials>
                </Author>
                <Author>
                    <LastName>Huang</LastName>
                    <ForeName>Xiao-Ru</ForeName>
                    <Initials>XR</Initials>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Xiao-Jing</ForeName>
                    <Initials>XJ</Initials>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Liu</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Lan</LastName>
                    <ForeName>Hui Yao</ForeName>
                    <Initials>HY</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Clin Exp Pharmacol Physiol</MedlineTA>
            <NlmUniqueID>0425076</NlmUniqueID>
            <ISSNLinking>0305-1870</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Psoriasis</Keyword>
            <Keyword MajorTopicYN="N">Smad3 inhibitor</Keyword>
            <Keyword MajorTopicYN="N">TGF-?? signaling</Keyword>
            <Keyword MajorTopicYN="N">Th17</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/1440-1681.12294</ArticleId>
            <ArticleId IdType="pubmed">25132073</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132062</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1527-3350</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Hepatology (Baltimore, Md.)</Title>
                <ISOAbbreviation>Hepatology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Deletion of splicing factor SRSF3 in hepatocytes predisposes to hepatocellular carcinoma in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/hep.27380</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Alterations in RNA splicing are associated with cancer, but it is not clear whether they result from malignant transformation or have a causative role. We show here that hepatocyte-specific deletion of splicing factor SRSF3 impairs hepatocyte maturation and metabolism in early adult life, and mice develop spontaneous hepatocellular carcinoma (HCC) with aging. Tumor development is preceded by chronic liver disease with progressive steatosis and fibrosis. SRSF3 protects mice against carbon tetrachloride-induced fibrosis and carcinogenesis, and suppresses inclusion of the profibrogenic EDA exon in fibronectin 1. Loss of SRSF3 increases expression of insulin like growth factor 2 (Igf2) and the A-isoform of the insulin receptor (Insr-A) allowing aberrant activation of mitogenic signaling, promotes aberrant splicing and expression of epithelial to mesenchymal transition (EMT) genes, and activates Wnt/??-catenin signaling leading to c-Myc induction. Finally, SRSF3 expression is either decreased or the protein miss-localized in human HCC. Conclusion- Our data suggest a potential role for SRSF3 in preventing hepatic carcinogenesis by regulating splicing to suppress fibrosis, mitogenic splicing and EMT. Thus, these mice may provide an attractive model to discover the pathogenic mechanisms linking aberrant pre-mRNA splicing with liver damage, fibrosis and HCC. (Hepatology 2014;).</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American Association for the Study of Liver Diseases.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Sen</LastName>
                    <ForeName>Supriya</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Medical Research Service, VA San Diego Healthcare System, San Diego, CA, 92161, USA; Department of Medicine, Division of Endocrinology and Metabolism, University of California San Diego, La Jolla, CA, 92093, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Langiewicz</LastName>
                    <ForeName>Magda</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Jumaa</LastName>
                    <ForeName>Hassan</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Webster</LastName>
                    <ForeName>Nicholas J G</ForeName>
                    <Initials>NJ</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Hepatology</MedlineTA>
            <NlmUniqueID>8302946</NlmUniqueID>
            <ISSNLinking>0270-9139</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">IGF2</Keyword>
            <Keyword MajorTopicYN="N">RNA</Keyword>
            <Keyword MajorTopicYN="N">fibronectin</Keyword>
            <Keyword MajorTopicYN="N">insulin receptor</Keyword>
            <Keyword MajorTopicYN="N">liver</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.27380</ArticleId>
            <ArticleId IdType="pubmed">25132062</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25132005</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1099-1263</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of applied toxicology : JAT</Title>
                <ISOAbbreviation>J Appl Toxicol</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Cardiolipin profiles as a potential biomarker of mitochondrial health in diet-induced obese mice subjected to exercise, diet-restriction and ephedrine treatment.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/jat.3030</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Cardiolipin (CL) is crucial for mitochondrial energy metabolism and structural integrity. Alterations in CL quantity or CL species have been associated with mitochondrial dysfunction in several pathological conditions and diseases, including mitochondrial dysfunction-related compound attrition and post-market withdrawal of promising drugs. Here we report alterations in the CL profiles in conjunction with morphology of soleus muscle (SM) and brown adipose tissue (BAT) in diet-induced obese (DIO) mice, subjected to ephedrine treatment (EPH: 200???mg???kg(-1) ???day(-1) orally), treadmill exercise (EX: 10 meters per min, 1???h per day), or dietary restriction (DR: 25% less of mean food consumed by the EX group) for 7???days. Mice from the DR and EPH groups had a significant decrease in percent body weight and reduced fat mass compared with DIO controls. Morphologic alterations in the BAT included brown adipocytes with reduced cytoplasmic lipid droplets and increased cytoplasmic eosinophilia in the EX, DR and EPH groups. Increased cytoplasmic eosinophilia in the BAT was ultrastructurally manifested by increased mitochondrial cristae, fenestration of mitochondrial cristae, increased electron density of mitochondrial matrix, and increased complexity of shape and elongation of mitochondria. Mitochondrial ultrastructural alterations in the SM of the EX and DR groups included increased mitochondrial cristae, cup-shaped mitochondria and mitochondrial degeneration. All four CL species (tri-linoleoyl-mono-docosahexaenoyl, tetralinoleoyl, tri-linoleoyl-mono-oleoyl, and di-linoleoyl-di-oleoyl) were increased in the BAT of the DR and EPH groups and in the SM of the EPH and EX groups. In conclusion, cardiolipin profiling supported standard methods for assessing mitochondrial biogenesis and health, and may serve as a potential marker of mitochondrial dysfunction in preclinical toxicity studies. Copyright ?? 2014 John Wiley &amp; Sons, Ltd.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 John Wiley &amp; Sons, Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Faber</LastName>
                    <ForeName>Catherine</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Comparative Pathobiology, Purdue University, West Lafayette, IN, 47907, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhu</LastName>
                    <ForeName>Zhaohai J</ForeName>
                    <Initials>ZJ</Initials>
                </Author>
                <Author>
                    <LastName>Castellino</LastName>
                    <ForeName>Stephen</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Wagner</LastName>
                    <ForeName>David S</ForeName>
                    <Initials>DS</Initials>
                </Author>
                <Author>
                    <LastName>Brown</LastName>
                    <ForeName>Roger H</ForeName>
                    <Initials>RH</Initials>
                </Author>
                <Author>
                    <LastName>Peterson</LastName>
                    <ForeName>Richard A</ForeName>
                    <Initials>RA</Initials>
                </Author>
                <Author>
                    <LastName>Gates</LastName>
                    <ForeName>Lisa</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Barton</LastName>
                    <ForeName>Joanna</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Bickett</LastName>
                    <ForeName>Mark</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Hagerty</LastName>
                    <ForeName>Laura</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Kimbrough</LastName>
                    <ForeName>Carie</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Sola</LastName>
                    <ForeName>Mario</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Bailey</LastName>
                    <ForeName>David</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Jordan</LastName>
                    <ForeName>Holly</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Elangbam</LastName>
                    <ForeName>Chandikumar S</ForeName>
                    <Initials>CS</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Appl Toxicol</MedlineTA>
            <NlmUniqueID>8109495</NlmUniqueID>
            <ISSNLinking>0260-437X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">brown adipose tissue</Keyword>
            <Keyword MajorTopicYN="N">cardiolipin</Keyword>
            <Keyword MajorTopicYN="N">ephedrine</Keyword>
            <Keyword MajorTopicYN="N">exercise</Keyword>
            <Keyword MajorTopicYN="N">mitochondrial health</Keyword>
            <Keyword MajorTopicYN="N">skeletal muscles</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jat.3030</ArticleId>
            <ArticleId IdType="pubmed">25132005</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131997</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1099-1573</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>8</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Phytotherapy research : PTR</Title>
                <ISOAbbreviation>Phytother Res</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Gallic Acid Regulates Skin Photoaging in UVB-exposed Fibroblast and Hairless Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/ptr.5198</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Ultraviolet (UV) radiation is the primary factor in skin photoaging, which is characterized by wrinkle formation, dryness, and thickening. The mechanisms underlying skin photoaging are closely associated with degradation of collagen via upregulation of matrix metalloproteinase (MMP) activity, which is induced by reactive oxygen species (ROS) production. Gallic acid (GA), a phenolic compound, possesses a variety of biological activities including antioxidant and antiinflammatory activities. We investigated the protective effects of GA against photoaging caused by UVB irradiation using normal human dermal fibroblasts (NHDFs) in vitro and hairless mice in vivo. The production levels of ROS, interlukin-6, and MMP-1 were significantly suppressed, and type I procollagen expression was stimulated in UVB-irradiated and GA-treated NHDFs. GA treatment inhibited the activity of transcription factor activation protein 1. The effects of GA following topical application and dietary administration were examined by measuring wrinkle formation, histological modification, protein expression, and physiological changes such as stratum corneum hydration, transepidermal water loss, and erythema index. We found that GA decreased dryness, skin thickness, and wrinkle formation via negative modulation of MMP-1 secretion and positive regulation of elastin, type I procollagen, and transforming growth factor-??1. Our data indicate that GA is a potential candidate for the prevention of UVB-induced premature skin aging. Copyright ?? 2014 John Wiley &amp; Sons, Ltd.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 John Wiley &amp; Sons, Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Hwang</LastName>
                    <ForeName>Eunson</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Department of Oriental Medicinal Material and Processing, College of Life Science, Kyung Hee University, Global Campus, 1732 Deokyoungdaero, Giheung-gu, Yongin-si, Gyeonggi-do, 446-701, Korea.</Affiliation>
                </Author>
                <Author>
                    <LastName>Park</LastName>
                    <ForeName>Sang-Yong</ForeName>
                    <Initials>SY</Initials>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Hyun Ji</ForeName>
                    <Initials>HJ</Initials>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Tae Youp</ForeName>
                    <Initials>TY</Initials>
                </Author>
                <Author>
                    <LastName>Sun</LastName>
                    <ForeName>Zheng-Wang</ForeName>
                    <Initials>ZW</Initials>
                </Author>
                <Author>
                    <LastName>Yi</LastName>
                    <ForeName>Tae Hoo</ForeName>
                    <Initials>TH</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>8</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Phytother Res</MedlineTA>
            <NlmUniqueID>8904486</NlmUniqueID>
            <ISSNLinking>0951-418X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">MMP-1</Keyword>
            <Keyword MajorTopicYN="N">ROS</Keyword>
            <Keyword MajorTopicYN="N">gallic acid</Keyword>
            <Keyword MajorTopicYN="N">hairless mice</Keyword>
            <Keyword MajorTopicYN="N">photoaging</Keyword>
            <Keyword MajorTopicYN="N">type I procollagen</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>9</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/ptr.5198</ArticleId>
            <ArticleId IdType="pubmed">25131997</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131991</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-4547</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neuroscience research</Title>
                <ISOAbbreviation>J. Neurosci. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Expression of ??-subunit of ??-glucosidase II in adult mouse brain regions and selected organs.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/jnr.23470</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">??-Glucosidase II (GII), a resident of endoplasmic reticulum (ER) and an important enzyme in the folding of nascent glycoproteins, is heterodimeric, consisting of ?? (GII??) and ?? (GII??) subunits. The catalytic GII?? subunit, with the help of mannose 6-phosphate receptor homology domain of GII??, sequentially hydrolyzes two ??1-3-linked glucose residues in the second step of N-linked oligosaccharide-mediated protein folding. The soluble GII?? subunit is retained in the ER through its interaction with the HDEL-containing GII?? subunit. N-glycosylation and correct protein folding are crucial for protein stability and trafficking and cell surface expression of several proteins in the brain. Alterations in N-glycosylation lead to abnormalities in neuronal migration and mental retardation, various neurodegenerative diseases, and invasion of malignant gliomas. Inhibitors of GII are used to inhibit cell proliferation and migration in a variety of different pathologies, such as viral infection, cancer, and diabetes. Despite the widespread use of GII?? inhibitory drugs and the role of GII?? in brain function, little is known about its expression in brain and other tissues. Here, we report generation of a highly specific chicken antibody to the GII?? subunit and its characterization by Western blotting and immunoprecipitation using cerebral cortical extracts. By using this antibody, we showed that the GII?? protein is highly expressed in testis, kidney, and lung, with the lowest amount in heart. GII?? polypeptide levels in whole brain were comparable to those in spleen. However, a higher expression of GII?? protein was detected in the cerebral cortex, reflecting its continuous requirement in correct folding of cell surface proteins. ?? 2014 Wiley Periodicals, Inc.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Anji</LastName>
                    <ForeName>Antje</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Anatomy and Physiology, CVM, Kansas State University, Manhattan, Kansas.</Affiliation>
                </Author>
                <Author>
                    <LastName>Miller</LastName>
                    <ForeName>Hayley</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Raman</LastName>
                    <ForeName>Chandrasekar</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Phillips</LastName>
                    <ForeName>Mathew</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Ciment</LastName>
                    <ForeName>Gary</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Kumari</LastName>
                    <ForeName>Meena</ForeName>
                    <Initials>M</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Neurosci Res</MedlineTA>
            <NlmUniqueID>7600111</NlmUniqueID>
            <ISSNLinking>0360-4012</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">GII??</Keyword>
            <Keyword MajorTopicYN="N">N-glycosylation</Keyword>
            <Keyword MajorTopicYN="N">Western blot analysis</Keyword>
            <Keyword MajorTopicYN="N">cerebral cortex</Keyword>
            <Keyword MajorTopicYN="N">chicken antibody</Keyword>
            <Keyword MajorTopicYN="N">immunoprecipitation</Keyword>
            <Keyword MajorTopicYN="N">mouse</Keyword>
            <Keyword MajorTopicYN="N">protein folding</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>1</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jnr.23470</ArticleId>
            <ArticleId IdType="pubmed">25131991</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131989</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-4172</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell</Title>
                <ISOAbbreviation>Cell</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Broadly Neutralizing Antibodies and Viral Inducers Decrease Rebound from HIV-1 Latent Reservoirs in Humanized Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0092-8674(14)00993-3</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.cell.2014.07.043</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Latent reservoirs of HIV-1-infected cells are refractory to antiretroviral therapies (ART) and remain the major barrier to curing HIV-1. Because latently infected cells are long-lived, immunologically invisible, and may undergo homeostatic proliferation, a &quot;shock and kill&quot; approach has been proposed to eradicate this reservoir by combining ART with inducers of viral transcription. However, all attempts to alter the HIV-1 reservoir in??vivo have failed to date. Using humanized mice, we show that broadly neutralizing antibodies (bNAbs) can interfere with establishment of a silent reservoir by Fc-FcR-mediated mechanisms. In established infection, bNAbs or bNAbs plus single inducers are ineffective in preventing viral rebound. However, bNAbs plus a combination of inducers that act by independent mechanisms synergize to decrease the reservoir as measured by viral rebound. Thus, combinations of inducers and bNAbs constitute a therapeutic strategy that impacts the establishment and maintenance of the HIV-1 reservoir in humanized mice.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Halper-Stromberg</LastName>
                    <ForeName>Ariel</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lu</LastName>
                    <ForeName>Ching-Lan</ForeName>
                    <Initials>CL</Initials>
                    <Affiliation>Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA; Weill Cornell Medical College, New York, NY 10065, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Klein</LastName>
                    <ForeName>Florian</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Horwitz</LastName>
                    <ForeName>Joshua A</ForeName>
                    <Initials>JA</Initials>
                    <Affiliation>Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bournazos</LastName>
                    <ForeName>Stylianos</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY 10065, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nogueira</LastName>
                    <ForeName>Lilian</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Eisenreich</LastName>
                    <ForeName>Thomas R</ForeName>
                    <Initials>TR</Initials>
                    <Affiliation>Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Cassie</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gazumyan</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Schaefer</LastName>
                    <ForeName>Uwe</ForeName>
                    <Initials>U</Initials>
                    <Affiliation>Laboratory of Lymphocyte Signaling, The Rockefeller University, New York, NY 10065, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Furze</LastName>
                    <ForeName>Rebecca C</ForeName>
                    <Initials>RC</Initials>
                    <Affiliation>Epinova DPU, Immuno-Inflammation Therapy Area, Medicines Research Centre, GlaxoSmithKline, Stevenage SG1 2NY, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Seaman</LastName>
                    <ForeName>Michael S</ForeName>
                    <Initials>MS</Initials>
                    <Affiliation>Beth Israel Deaconess Medical Center, Boston, MA 02215, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Prinjha</LastName>
                    <ForeName>Rab</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Epinova DPU, Immuno-Inflammation Therapy Area, Medicines Research Centre, GlaxoSmithKline, Stevenage SG1 2NY, UK.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tarakhovsky</LastName>
                    <ForeName>Alexander</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Laboratory of Lymphocyte Signaling, The Rockefeller University, New York, NY 10065, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ravetch</LastName>
                    <ForeName>Jeffrey V</ForeName>
                    <Initials>JV</Initials>
                    <Affiliation>Laboratory of Molecular Genetics and Immunology, The Rockefeller University, New York, NY 10065, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nussenzweig</LastName>
                    <ForeName>Michel C</ForeName>
                    <Initials>MC</Initials>
                    <Affiliation>Laboratory of Molecular Immunology, The Rockefeller University, New York, NY 10065, USA; Howard Hughes Medical Institute. Electronic address: nussen@rockefeller.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cell</MedlineTA>
            <NlmUniqueID>0413066</NlmUniqueID>
            <ISSNLinking>0092-8674</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0092-8674(14)00993-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cell.2014.07.043</ArticleId>
            <ArticleId IdType="pubmed">25131989</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131933</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1527-3350</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Hepatology (Baltimore, Md.)</Title>
                <ISOAbbreviation>Hepatology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A screen in mice uncovers repression of lipoprotein lipase by microRNA-29a as a mechanism for lipid distribution away from the liver.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/hep.27379</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Identification of microRNAs (miRNAs) that regulate lipid metabolism is important to advance the understanding and treatment of some of the most common human diseases. In the liver, a few key miRNAs have been reported that regulate lipid metabolism, but since many genes contribute to hepatic lipid metabolism, we hypothesized that other such miRNAs exist. To identify genes repressed by miRNAs in mature hepatocytes in vivo, we injected adult mice carrying floxed Dicer1 alleles with an adenoassociated viral vector expressing Cre recombinase specifically in hepatocytes. By inactivating Dicer in adult quiescent hepatocytes we avoided the hepatocyte injury and regeneration observed in previous mouse models of global miRNA deficiency in hepatocytes. Next, we combined gene and miRNA expression profiling to identify candidate gene/miRNA interactions involved in hepatic lipid metabolism, and validated their function in vivo using antisense oligonucleotides. A candidate gene that emerged from our screen was lipoprotein lipase (Lpl), which encodes an enzyme that facilitates cellular uptake of lipids from the circulation. Unlike in energy-dependent cells like myocytes, Lpl is normally repressed in adult hepatocytes. We identified miR-29a as the miRNA responsible for repressing Lpl in hepatocytes, and found that decreasing hepatic miR-29a levels causes lipids to accumulate in mouse livers. Conclusion: Our screen suggests several new miRNAs are regulators of hepatic lipid metabolism. We show that one of these, miR-29a, contributes to physiological lipid distribution away from the liver and protects hepatocytes from steatosis. Our results, together with miR-29a's known anti-fibrotic effect, suggest miR-29a is a therapeutic target in fatty liver disease. (Hepatology 2014).</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American Association for the Study of Liver Diseases.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Mattis</LastName>
                    <ForeName>Aras N</ForeName>
                    <Initials>AN</Initials>
                    <Affiliation>Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California San Francisco, San Francisco, CA, 94143, USA; Department of Pathology, University of California San Francisco, San Francisco, CA, 94143, USA; Liver Center, University of California San Francisco, San Francisco, CA, 94143, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Song</LastName>
                    <ForeName>Guisheng</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Hitchner</LastName>
                    <ForeName>Kelly</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Roy Y</ForeName>
                    <Initials>RY</Initials>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Andrew Y</ForeName>
                    <Initials>AY</Initials>
                </Author>
                <Author>
                    <LastName>Sharma</LastName>
                    <ForeName>Amar D</ForeName>
                    <Initials>AD</Initials>
                </Author>
                <Author>
                    <LastName>Malato</LastName>
                    <ForeName>Yann</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>McManus</LastName>
                    <ForeName>Michael T</ForeName>
                    <Initials>MT</Initials>
                </Author>
                <Author>
                    <LastName>Esau</LastName>
                    <ForeName>Christine C</ForeName>
                    <Initials>CC</Initials>
                </Author>
                <Author>
                    <LastName>Koller</LastName>
                    <ForeName>Erich</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Koliwad</LastName>
                    <ForeName>Suneil</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Lim</LastName>
                    <ForeName>Lee P</ForeName>
                    <Initials>LP</Initials>
                </Author>
                <Author>
                    <LastName>Maher</LastName>
                    <ForeName>Jacquelyn J</ForeName>
                    <Initials>JJ</Initials>
                </Author>
                <Author>
                    <LastName>Raffai</LastName>
                    <ForeName>Robert L</ForeName>
                    <Initials>RL</Initials>
                </Author>
                <Author>
                    <LastName>Willenbring</LastName>
                    <ForeName>Holger</ForeName>
                    <Initials>H</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Hepatology</MedlineTA>
            <NlmUniqueID>8302946</NlmUniqueID>
            <ISSNLinking>0270-9139</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.27379</ArticleId>
            <ArticleId IdType="pubmed">25131933</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131924</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1874-1754</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>1</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of cardiology</Title>
                <ISOAbbreviation>Int. J. Cardiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>MicroRNA-29b promotes high-fat diet-stimulated endothelial permeability and apoptosis in apoE knock-out mice by down-regulating MT1 expression.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0167-5273(14)01305-9</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.ijcard.2014.07.095</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">High-fat diet has been reported to be associated with cardiovascular diseases which is implicated in atherosclerosis. However, the underlying mechanisms remain unknown. MicroRNAs (miRNAs) are non-coding small RNAs that control gene expression at the post-transcriptional level. Dysregulated miRNAs have been shown to be involved in atherosclerosis.</AbstractText>
                <AbstractText Label="METHODS AND RESULTS" NlmCategory="RESULTS">This study examined whether microRNA-29b (miR-29b) regulates high-fat diet induced endothelial permeability and apoptosis by targeting MT1, a known melatonin membrane receptor. In apoE knock-out mice, a high-fat diet increased miR-29b expression and induced apoptosis as determined by up-regulation of caspase-3 activity. However, a standard diet did not alter apoptosis. miR-29b antagomir decreased endothelial permeability and apoptosis in high-fat diet-stimulated mice. In contrast, a miR-29b mimic enhanced endothelial permeability and apoptosis. The induction of miR-29b correlated with a reduction in Bcl-2 and MT1 in high-fat diet-stimulated mice. miR-29b have an effect on the marker of inflammation (NF-??B) and cell adhesion molecule (ICAM-1). We further showed that miR-29b targeted and inhibited MT1 expression through a target site located in the 3'un-translational region of MT1 mRNA. This study demonstrates a role of miR-29b in atherosclerosis and identifies MT1 as a direct target of miR-29b.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The effect of miR-29b on endothelial permeability and apoptosis is mediated through the down-regulation of MT1. Thus, miR-29b may be a new therapeutic target for atherosclerosis.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ireland Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Zhu</LastName>
                    <ForeName>Hua-Qing</ForeName>
                    <Initials>HQ</Initials>
                    <Affiliation>Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University, Hefei, Anhui, People's Republic of China; Key Laboratory of Gene Research of Anhui Province, Hefei, Anhui, People's Republic of China. Electronic address: aydzhq@126.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Qing</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University, Hefei, Anhui, People's Republic of China; Key Laboratory of Gene Research of Anhui Province, Hefei, Anhui, People's Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dong</LastName>
                    <ForeName>Liu-Yi</ForeName>
                    <Initials>LY</Initials>
                    <Affiliation>Department of Pharmacology, Anhui Medical University, Hefei, Anhui, People's Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhou</LastName>
                    <ForeName>Qing</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University, Hefei, Anhui, People's Republic of China; Key Laboratory of Gene Research of Anhui Province, Hefei, Anhui, People's Republic of China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Hua</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Oncology, The first Affiliated Hospital of Anhui Medical University, Anhui, People's Republic of China. Electronic address: wanghua@ahmu.edu.cn.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Yuan</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Laboratory of Molecular Biology and Department of Biochemistry, Anhui Medical University, Hefei, Anhui, People's Republic of China; Key Laboratory of Gene Research of Anhui Province, Hefei, Anhui, People's Republic of China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>1</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Int J Cardiol</MedlineTA>
            <NlmUniqueID>8200291</NlmUniqueID>
            <ISSNLinking>0167-5273</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Apoptosis</Keyword>
            <Keyword MajorTopicYN="N">High-fat diet</Keyword>
            <Keyword MajorTopicYN="N">MT1</Keyword>
            <Keyword MajorTopicYN="N">MicroRNA-29b</Keyword>
            <Keyword MajorTopicYN="N">Permeability</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>26</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0167-5273(14)01305-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ijcard.2014.07.095</ArticleId>
            <ArticleId IdType="pubmed">25131924</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131829</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-4547</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neuroscience research</Title>
                <ISOAbbreviation>J. Neurosci. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Lentiviral-mediated silencing of glial fibrillary acidic protein and vimentin promotes anatomical plasticity and functional recovery after spinal cord injury.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/jnr.23468</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">In spinal cord injury (SCI), absence of functional recovery and lack of spontaneous axonal regeneration are attributed, among other factors, to the formation of a glial scar that forms both physical and chemical barriers. The glial scar is composed mainly of reactive astrocytes that overexpress two intermediate filament proteins, glial fibrillary acidic protein (GFAP) and vimentin (VIM). To promote regeneration and sprouting of spared axons after spinal cord trauma and with the objective of translation to clinics, we designed an original in vivo gene transfer strategy to reduce glial scar formation after SCI, based on the RNA interference (RNAi)-mediated inhibition of GFAP and VIM. We first show that direct injection of lentiviral vectors expressing short hairpin RNA (shRNA) against GFAP and VIM in a mouse model of SCI allows efficient and specific targeting of astrocytes. We then demonstrate that the lentiviral-mediated and stable expression of shGFAP and shVIM leads to a strong reduction of astrogliosis, improves functional motor recovery, and promotes axonal regrowth and sprouting of spared axons. This study thus examplifies how the nonneuronal environment might be a major target within the lesioned central nervous system to promote axonal regeneration (and sprouting) and validates the use of lentiviral-mediated RNAi in SCI. ?? 2014 Wiley Periodicals, Inc.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Desclaux</LastName>
                    <ForeName>Mathieu</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Biotechnology and Biotherapy, Centre de Recherche de l'Institut du Cerveau et de la Moelle Epiniere, Centre National de la Recherche Scientifique (CNRS) UMR 7225, Institut National de la Sant?? et de la Recherche M??dicale (INSERM) UMRS 975, Universit?? Pierre et Marie Curie (UPMC), H??pital de la Piti?? Salp??tri??re, Paris, France; Columbia University, Department of Pathology and Cell Biology Project A.L.S.-Jenifer Estess Laboratory for Stem Cell Research, New York, New York.</Affiliation>
                </Author>
                <Author>
                    <LastName>Perrin</LastName>
                    <ForeName>Florence E</ForeName>
                    <Initials>FE</Initials>
                </Author>
                <Author>
                    <LastName>Do-Thi</LastName>
                    <ForeName>Anh</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Prieto-Cappellini</LastName>
                    <ForeName>Monica</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Gimenez Y Ribotta</LastName>
                    <ForeName>Minerva</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Mallet</LastName>
                    <ForeName>Jacques</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Privat</LastName>
                    <ForeName>Alain</ForeName>
                    <Initials>A</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Neurosci Res</MedlineTA>
            <NlmUniqueID>7600111</NlmUniqueID>
            <ISSNLinking>0360-4012</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">astrocyte</Keyword>
            <Keyword MajorTopicYN="N">functional recovery</Keyword>
            <Keyword MajorTopicYN="N">gene transfer</Keyword>
            <Keyword MajorTopicYN="N">glial scar</Keyword>
            <Keyword MajorTopicYN="N">spinal cord injury repair</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jnr.23468</ArticleId>
            <ArticleId IdType="pubmed">25131829</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25131785</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0371-0874</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>66</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>25</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Sheng li xue bao : [Acta physiologica Sinica]</Title>
                <ISOAbbreviation>Sheng Li Xue Bao</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Effect of pulse magnetic field on distribution of neuronal action potential].</ArticleTitle>
            <Pagination>
                <MedlinePgn>438-48</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>The biological effect on the organism generated by magnetic field is widely studied. The present study was aimed to observe the change of sodium channel under magnetic field in neurons. Cortical neurons of Kunming mice were isolated, subjected to 15 Hz, 1 mT pulse magnetic stimulation, and then the currents of neurons were recorded by whole-cell patch clamp. The results showed that, under magnetic stimulation, the activation process of Na(+) channel was delayed, and the inactivation process was accelerated. Given the classic three-layer model, the polarization diagram of cell membrane potential distribution under pulse magnetic field was simulated, and it was found that the membrane potential induced was associated with the frequency and intensity of magnetic field. Also the effect of magnetic field-induced current on action potential was simulated by Hodgkin-Huxley (H-H) model. The result showed that the generation of action potential was delayed, and frequency and the amplitudes were decreased when working current was between -1.32 ??A and 0 ??A. When the working current was higher than 0 ??A, the generation frequency of action potential was increased, and the change of amplitudes was not obvious, and when the working current was lower than -1.32 ??A, the time of rising edge and amplitudes of action potential were decreased drastically, and the action potential was unable to generate. These results suggest that the magnetic field simulation can affect the distribution frequency and amplitude of action potential of neuron via sodium channel mediation.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Zheng</LastName>
                    <ForeName>Yu</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>School of Electronics and Information Engineering, Tianjin Polytechnic University, Tianjin 300387, China; State Key Laboratory of Precision Measurement Technology and Instruments, Tianjin University, Tianjin 300072, China. wangjinhai@tjpu.edu.cn.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cai</LastName>
                    <ForeName>Di</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wang</LastName>
                    <ForeName>Jin-Hai</ForeName>
                    <Initials>JH</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Gang</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lin</LastName>
                    <ForeName>Ling</ForeName>
                    <Initials>L</Initials>
                </Author>
            </AuthorList>
            <Language>chi</Language>
            <PublicationTypeList>
                <PublicationType>English Abstract</PublicationType>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Sheng Li Xue Bao</MedlineTA>
            <NlmUniqueID>20730130R</NlmUniqueID>
            <ISSNLinking>0371-0874</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25131785</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25131784</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">0371-0874</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>66</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>25</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Sheng li xue bao : [Acta physiologica Sinica]</Title>
                <ISOAbbreviation>Sheng Li Xue Bao</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Upregulation of P2X3 receptors in dorsal root ganglion of TRPV1 knockout female mice].</ArticleTitle>
            <Pagination>
                <MedlinePgn>431-7</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText>The study was aimed to investigate the changes in mechanical pain threshold in the condition of chronic inflammatory pain after transient receptor potential vanilloid 1 (TRPV1) gene was knockout. Hind-paw intraplantar injection of complete freund's adjuvant (CFA, 20 ??L) produced peripheral inflammation in wild-type and TRPV1 knockout female mice. The mechanical pain thresholds were measured during the 8 days after injection and pre-injection by using Von-Frey hair. Nine days after injection, mice were killed and the differences of expression of c-Fos and P2X3 receptor in the dorsal root ganglia (DRG) and spinal cord dorsal horn were examined by Western blotting between the two groups. Compared with that in wild-type mice, the mechanical pain threshold was increased significantly in TRPV1 knockout mice (P &lt; 0.05); 3 days after CFA injection, the baseline mechanical pain threshold in the TRPV1 knockout mice group was significantly higher than that in the wild-type mice group (P &lt; 0.05); The result of Western blotting showed that the expression of c-Fos protein both in DRG and spinal cord dorsal horn of TRPV1 knockout mice group was decreased significantly compared with that in wild-type mice group (P &lt; 0.01, P &lt; 0.05), while the expression of P2X3 receptor in DRG of TRPV1 knockout mice group was increased significantly compared with that in wild-type mice group (P &lt; 0.05). Our findings indicate that TRPV1 may influence the peripheral mechanical pain threshold by mediating the expression of c-Fos protein both in DRG and spinal cord dorsal horn and changing the expression of P2X3 receptor in DRG.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Fang</LastName>
                    <ForeName>Xiao</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Physiology, Secondary Military Medical University, Shanghai 200433, China; Department of Physiology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China. mabei08@aliyun.com.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shi</LastName>
                    <ForeName>Xiao-Han</ForeName>
                    <Initials>XH</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Huang</LastName>
                    <ForeName>Li-Bin</ForeName>
                    <Initials>LB</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rong</LastName>
                    <ForeName>Wei-Fang</ForeName>
                    <Initials>WF</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ma</LastName>
                    <ForeName>Bei</ForeName>
                    <Initials>B</Initials>
                </Author>
            </AuthorList>
            <Language>chi</Language>
            <PublicationTypeList>
                <PublicationType>English Abstract</PublicationType>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Sheng Li Xue Bao</MedlineTA>
            <NlmUniqueID>20730130R</NlmUniqueID>
            <ISSNLinking>0371-0874</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25131784</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131778</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1527-3350</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Hepatology (Baltimore, Md.)</Title>
                <ISOAbbreviation>Hepatology</ISOAbbreviation>
            </Journal>
            <ArticleTitle>TIMP-1 creates a pre-metastatic niche in the liver through SDF-1/CXCR4-dependent neutrophil recruitment in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/hep.27378</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Due to its ability to inhibit pro-metastatic matrix metalloproteinases, tissue inhibitor of metalloproteinases (TIMP)-1 has been thought to suppress tumor metastasis. However, elevated systemic levels of TIMP-1 correlate with poor prognosis in cancer patients suggesting a metastasis-stimulating role of TIMP-1. In colorectal cancer patients, tumor as well as plasma TIMP-1 levels were correlated with synchronous liver metastasis or distant metastasis-associated disease relapse. In mice, high systemic TIMP-1 levels increased the liver susceptibility towards metastasis by triggering the formation of a pre-metastatic niche. This promoted hepatic metastasis independent of origin or intrinsic metastatic potential of tumor cells. High systemic TIMP-1 led to increased hepatic SDF-1 levels, which in turn promoted recruitment of neutrophils to the liver. Both inhibition of SDF-1-mediated neutrophil recruitment and systemic depletion of neutrophils reduced TIMP-1-induced increased liver susceptibility towards metastasis. This indicates a crucial functional role of neutrophils in the TIMP-1-induced pre-metastatic niche. Conclusion: Our results identify TIMP-1 as an essential promoter of hepatic pre-metastatic niche formation. (Hepatology 2014).</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American Association for the Study of Liver Diseases.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Seubert</LastName>
                    <ForeName>Bastian</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Institut f??r Experimentelle Onkologie und Therapieforschung, Institute of Molecular Immunology, Technische Universit??t M??nchen, M??nchen, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gr??nwald</LastName>
                    <ForeName>Barbara</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author>
                    <LastName>Kobuch</LastName>
                    <ForeName>Julia</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Cui</LastName>
                    <ForeName>Haissi</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Schelter</LastName>
                    <ForeName>Florian</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author>
                    <LastName>Schaten</LastName>
                    <ForeName>Susanne</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Siveke</LastName>
                    <ForeName>Jens T</ForeName>
                    <Initials>JT</Initials>
                </Author>
                <Author>
                    <LastName>Lim</LastName>
                    <ForeName>Ngee H</ForeName>
                    <Initials>NH</Initials>
                </Author>
                <Author>
                    <LastName>Nagase</LastName>
                    <ForeName>Hideaki</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Simonavicius</LastName>
                    <ForeName>Nicole</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author>
                    <LastName>Heikenw??lder</LastName>
                    <ForeName>Mathias</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Reinheckel</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Sleeman</LastName>
                    <ForeName>Jonathan P</ForeName>
                    <Initials>JP</Initials>
                </Author>
                <Author>
                    <LastName>Janssen</LastName>
                    <ForeName>Klaus-Peter</ForeName>
                    <Initials>KP</Initials>
                </Author>
                <Author>
                    <LastName>Knolle</LastName>
                    <ForeName>Percy A</ForeName>
                    <Initials>PA</Initials>
                </Author>
                <Author>
                    <LastName>Kr??ger</LastName>
                    <ForeName>Achim</ForeName>
                    <Initials>A</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Hepatology</MedlineTA>
            <NlmUniqueID>8302946</NlmUniqueID>
            <ISSNLinking>0270-9139</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">liver metastasis</Keyword>
            <Keyword MajorTopicYN="N">microenvironment</Keyword>
            <Keyword MajorTopicYN="N">natural protease inhibitor</Keyword>
            <Keyword MajorTopicYN="N">neutrophil granulocytes</Keyword>
            <Keyword MajorTopicYN="N">organ susceptibility</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.27378</ArticleId>
            <ArticleId IdType="pubmed">25131778</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131777</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1090-2449</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Experimental parasitology</Title>
                <ISOAbbreviation>Exp. Parasitol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>One minute ultraviolet exposure inhibits Toxoplasma gondii tachyzoite replication and cyst conversion without diminishing host humoral-mediated immune response.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0014-4894(14)00191-X</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.exppara.2014.08.001</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">We developed a protocol to inactivate Toxoplasma gondii (T. gondii) tachyzoites employing 1min of ultraviolet (UV) exposure. We show that this treatment completely inhibited parasite replication and cyst formation in vitro and in vivo but did not affect the induction of a robust IgG response in mice. We propose that our protocol can be used to study the contribution of the humoral immune response to rodent behavioral alterations following T. gondii infection.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Kannan</LastName>
                    <ForeName>Geetha</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Division of Neurobiology, Department of Psychiatry, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA. Electronic address: gkannan1@jhmi.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Prandovszky</LastName>
                    <ForeName>Emese</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Stanley Division of Developmental Neurovirology, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Steinfeldt</LastName>
                    <ForeName>Curtis B</ForeName>
                    <Initials>CB</Initials>
                    <Affiliation>Stanley Division of Developmental Neurovirology, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gressitt</LastName>
                    <ForeName>Kristin L</ForeName>
                    <Initials>KL</Initials>
                    <Affiliation>Stanley Division of Developmental Neurovirology, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>ChunXia</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Division of Neurobiology, Department of Psychiatry, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yolken</LastName>
                    <ForeName>Robert H</ForeName>
                    <Initials>RH</Initials>
                    <Affiliation>Stanley Division of Developmental Neurovirology, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Severance</LastName>
                    <ForeName>Emily G</ForeName>
                    <Initials>EG</Initials>
                    <Affiliation>Stanley Division of Developmental Neurovirology, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jones-Brando</LastName>
                    <ForeName>Lorraine</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Stanley Division of Developmental Neurovirology, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Pletnikov</LastName>
                    <ForeName>Mikhail V</ForeName>
                    <Initials>MV</Initials>
                    <Affiliation>Division of Neurobiology, Department of Psychiatry, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA; Department of Molecular and Comparative Pathobiology, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA; Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, 600 North Wolfe Street, Baltimore, MD 21287, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Exp Parasitol</MedlineTA>
            <NlmUniqueID>0370713</NlmUniqueID>
            <ISSNLinking>0014-4894</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Animal models</Keyword>
            <Keyword MajorTopicYN="N">Behavior</Keyword>
            <Keyword MajorTopicYN="N">Cysts</Keyword>
            <Keyword MajorTopicYN="N">Immune response</Keyword>
            <Keyword MajorTopicYN="N">Inactivation</Keyword>
            <Keyword MajorTopicYN="N">Toxoplasma</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25131777</ArticleId>
            <ArticleId IdType="pii">S0014-4894(14)00191-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.exppara.2014.08.001</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25131766</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1447-0756</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>40</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>The journal of obstetrics and gynaecology research</Title>
                <ISOAbbreviation>J. Obstet. Gynaecol. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Decreased expression of elastin and lysyl oxidase family genes in urogenital tissues of aging mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1998-2004</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/jog.12425</ELocationID>
            <Abstract>
                <AbstractText Label="AIM" NlmCategory="OBJECTIVE">This study aims to investigate the expression levels of elastin and lysyl oxidase (LOX) family members in the urogenital tissues of natural aging mice and accelerated ovarian aging mice.</AbstractText>
                <AbstractText Label="METHOD" NlmCategory="METHODS">Uteri, vaginas and bladders were harvested from 18-month-old female mice and accelerated ovarian aging mice developed by chemotherapeutic agents. Untreated 3-month-old female mice were used as controls. The expression levels of elastin and LOX family members were determined by real-time polymerase chain reaction and western blot.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Compared with untreated young female mice, the expression of elastin and LOX family members significantly decreased both in natural aging mice and accelerated ovarian aging mice.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Aging is a high-risk factor for pelvic floor disorders. The failure of elastic fiber synthesis and assembly due to the decline in expression levels of elastin and LOX family members during aging may explain the molecular mechanism causing pelvic floor disorders.</AbstractText>
                <CopyrightInformation>?? 2014 The Authors. Journal of Obstetrics and Gynaecology Research ?? 2014 Japan Society of Obstetrics and Gynecology.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Jiang</LastName>
                    <ForeName>Yan</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Key Laboratory of the Ministry of Education for Experimental Teratology, School of Life Science, Shandong University, Jinan, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zong</LastName>
                    <ForeName>Wen</ForeName>
                    <Initials>W</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Luan</LastName>
                    <ForeName>Hong</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Jian-Hua</ForeName>
                    <Initials>JH</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Ai-Zhen</ForeName>
                    <Initials>AZ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Xiao-Lin</ForeName>
                    <Initials>XL</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Shuo-Yang</ForeName>
                    <Initials>SY</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Shi-Qian</ForeName>
                    <Initials>SQ</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gao</LastName>
                    <ForeName>Jian-Gang</ForeName>
                    <Initials>JG</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>Australia</Country>
            <MedlineTA>J Obstet Gynaecol Res</MedlineTA>
            <NlmUniqueID>9612761</NlmUniqueID>
            <ISSNLinking>1341-8076</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">elastin</Keyword>
            <Keyword MajorTopicYN="N">lysyl oxidase family</Keyword>
            <Keyword MajorTopicYN="N">pelvic floor disorders</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>5</Month>
                <Day>27</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jog.12425</ArticleId>
            <ArticleId IdType="pubmed">25131766</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131752</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1525-2191</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The American journal of pathology</Title>
                <ISOAbbreviation>Am. J. Pathol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Myeloid-Derived Tissue-Type Plasminogen Activator Promotes Macrophage Motility through FAK, Rac1, and NF-??B Pathways.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0002-9440(14)00368-X</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.ajpath.2014.06.013</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Macrophage accumulation is one of the hallmarks of progressive kidney disease. Tissue-type plasminogen activator (tPA) is known to promote macrophage infiltration and renal inflammation during chronic kidney injury. However, the underlying mechanism remains largely unknown. We examined the role of tPA in macrophage motility in??vivo by tracking fluorescence-labeled bone marrow-derived macrophages, and found that tPA-deficient mice had markedly fewer infiltrating fluorescence-labeled macrophages than the wild-type (WT) mice. Experiments in bone marrow chimeric mice further demonstrated that myeloid cells are the main source of endogenous tPA that promotes macrophage migration. In??vitro studies showed that tPA promoted macrophage motility through its CD11b-mediated protease-independent function; and FAK, Rac-1, and NF-??B were indispensable to tPA-induced macrophage migration as either infection of FAK dominant-negative adenovirus or treatment with a Rac-1-specific inhibitor or NF-??B inhibitor abolished the effect of tPA. Moreover, ectopic FAK mimicked tPA and induced macrophage motility. tPA also activated migratory signaling in??vivo. The accumulation of phospho-FAK-positive CD11b macrophages in the obstructed kidneys from WT mice was clearly attenuated in tPA knockout mice, which also displayed lower Rac-1 activity than their WT counterparts. Therefore, our results indicate that myeloid-derived tPA promotes macrophage migration through a novel signaling cascade involving FAK, Rac-1, and NF-??B.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lin</LastName>
                    <ForeName>Ling</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Division of Nephrology, Department of Medicine, Penn State University College of Medicine, Hershey, Pennsylvania.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jin</LastName>
                    <ForeName>Yang</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Division of Pulmonary and Critical Care Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mars</LastName>
                    <ForeName>Wendy M</ForeName>
                    <Initials>WM</Initials>
                    <Affiliation>Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.</Affiliation>
                </Author>
                <Author>
                    <LastName>Reeves</LastName>
                    <ForeName>W Brian</ForeName>
                    <Initials>WB</Initials>
                    <Affiliation>Division of Nephrology, Department of Medicine, Penn State University College of Medicine, Hershey, Pennsylvania.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hu</LastName>
                    <ForeName>Kebin</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Division of Nephrology, Department of Medicine, Penn State University College of Medicine, Hershey, Pennsylvania. Electronic address: kebinhu@hmc.psu.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Am J Pathol</MedlineTA>
            <NlmUniqueID>0370502</NlmUniqueID>
            <ISSNLinking>0002-9440</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>12</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>13</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0002-9440(14)00368-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ajpath.2014.06.013</ArticleId>
            <ArticleId IdType="pubmed">25131752</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131750</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-5381</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>British journal of pharmacology</Title>
                <ISOAbbreviation>Br. J. Pharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>4-bromopropofol decreases action potential generation in spinal neurons by inducing a glycine receptor-mediated tonic conductance.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/bph.12880</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND AND PURPOSE" NlmCategory="OBJECTIVE">Impaired function of spinal strychnine-sensitive glycine receptors (GlyRs) gives rise to chronic pain states and movement disorders. Therefore drugs that enhance the activity of GlyRs are supposed to be useful for the therapy in these diseases. Unfortunately, pharmaceuticals that target GlyRs with a high selectivity are lacking. Recently, halogenated propofol analogues have been considered as potential candidates. Therefore we asked whether 4-bromopropofol attenuates the excitability of spinal neurons by promoting GlyR-dependent inhibition.</AbstractText>
                <AbstractText Label="EXPERIMENTAL APPROACH" NlmCategory="METHODS">The actions of sub-anaesthetic concentrations of propofol and 4-bromopropofol were investigated in spinal tissue cultures prepared from mice. Drug-induced alterations in action potential firing were monitored by extracellular multi-unit recordings. The effects on GABA(A)- and GlyR-mediated inhibition were quantified by whole-cell voltage-clamp recordings.</AbstractText>
                <AbstractText Label="KEY RESULTS" NlmCategory="RESULTS">Low concentrations of 4-bromopropofol (50 nM, n=31) significantly reduced action potential activity of ventral horn neurons by about 30% as compared to sham-treated slices (ANOVA, p&lt;0.01). This effect was completely abolished by strychnine (1 ??M, n=35). In voltage-clamped neurons, 4-bromopropofol activated GlyRs, thereby inducing a tonic current of 65??10 pA (mean??SEM, n=7, p&lt;0.01), while GABA(A)- and GlyR-mediated synaptic transmission remained unaffected.</AbstractText>
                <AbstractText Label="CONCLUSIONS AND IMPLICATIONS" NlmCategory="CONCLUSIONS">The highest glycine levels in the CNS were reported in the ventral horn of the spinal cord. This region mediates pain-induced motor reflexes and participates in the control of muscle tone. We conclude that 4-bromopropofol may serve as a starting point for the development of non-sedative non-addictive muscle relaxants and analgesics to be used in the therapy of patients suffering from low back pain.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Eckle</LastName>
                    <ForeName>V S</ForeName>
                    <Initials>VS</Initials>
                    <Affiliation>Experimental Anaesthesiology Section, Department of Anaesthesiology and Intensive Care, Eberhard-Karls-University, T??bingen, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Grasshoff</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Mirakaj</LastName>
                    <ForeName>V</ForeName>
                    <Initials>V</Initials>
                </Author>
                <Author>
                    <LastName>O'Neill</LastName>
                    <ForeName>P M</ForeName>
                    <Initials>PM</Initials>
                </Author>
                <Author>
                    <LastName>Berry</LastName>
                    <ForeName>N G</ForeName>
                    <Initials>NG</Initials>
                </Author>
                <Author>
                    <LastName>Leuwer</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Antkowiak</LastName>
                    <ForeName>B</ForeName>
                    <Initials>B</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Br J Pharmacol</MedlineTA>
            <NlmUniqueID>7502536</NlmUniqueID>
            <ISSNLinking>0007-1188</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bph.12880</ArticleId>
            <ArticleId IdType="pubmed">25131750</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131740</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Studies on recombinant glucokinase (r-glk) protein of Brucella abortus as a candidate vaccine molecule for brucellosis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0264-410X(14)01088-3</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.vaccine.2014.07.106</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Brucellosis is one of the most prevalent zoonotic diseases of worldwide distribution caused by the infection of genus Brucella. Live attenuated vaccines such as B. abortus S19, B. abortus RB51 and B. melitensis Rev1 are found most effective against brucellosis infection in animals, contriving a number of serious side effects and having chances to revert back into their active pathogenic form. In order to engineer a safe and effective vaccine candidate to be used in both animals and human, a recombinant subunit vaccine molecule comprising the truncated region of glucokinase (r-glk) gene from B. abortus S19 was cloned and expressed in Escherichia coli BL21DE3 host. Female BALB/c mice immunized with purified recombinant protein developed specific antibody titer of 1:64,000. The predominant IgG2a and IgG2b isotypes signified development of Th1 directed immune responses. In vitro cell cytotoxicity assay using anti-r-glk antibodies incubated with HeLa cells showed 81.20% and 78.5% cell viability against lethal challenge of B. abortus 544 and B. melitensis 16M, respectively. The lymphocyte proliferative assay indicated a higher splenic lymphocyte responses at 25??g/ml concentration of protein which implies the elevated development of memory immune responses. In contrast to control, the immunized group of mice intra-peritoneal (I.P.) challenged with B. abortus 544 were significantly protected with no signs of necrosis and vacuolization in their liver and spleen tissue. The elevated B-cell response associated with Th1 adopted immunity, significant in vitro cell viability as well as protection afforded in experimental animals after challenge, supplemented with histopathological analysis are suggestive of r-glk protein as a prospective candidate vaccine molecule against brucellosis.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Vrushabhendrappa</LastName>
                    <Affiliation>Division of Microbiology, Defence Food Research Laboratory, Siddartha Nagar, Mysore 570011, Karnataka, India.</Affiliation>
                </Author>
                <Author>
                    <LastName>Singh</LastName>
                    <ForeName>Amit Kumar</ForeName>
                    <Initials>AK</Initials>
                    <Affiliation>Division of Microbiology, Defence Food Research Laboratory, Siddartha Nagar, Mysore 570011, Karnataka, India.</Affiliation>
                </Author>
                <Author>
                    <LastName>Balakrishna</LastName>
                    <ForeName>Konduru</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Division of Microbiology, Defence Food Research Laboratory, Siddartha Nagar, Mysore 570011, Karnataka, India.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sripathy</LastName>
                    <ForeName>Murali Harishchandra</ForeName>
                    <Initials>MH</Initials>
                    <Affiliation>Division of Microbiology, Defence Food Research Laboratory, Siddartha Nagar, Mysore 570011, Karnataka, India.</Affiliation>
                </Author>
                <Author>
                    <LastName>Batra</LastName>
                    <ForeName>Harsh Vardhan</ForeName>
                    <Initials>HV</Initials>
                    <Affiliation>Division of Microbiology, Defence Food Research Laboratory, Siddartha Nagar, Mysore 570011, Karnataka, India. Electronic address: drharshvardhanbatra@gmail.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">B. abortus</Keyword>
            <Keyword MajorTopicYN="N">B. melitensis</Keyword>
            <Keyword MajorTopicYN="N">Brucellosis</Keyword>
            <Keyword MajorTopicYN="N">In vitro protection</Keyword>
            <Keyword MajorTopicYN="N">In vivo protection</Keyword>
            <Keyword MajorTopicYN="N">r-glk subunit vaccines</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0264-410X(14)01088-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2014.07.106</ArticleId>
            <ArticleId IdType="pubmed">25131740</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131738</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Chronic helminth infections impair pneumococcal vaccine responses.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0264-410X(14)01089-5</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.vaccine.2014.07.107</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Pneumonia is the leading killer of children and disproportionately affects developing countries. Vaccination campaigns against Streptococcus pneumoniae, the leading cause of pneumonia, have recently been launched with a new conjugate vaccine in Africa. Using a mouse model, we assessed the potential role that the high burden of helminth infections in the countries targeted for vaccine might have on vaccine effectiveness. Mice vaccinated with either commercial conjugate or purified polysaccharide vaccines had impaired antibody responses if they were chronically infected with Taenia crassiceps. This translated to increased susceptibility to pneumococcal pneumonia and high mortality compared to helminth-negative vaccinated animals, which were fully protected from disease and death. Antibodies taken from Taenia-infected, vaccinated mice were unable to effectively opsonize S. pneumoniae for killing by alveolar macrophages, and did not protect against pneumococcal challenge when adoptively transferred into na??ve animals. These data may have implications for vaccination programs in countries endemic with helminths.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Apiwattanakul</LastName>
                    <ForeName>Nopporn</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Infectious Diseases, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Thomas</LastName>
                    <ForeName>Paul G</ForeName>
                    <Initials>PG</Initials>
                    <Affiliation>Department of Immunology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Iverson</LastName>
                    <ForeName>Amy R</ForeName>
                    <Initials>AR</Initials>
                    <Affiliation>Department of Infectious Diseases, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>McCullers</LastName>
                    <ForeName>Jonathan A</ForeName>
                    <Initials>JA</Initials>
                    <Affiliation>Department of Infectious Diseases, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA; Department of Pediatrics, University of Tennessee Health Sciences Center, 50 North Dunlap Street, Memphis, TN 38103, USA. Electronic address: jmccullers@uthsc.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Helminths</Keyword>
            <Keyword MajorTopicYN="N">Pneumococcal vaccine</Keyword>
            <Keyword MajorTopicYN="N">Pneumonia</Keyword>
            <Keyword MajorTopicYN="N">Pneumovax</Keyword>
            <Keyword MajorTopicYN="N">Prevnar</Keyword>
            <Keyword MajorTopicYN="N">Streptococcus pneumoniae</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25131738</ArticleId>
            <ArticleId IdType="pii">S0264-410X(14)01089-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2014.07.107</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131731</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Activation of dendritic cell function by soypeptide lunasin as a novel vaccine adjuvant.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0264-410X(14)01085-8</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.vaccine.2014.07.103</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The addition of an appropriate adjuvant that activates the innate immunity is essential to subsequent development of the adaptive immunity specific to the vaccine antigens. Thus, any innovation capable of improving the immune responses may lead to a more efficacious vaccine. We recently identified a novel immune modulator using a naturally occurring seed peptide called lunasin. Lunasin was originally isolated from soybeans, and it is a small peptide containing 43 amino acids. Our studies revealed stimulatory effects of lunasin on innate immune cells by regulating expression of a number of genes that are important for immune responses. The objective was to define the effectiveness of lunasin as an adjuvant that enhances immune responses. The immune modulating functions of lunasin were characterized in dendritic cells (DCs) from human peripheral blood mononuclear cells (PBMCs). Lunasin-treated conventional DCs (cDCs) not only expressed elevated levels of co-stimulatory molecules (CD86, CD40) but also exhibited up-regulation of cytokines (IL1B, IL6) and chemokines (CCL3, CCL4). Lunasin-treated cDCs induced higher proliferation of allogeneic CD4+ T cells when comparing with medium control treatment in the mixed leukocyte reaction (MLR). Immunization of mice with ovalbumin (OVA) and lunasin inhibited the growth of OVA-expressing A20 B-lymphomas, which was correlated with OVA-specific CD8+ T cells. In addition, lunasin was an effective adjuvant for immunization with OVA, which together improved animal survival against lethal challenge with influenza virus expressing the MHC class I OVA peptide SIINFEKL (PR8-OTI). These results suggest that lunasin may function as a vaccine adjuvant by promoting DC maturation, which in turn enhances the development of protective immune responses to the vaccine antigens.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Tung</LastName>
                    <ForeName>Chun-Yu</ForeName>
                    <Initials>CY</Initials>
                    <Affiliation>Department of Biology, Indiana University-Purdue University Indianapolis School of Science, Indianapolis, IN, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lewis</LastName>
                    <ForeName>David E</ForeName>
                    <Initials>DE</Initials>
                    <Affiliation>Department of Biology, Indiana University-Purdue University Indianapolis School of Science, Indianapolis, IN, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Han</LastName>
                    <ForeName>Ling</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Biology, Indiana University-Purdue University Indianapolis School of Science, Indianapolis, IN, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jaja</LastName>
                    <ForeName>Morayo</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Biology, Indiana University-Purdue University Indianapolis School of Science, Indianapolis, IN, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yao</LastName>
                    <ForeName>Shuyu</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>HB Wells Center for Pediatric Research, Departments of Pediatrics and Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Fang</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Department of Mathematical Sciences, Indiana University-Purdue University Indianapolis School of Science, Indianapolis, IN, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Robertson</LastName>
                    <ForeName>Michael J</ForeName>
                    <Initials>MJ</Initials>
                    <Affiliation>Bone Marrow and Stem Cell Transplantation Program, Lymphoma Program, Division of Hematology/Oncology, Indiana University School of Medicine, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhou</LastName>
                    <ForeName>Baohua</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>HB Wells Center for Pediatric Research, Departments of Pediatrics and Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sun</LastName>
                    <ForeName>Jie</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>HB Wells Center for Pediatric Research, Departments of Pediatrics and Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chang</LastName>
                    <ForeName>Hua-Chen</ForeName>
                    <Initials>HC</Initials>
                    <Affiliation>Department of Biology, Indiana University-Purdue University Indianapolis School of Science, Indianapolis, IN, United States. Electronic address: huchang@iupui.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">DC maturation</Keyword>
            <Keyword MajorTopicYN="N">Immune modulating agent</Keyword>
            <Keyword MajorTopicYN="N">Lunasin</Keyword>
            <Keyword MajorTopicYN="N">Vaccine adjuvant</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25131731</ArticleId>
            <ArticleId IdType="pii">S0264-410X(14)01085-8</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2014.07.103</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131730</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>TLR7/8 agonists activate a mild immune response in rabbits through TLR8 but not TLR7.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0264-410X(14)01086-X</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.vaccine.2014.07.104</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Toll-like receptors 7 (TLR7) and 8 (TLR8) recognize viral single-stranded RNA and small molecular weight agonists to activate anti-viral immune responses. TLR8s from different species have distinct ligand recognitions. For example, human TLR8 is responsive to ligand stimulation, but mouse and rat TLR8 are activated by small molecular weight agonists only in the presence of polyT-oligodeoxynucleotides. TLR7 and TLR8 have been reported to be absent and pseudogenized, respectively, in rabbit (Oryctolagus cuniculus). In this study, we detected the expression of rabbit (rab)TLR8 in immune-cell-associated tissues. Cell proliferation and cytokine expressions in rabbit splenocytes were induced by the TLR7/8 ligand but not by the TLR7 ligands, suggesting that rabTLR8 is functional but rabTLR7 is not. In rabbits, CL075, a TLR7/8 ligand, activated an antigen-specific antibody response, although one not as potent as aluminum salt or Freund's adjuvant. Nevertheless, CL075, alone or in combination with aluminum salt, generates fewer adverse effects than Freund's adjuvant at the injection sites. To further investigate the activation of rabTLR8, we cloned its cDNA. In cell-based assay, this rabTLR8 is activated by TLR7/8 ligand but not activated by TLR7 ligand. Upon stimulation the rabTLR8 had a lower activation compared to the activation of TLR8 from other species, except the mouse and rat TLR8s. Using different deletion and human-rabbit chimeric TLR8 expressing constructs, we showed that an extra peptide in the undefined region results in reduced activity of rabTLR8. These results provide a molecular basis for the mild activities of TLR7/8 ligands in rabbits, and suggest TLR7/8 agonists may provide safer immune stimuli in rabbits than in other non-rodent species.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Lai</LastName>
                    <ForeName>Chao-Yang</ForeName>
                    <Initials>CY</Initials>
                    <Affiliation>Immunology Research Center, National Health Research Institutes, Miaoli 35053, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Yi-Ling</ForeName>
                    <Initials>YL</Initials>
                    <Affiliation>Immunology Research Center, National Health Research Institutes, Miaoli 35053, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yu</LastName>
                    <ForeName>Guann-Yi</ForeName>
                    <Initials>GY</Initials>
                    <Affiliation>National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes, Miaoli 35053, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Maa</LastName>
                    <ForeName>Ming-Chei</ForeName>
                    <Initials>MC</Initials>
                    <Affiliation>Graduate Institute of Basic Medical Science, China Medical University, Taichung 40402, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Leu</LastName>
                    <ForeName>Tzeng-Horng</ForeName>
                    <Initials>TH</Initials>
                    <Affiliation>Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Xu</LastName>
                    <ForeName>Congfeng</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Shanghai Institute of Immunology, Institutes of Medical Sciences, Shanghai Jiaotong University School of Medicine, Shanghai 200025, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Luo</LastName>
                    <ForeName>Yunping</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Immunology, School of Basic Medicine, Peking Union Medical College, Beijing 100005, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Xiang</LastName>
                    <ForeName>Rong</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>School of Medicine, University of Nankai, Tianjin 300071, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chuang</LastName>
                    <ForeName>Tsung-Hsien</ForeName>
                    <Initials>TH</Initials>
                    <Affiliation>Immunology Research Center, National Health Research Institutes, Miaoli 35053, Taiwan; Program in Environmental and Occupational Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan. Electronic address: thchuang@nhri.org.tw.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Adjuvant activity</Keyword>
            <Keyword MajorTopicYN="N">Innate immunity</Keyword>
            <Keyword MajorTopicYN="N">Pattern recognition receptor</Keyword>
            <Keyword MajorTopicYN="N">Species-specific recognition</Keyword>
            <Keyword MajorTopicYN="N">Toll-like receptor</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25131730</ArticleId>
            <ArticleId IdType="pii">S0264-410X(14)01086-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2014.07.104</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131728</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>25</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-2518</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Vaccine</Title>
                <ISOAbbreviation>Vaccine</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Characterization and immunogenicity in mice of recombinant influenza haemagglutinins produced in Leishmania tarentolae.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0264-410X(14)01074-3</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.vaccine.2014.07.092</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The membrane displayed antigen haemagglutinin (HA) from several influenza strains were expressed in the Leishmania tarentolae system. This non-conventional expression system based on a parasite of lizards, can be readily propagated to high cell density (&gt;10(8)cells/mL) in a simple incubator at 26??C. The genes encoding HA proteins were cloned from six influenza strains, among these being a 2009 A/H1N1 pandemic strain from swine origin, namely A/California/07/09(H1N1). Soluble HA proteins were secreted into the cell culture medium and were easily and successfully purified via a His-Tag domain fused to the proteins. The overall process could be conducted in less than 3 months and resulted in a yield of approximately 1.5-5mg of HA per liter of biofermenter culture after purification. The recombinant HA proteins expressed by L. tarentolae were characterized by dynamic light scattering and were observed to be mostly monomeric. The L. tarentolae recombinant HA proteins were immunogenic in mice at a dose of 10??g when administered twice with an oil-in-water emulsion-based adjuvant. These results suggest that the L. tarentolae expression system may be an alternative to the current egg-based vaccine production.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Pion</LastName>
                    <ForeName>Corinne</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Research and Development, Sanofi Pasteur, 1541 Avenue Marcel M??rieux, 69280 Marcy L'Etoile, France. Electronic address: corinne.pion@sanofipasteur.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Courtois</LastName>
                    <ForeName>Virginie</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>Department of Research and Development, Sanofi Pasteur, 1541 Avenue Marcel M??rieux, 69280 Marcy L'Etoile, France. Electronic address: virginie.courtois@sanofipasteur.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Husson</LastName>
                    <ForeName>St??phanie</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Research and Development, Sanofi Pasteur, 1541 Avenue Marcel M??rieux, 69280 Marcy L'Etoile, France. Electronic address: stephanie.husson@sanofipasteur.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Bernard</LastName>
                    <ForeName>Marie-Clotilde</ForeName>
                    <Initials>MC</Initials>
                    <Affiliation>Department of Research and Development, Sanofi Pasteur, 1541 Avenue Marcel M??rieux, 69280 Marcy L'Etoile, France. Electronic address: marie-clotilde.bernard@sanofipasteur.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nicolai</LastName>
                    <ForeName>Marie-Claire</ForeName>
                    <Initials>MC</Initials>
                    <Affiliation>Department of Research and Development, Sanofi Pasteur, 1541 Avenue Marcel M??rieux, 69280 Marcy L'Etoile, France. Electronic address: marie-claire.nicolai@sanofipasteur.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Talaga</LastName>
                    <ForeName>Philippe</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Research and Development, Sanofi Pasteur, 1541 Avenue Marcel M??rieux, 69280 Marcy L'Etoile, France. Electronic address: philippe.talaga@sanofipasteur.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Trannoy</LastName>
                    <ForeName>Emanuelle</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Department of Research and Development, Sanofi Pasteur, 1541 Avenue Marcel M??rieux, 69280 Marcy L'Etoile, France. Electronic address: emanuelle.trannoy@sanofipasteur.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Moste</LastName>
                    <ForeName>Catherine</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Research and Development, Sanofi Pasteur, 1541 Avenue Marcel M??rieux, 69280 Marcy L'Etoile, France. Electronic address: catherine.moste@sanofipasteur.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sodoyer</LastName>
                    <ForeName>R??gis</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Department of Research and Development, Sanofi Pasteur, 1541 Avenue Marcel M??rieux, 69280 Marcy L'Etoile, France; Technology Research Institute Bioaster, 317 Avenue Jean-Jaur??s, 69007 Lyon, France. Electronic address: regis.sodoyer@sanofipasteur.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Legastelois</LastName>
                    <ForeName>Isabelle</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Department of Research and Development, Sanofi Pasteur, 1541 Avenue Marcel M??rieux, 69280 Marcy L'Etoile, France. Electronic address: isabelle.legastelois@sanofipasteur.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Vaccine</MedlineTA>
            <NlmUniqueID>8406899</NlmUniqueID>
            <ISSNLinking>0264-410X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Haemagglutinin</Keyword>
            <Keyword MajorTopicYN="N">Influenza</Keyword>
            <Keyword MajorTopicYN="N">Leishmania tarentolae</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25131728</ArticleId>
            <ArticleId IdType="pii">S0264-410X(14)01074-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.vaccine.2014.07.092</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131712</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1462-5822</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cellular microbiology</Title>
                <ISOAbbreviation>Cell. Microbiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Withdrawal of skeletal muscle cells from cell cycle progression triggers differentiation of Toxoplasma gondii towards the bradyzoite stage.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/cmi.12342</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Toxoplasma gondii is a widespread intracellular parasite of mammals and birds and an important opportunistic pathogen of humans. Following primary infection, fast replicating tachyzoites disseminate within the host and are subsequently either eliminated by the immune system or transform to latent bradyzoites which preferentially persist in brain and muscle tissues. The factors which determine the parasites' tissue distribution during chronic toxoplasmosis are unknown. Here we show that mouse skeletal muscle cells (SkMCs) after differentiation to mature, myosin heavy chain-positive, polynucleated myotubes, significantly restrict tachyzoite replication and facilitate expression of bradyzoite-specific antigens and tissue cyst formation. In contrast, proliferating mononuclear myoblasts and control fibroblasts enable vigorous T. gondii replication but do not sustain bradyzoite or tissue cyst formation. Bradyzoite formation correlates with up-regulation of testis-specific Y-encoded-like protein-2 gene expression (Tspyl2) and p21(Waf1/Cip1) as well as down-regulation of cyclin B1 and absence of DNA synthesis, i.e. a cell cycle arrest of syncytial myotubes. Following infection with T. gondii, myotubes but not myoblasts or fibroblasts further up-regulate the negative cell cycle regulator Tspyl2. Importantly, RNA interference-mediated knockdown of Tspyl2 abrogates differentiation of SkMCs to myotubes and enables T. gondii to replicate vigorously but abolishes bradyzoite-specific gene expression and tissue cyst formation. Together, these data indicate that Tspyl2-mediated host cell cycle withdrawal is a physiological trigger of Toxoplasma stage conversion in mature SkMCs. This finding might explain the preferred distribution of T. gondii tissue cysts in vivo.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Swierzy</LastName>
                    <ForeName>Izabela J</ForeName>
                    <Initials>IJ</Initials>
                    <Affiliation>Institute for Medical Microbiology, University Medical Center, Georg-August-University, Kreuzbergring 57, D-37075 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>L??der</LastName>
                    <ForeName>Carsten G K</ForeName>
                    <Initials>CG</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Cell Microbiol</MedlineTA>
            <NlmUniqueID>100883691</NlmUniqueID>
            <ISSNLinking>1462-5814</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/cmi.12342</ArticleId>
            <ArticleId IdType="pubmed">25131712</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131706</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1365-2885</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>1</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of veterinary pharmacology and therapeutics</Title>
                <ISOAbbreviation>J. Vet. Pharmacol. Ther.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Brain penetration of emodepside is increased in P-glycoprotein-deficient mice and leads to neurotoxicosis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/jvp.12149</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The antiparasitic drug emodepside (EMO) is a substrate of the P-glycoprotein multidrug efflux carrier (P-gp; syn. MDR1, ABCB1), which has an important function in protecting the brain from potentially toxic compounds by functional drug efflux at the blood-brain barrier (BBB). Many dogs of the Collie breed and even dogs of many other breeds have a loss-of-function 4-bp deletion mutation in the MDR1 gene. In these dogs, brain penetration of many P-gp-transported drugs is increased and so their therapeutic usage is restricted. To elucidate the role of P-gp at the BBB for the brain penetration of EMO, we applied EMO at 1??mg/kg to mdr1-deficient (PGP(mut) ) and mdr1-intact (PGP(WT) ) CF1 mice. Whereas in the brain of the PGP(WT) mice, EMO was below the detection level of 10??ng/g, its concentration was at 43.7??ng/g in the PGP(mut) mice. Furthermore, appearance of neurological toxicity was analyzed in these mice after application of 1??mg/kg EMO using a rotarod setup. In all PGP(mut) mice, but not in the PGP(WT) mice, the walking performance on the rotarod was impaired by EMO with clear differences in the degree and duration of neurological toxicity. Some of the mice were completely unable to walk on the rotarod already at 2??h after drug application and showed long-lasting ataxia over &gt;24??h. Others even showed significantly reduced walking performance, but completely recovered within 1??day. In conclusion, P-gp restricts brain penetration of EMO and prevents neurological toxicity of this drug in mice.</AbstractText>
                <CopyrightInformation>?? 2014 John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Elmsh??user</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Institute of Pharmacology and Toxicology, Justus Liebig University of Giessen, Giessen, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Straehle</LastName>
                    <ForeName>L C</ForeName>
                    <Initials>LC</Initials>
                </Author>
                <Author>
                    <LastName>Kranz</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Krebber</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Geyer</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>1</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Vet Pharmacol Ther</MedlineTA>
            <NlmUniqueID>7910920</NlmUniqueID>
            <ISSNLinking>0140-7783</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>9</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>5</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jvp.12149</ArticleId>
            <ArticleId IdType="pubmed">25131706</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131692</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1097-4547</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>8</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of neuroscience research</Title>
                <ISOAbbreviation>J. Neurosci. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mutant disrupted-in-schizophrenia 1 in astrocytes: Focus on glutamate metabolism.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/jnr.23459</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Disrupted-in-schizophrenia 1 (DISC1) is a genetic risk factor that has been implicated in major mental disorders. DISC1 binds to and stabilizes serine racemase to regulate production of D-serine by astrocytes, contributing to glutamate (GLU) neurotransmission. However, the possible involvement of astrocytic DISC1 in synthesis, metabolism, reuptake, or secretion of GLU remains unexplored. Therefore, we studied the effects of dominant-negative mutant DISC1 on various aspects of GLU metabolism by using primary astrocyte cultures and hippocampal tissue from transgenic mice with astrocyte-restricted expression of mutant DISC1. Although mutant DISC1 had no significant effects on astrocyte proliferation, GLU reuptake, glutaminase, or glutamate carboxypeptidase II activity, expression of mutant DISC1 was associated with increased levels of alanine-serine-cysteine transporter 2, vesicular glutamate transporters 1 and 3 in primary astrocytes and in the hippocampus, and elevated expression of the NR1 subunit and diminished expression of the NR2A subunit of N-methyl-D-aspartate (NMDA) receptors in the hippocampus, at postnatal day 21. Our findings indicate that decreased D-serine production by astrocytic mutant DISC1 might lead to compensatory changes in levels of the amino acid transporters and NMDA receptors in the context of tripartite synapse. ?? 2014 Wiley Periodicals, Inc.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Abazyan</LastName>
                    <ForeName>Sofya</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Departments of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Eun Ju</ForeName>
                    <Initials>EJ</Initials>
                </Author>
                <Author>
                    <LastName>Abazyan</LastName>
                    <ForeName>Bagrat</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author>
                    <LastName>Xia</LastName>
                    <ForeName>Meng</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Chunxia</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Rojas</LastName>
                    <ForeName>Camilo</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Slusher</LastName>
                    <ForeName>Barbara</ForeName>
                    <Initials>B</Initials>
                </Author>
                <Author>
                    <LastName>Sattler</LastName>
                    <ForeName>Rita</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Pletnikov</LastName>
                    <ForeName>Mikhail</ForeName>
                    <Initials>M</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>8</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Neurosci Res</MedlineTA>
            <NlmUniqueID>7600111</NlmUniqueID>
            <ISSNLinking>0360-4012</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">ASCT2</Keyword>
            <Keyword MajorTopicYN="N">D-serine</Keyword>
            <Keyword MajorTopicYN="N">NMDA</Keyword>
            <Keyword MajorTopicYN="N">VGLUT</Keyword>
            <Keyword MajorTopicYN="N">glutamate uptake</Keyword>
            <Keyword MajorTopicYN="N">psychiatric disease</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jnr.23459</ArticleId>
            <ArticleId IdType="pubmed">25131692</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131673</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-0445</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Current biology : CB</Title>
                <ISOAbbreviation>Curr. Biol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Antibiotic Treatment Selects for Cooperative Virulence of Salmonella Typhimurium.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0960-9822(14)00854-9</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.cub.2014.07.028</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Antibiotics are powerful therapeutics but are not equally effective against all cells in bacterial populations. Bacteria that express an antibiotic-tolerant phenotype (&quot;persisters&quot;) can evade treatment [1]. Persisters can cause relapses of the infection after the end of the therapy [2]. It is still poorly understood whether persistence affects the evolution of bacterial virulence. During infections, persisters have been found preferentially at particular sites within the host [3, 4]. If bacterial virulence factors are required to reach such sites, treatment with antibiotics could impose selection on the expression of virulence genes, in addition to their well-established effects on bacterial resistance. Here, we report that treatment with antibiotics selects for virulence and fosters transmissibility of Salmonella Typhimurium. In a mouse model for Salmonella diarrhea, treatment with the broad-spectrum antibiotic ciprofloxacin reverses the outcome of competition between wild-type bacteria and avirulent mutants that can spontaneously arise during within-host evolution [5]. While avirulent mutants take over the gut lumen and abolish disease transmission in untreated mice, ciprofloxacin tilts the balance in favor of virulent, wild-type bacteria. This is explained by the need for virulence factors to invade gut tissues and form a persistent reservoir. Avirulent mutants remain in the gut lumen and are eradicated. Upon cessation of antibiotic treatment, tissue-lodged wild-type pathogens reseed the gut lumen and thereby facilitate disease transmissibility to new hosts. Our results suggest a general principle by which antibiotic treatment can promote cooperative virulence during within-host evolution, increase duration of transmissibility, and thereby enhance the spread of an infectious disease.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Diard</LastName>
                    <ForeName>M??d??ric</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Institute of Microbiology, ETH Zurich, 8093 Zurich, Switzerland. Electronic address: mederic.diard@micro.biol.ethz.ch.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sellin</LastName>
                    <ForeName>Mikael E</ForeName>
                    <Initials>ME</Initials>
                    <Affiliation>Institute of Microbiology, ETH Zurich, 8093 Zurich, Switzerland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dolowschiak</LastName>
                    <ForeName>Tamas</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Institute of Microbiology, ETH Zurich, 8093 Zurich, Switzerland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Arnoldini</LastName>
                    <ForeName>Markus</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Environmental Systems Science, ETH Zurich, 8092 Zurich, Switzerland; Department of Environmental Microbiology, Eawag, 8600 D??bendorf, Switzerland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ackermann</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Environmental Systems Science, ETH Zurich, 8092 Zurich, Switzerland; Department of Environmental Microbiology, Eawag, 8600 D??bendorf, Switzerland. Electronic address: martin.ackermann@env.ethz.ch.</Affiliation>
                </Author>
                <Author>
                    <LastName>Hardt</LastName>
                    <ForeName>Wolf-Dietrich</ForeName>
                    <Initials>WD</Initials>
                    <Affiliation>Institute of Microbiology, ETH Zurich, 8093 Zurich, Switzerland. Electronic address: hardt@micro.biol.ethz.ch.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Curr Biol</MedlineTA>
            <NlmUniqueID>9107782</NlmUniqueID>
            <ISSNLinking>0960-9822</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0960-9822(14)00854-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.cub.2014.07.028</ArticleId>
            <ArticleId IdType="pubmed">25131673</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131655</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1365-2990</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neuropathology and applied neurobiology</Title>
                <ISOAbbreviation>Neuropathol. Appl. Neurobiol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Membrane pathology and microglial activation of mice expressing membrane anchored or membrane released forms of A?? and mutated human APP.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/nan.12173</ELocationID>
            <Abstract>
                <AbstractText Label="AIMS" NlmCategory="OBJECTIVE">Alzheimer's disease and the transmissible spongiform encephalopathies or prion diseases accumulate misfolded and aggregated forms of neuronal cell membrane proteins. Distinctive membrane lesions caused by the accumulation of disease-associated prion protein (PrP(d) ) are found in prion disease but morphological changes of membranes are not associated with A?? in Alzheimer's disease. Membrane changes occur in all prion diseases where PrP(d) is attached to cell membranes by a glycosyl-phosphoinositol (GPI) anchor but are absent from transgenic mice expressing anchorless PrP(d) . Here we investigate whether GPI membrane attached A?? may also cause prion-like membrane lesions.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We used immunogold electron microscopy to determine the localization and pathology of A?? accumulation in groups of transgenic mice expressing anchored or unanchored forms of A?? or mutated human Alzheimer's precursor protein.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">GPI attached A?? did not replicate the membrane lesions of PrP(d) . However, as with PrP(d) in prion disease, A?? peptides derived from each transgenic mouse line initially accumulated on morphologically normal neurite membranes, elicited rapid glial recognition and neurite A?? was transferred to attenuated microglial and astrocytic processes.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">GPI attachment of misfolded membrane proteins is insufficient to cause prion-like membrane lesions. Prion disease and murine A?? amyloidosis both accumulate misfolded monomeric or oligomeric membrane proteins that are recognised by glial processes and acquire such misfolded proteins prior to their accumulation in the extracellular space. In contrast to prion disease where glial cells efficiently endocytose PrP(d) to endo-lysosomes, activated microglial cells in murine A?? amyloidosis are not as efficient phagocytes.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Jeffrey</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Animal Health and Veterinary Laboratories agency. Lasswade Laboratory, Pentlands Science Park, Bush Loan , Penicuik, Midlothian Scotland EH26 0PZ.</Affiliation>
                </Author>
                <Author>
                    <LastName>McGovern</LastName>
                    <ForeName>G</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Barron</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Baumann</LastName>
                    <ForeName>F</ForeName>
                    <Initials>F</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neuropathol Appl Neurobiol</MedlineTA>
            <NlmUniqueID>7609829</NlmUniqueID>
            <ISSNLinking>0305-1846</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">A??</Keyword>
            <Keyword MajorTopicYN="N">Mutant Alzheimer's Precursor Protein</Keyword>
            <Keyword MajorTopicYN="N">Prion disease</Keyword>
            <Keyword MajorTopicYN="N">glycosyl-phosphoinositol</Keyword>
            <Keyword MajorTopicYN="N">microglia</Keyword>
            <Keyword MajorTopicYN="N">protein misfolding</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/nan.12173</ArticleId>
            <ArticleId IdType="pubmed">25131655</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131640</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>20</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1090-2430</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Experimental neurology</Title>
                <ISOAbbreviation>Exp. Neurol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Epigenetics and sex differences in the brain: A genome-wide comparison of histone-3 lysine-4 trimethylation (H3K4me3) in male and female mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0014-4886(14)00258-1</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.expneurol.2014.08.006</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Many neurological and psychiatric disorders exhibit gender disparities, and sex differences in the brain likely explain some of these effects. Recent work in rodents points to a role for epigenetics in the development or maintenance of neural sex differences, although genome-wide studies have so far been lacking. Here we review the existing literature on epigenetics and brain sexual differentiation and present preliminary analyses on the genome-wide distribution of histone-3 lysine-4 trimethylation in a sexually dimorphic brain region in male and female mice. H3K4me3 is a histone mark primarily organized as 'peaks' surrounding the transcription start site of active genes. We microdissected the bed nucleus of the stria terminalis and preoptic area (BNST/POA) in adult male and female mice and used ChIP-Seq to compare the distribution of H3K4me3 throughout the genome. We found 248 genes and loci with a significant sex difference in H3K4me3. Of these, the majority (71%) had larger H3K4me3 peaks in females. Comparisons with existing databases indicate that genes and loci with increased H3K4me3 in females are associated with synaptic function and with expression atlases from related brain areas. Based on RT-PCR, only a minority of genes with a sex difference in H3K4me3 has detectable sex differences in expression at baseline conditions. Together with previous findings, our data suggest that there may be sex biases in the use of epigenetic marks. Such biases could underlie sex differences in vulnerabilities to drugs or diseases that disrupt specific epigenetic processes.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Shen</LastName>
                    <ForeName>Erica Y</ForeName>
                    <Initials>EY</Initials>
                    <Affiliation>Department of Psychiatry, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ahern</LastName>
                    <ForeName>Todd H</ForeName>
                    <Initials>TH</Initials>
                    <Affiliation>Center for Behavioral Neuroscience, Department of Psychology, Quinnipiac University, Hamden, CT 06518, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cheung</LastName>
                    <ForeName>Iris</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Brudnick Neuropsychiatric Research Institute, University of Massachusetts Medical School, Worcester, MA 01604, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Straubhaar</LastName>
                    <ForeName>Juerg</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Brudnick Neuropsychiatric Research Institute, University of Massachusetts Medical School, Worcester, MA 01604, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dincer</LastName>
                    <ForeName>Aslihan</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Genetics and Genomics Science, Icahn Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Houston</LastName>
                    <ForeName>Isaac</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Brudnick Neuropsychiatric Research Institute, University of Massachusetts Medical School, Worcester, MA 01604, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>de Vries</LastName>
                    <ForeName>Geert J</ForeName>
                    <Initials>GJ</Initials>
                    <Affiliation>Neuroscience Institute, Georgia State University, Atlanta, GA 30302, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Akbarian</LastName>
                    <ForeName>Schahram</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Psychiatry, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Department of Neuroscience, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA; Center for Behavioral Neuroscience, Department of Psychology, Quinnipiac University, Hamden, CT 06518, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Forger</LastName>
                    <ForeName>Nancy G</ForeName>
                    <Initials>NG</Initials>
                    <Affiliation>Neuroscience Institute, Georgia State University, Atlanta, GA 30302, USA. Electronic address: nforger@gsu.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Exp Neurol</MedlineTA>
            <NlmUniqueID>0370712</NlmUniqueID>
            <ISSNLinking>0014-4886</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Bed nucleus of the stria terminalis</Keyword>
            <Keyword MajorTopicYN="N">ChIP-Seq</Keyword>
            <Keyword MajorTopicYN="N">Histone</Keyword>
            <Keyword MajorTopicYN="N">Methylation</Keyword>
            <Keyword MajorTopicYN="N">Preoptic area</Keyword>
            <Keyword MajorTopicYN="N">Sex difference</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>5</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25131640</ArticleId>
            <ArticleId IdType="pii">S0014-4886(14)00258-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.expneurol.2014.08.006</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131634</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-9861</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of comparative neurology</Title>
                <ISOAbbreviation>J. Comp. Neurol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Expression profile analysis of vulnerable CA1 pyramidal neurons in young-middle aged Ts65Dn mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/cne.23663</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Down syndrome (DS) is the most prevalent cause of intellectual disability (ID). Individuals with DS show a variety of cognitive deficits, most notably in hippocampal learning and memory, and display pathological hallmarks of Alzheimer's disease (AD), with neurodegeneration of cholinergic basal forebrain (CBF) neurons. Elucidation of the molecular and cellular underpinnings of neuropathology has been assessed via gene expression analysis in a relevant animal model, termed the Ts65Dn mouse. The Ts65Dn mouse is a segmental trisomy model of DS which mimics DS/AD pathology, notably age-related cognitive dysfunction and degeneration of basal forebrain cholinergic neurons (BFCNs). To determine expression level changes, molecular fingerprinting of Cornu Ammonis 1 (CA1) pyramidal neurons was performed in adult (4-9 month old) Ts65Dn mice, at the initiation of BFCN degeneration. To quantitate transcriptomic changes during this early time period, laser capture microdissection (LCM), terminal continuation (TC) RNA amplification, custom-designed microarray analysis, and subsequent validation of individual transcripts by qPCR and protein analysis via immunoblotting was performed. Results indicate significant alterations within CA1 pyramidal neurons of Ts65Dn mice compared to normal disomic (2N) littermates, notably in the downregulation of neurotrophins and their cognate neurotrophin receptors among other classes of transcripts relevant to neurodegeneration. These results of this single population gene expression analysis at the time of septohippocampal deficits in a trisomic mouse model shed light on a vulnerable circuit that may cause the AD-like pathology invariably seen in DS that could help to identify mechanisms of degeneration, and provide novel gene targets for therapeutic interventions. J. Comp. Neurol., 2014. ?? 2014 Wiley Periodicals, Inc.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Wiley Periodicals, Inc., A Wiley Company.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Alldred</LastName>
                    <ForeName>Melissa J</ForeName>
                    <Initials>MJ</Initials>
                    <Affiliation>Center for Dementia Research, Nathan Kline Institute, Orangeburg, NY; Department of Psychiatry, New York University Langone Medical Center, New York, NY.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Sang Han</ForeName>
                    <Initials>SH</Initials>
                </Author>
                <Author>
                    <LastName>Petkova</LastName>
                    <ForeName>Eva</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Ginsberg</LastName>
                    <ForeName>Stephen D</ForeName>
                    <Initials>SD</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <GrantList>
                <Grant>
                    <GrantID>P01 AG014449</GrantID>
                    <Acronym>AG</Acronym>
                    <Agency>NIA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>P01 AG017617</GrantID>
                    <Acronym>AG</Acronym>
                    <Agency>NIA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 AG043375</GrantID>
                    <Acronym>AG</Acronym>
                    <Agency>NIA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Comp Neurol</MedlineTA>
            <NlmUniqueID>0406041</NlmUniqueID>
            <ISSNLinking>0021-9967</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Alzheimer's disease</Keyword>
            <Keyword MajorTopicYN="N">BDNF</Keyword>
            <Keyword MajorTopicYN="N">Down syndrome</Keyword>
            <Keyword MajorTopicYN="N">RRID:AB_2314574, AB_397508, AB_2154265, AB_630940, AB_477580, AB_477262</Keyword>
            <Keyword MajorTopicYN="N">RRID:IMSR_JAX:001924</Keyword>
            <Keyword MajorTopicYN="N">TrkB</Keyword>
            <Keyword MajorTopicYN="N">TrkC</Keyword>
            <Keyword MajorTopicYN="N">hippocampus</Keyword>
            <Keyword MajorTopicYN="N">laser capture microdissection</Keyword>
            <Keyword MajorTopicYN="N">microarray</Keyword>
            <Keyword MajorTopicYN="N">qPCR</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cne.23663</ArticleId>
            <ArticleId IdType="pubmed">25131634</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131623</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1476-5381</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>British journal of pharmacology</Title>
                <ISOAbbreviation>Br. J. Pharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Characterising pharmacological ligands to study the long chain fatty acid receptors GPR40/FFA1 and GPR120/FFA4.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/bph.12879</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The G protein-coupled receptors FFA1 (previously designated GPR40) and FFA4 (previously GPR120) are both activated by saturated and unsaturated longer-chain free fatty acids. With expression patterns and functions anticipated to directly or indirectly promote insulin secretion, provide homeostatic control of blood glucose and improve tissue insulin sensitivity, both receptors are being studied as potential therapeutic targets for the control of type II diabetes. Furthermore, genetic and systems biology studies in both humans and mouse models link FFA4 to diabetes and obesity. Although activated by the same group of free fatty acids, FFA1 and FFA4 are not closely related and whilst the basis of recognition of fatty acids by FFA1 is similar to that of the short-chain fatty acid receptors FFA2 and FFA3, amino acid residues involved in endogenous ligand recognition by FFA4 are more akin to those of the sphingosine 1 phosphate receptor S1P1 . Screening and subsequent medicinal chemistry programmes have developed a number of FFA1 selective agonists that are effective in promoting insulin secretion in a glucose concentration-dependent manner, and in lowering blood glucose levels. However, the recent termination of phase III clinical trials employing TAK-875/Fasiglifam has caused a setback and raises important questions over the exact nature and mechanistic causes of the problems. Progress in the identification and development of highly FFA4-selective pharmacological tools has been less rapid and several issues remain to be clarified to fully validate this receptor as a therapeutic target. Despite this the ongoing development of a range of novel ligands offers great opportunities to further unravel the contributions of these receptors.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Milligan</LastName>
                    <ForeName>G</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Molecular Pharmacology Group, Institute of Molecular, Cell and Systems Biology, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8QQ, Scotland, U.K.</Affiliation>
                </Author>
                <Author>
                    <LastName>Alvarez-Curto</LastName>
                    <ForeName>E</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Watterson</LastName>
                    <ForeName>K R</ForeName>
                    <Initials>KR</Initials>
                </Author>
                <Author>
                    <LastName>Ulven</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Hudson</LastName>
                    <ForeName>B D</ForeName>
                    <Initials>BD</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Br J Pharmacol</MedlineTA>
            <NlmUniqueID>7502536</NlmUniqueID>
            <ISSNLinking>0007-1188</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bph.12879</ArticleId>
            <ArticleId IdType="pubmed">25131623</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131612</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-1063</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Hippocampus</Title>
                <ISOAbbreviation>Hippocampus</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Blockade of 2-arachidonoylglycerol hydrolysis produces antidepressant-like effects and enhances adult hippocampal neurogenesis and synaptic plasticity.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/hipo.22344</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The endocannabinoid ligand 2-arachidonoylglycerol (2-AG) is inactivated primarily by monoacylglycerol lipase (MAGL). We have shown recently that chronic treatments with MAGL inhibitor JZL184 produce antidepressant- and anxiolytic-like effects in a chronic unpredictable stress (CUS) model of depression in mice. However, the underlying mechanisms remain poorly understood. Adult hippocampal neurogenesis has been implicated in animal models of anxiety and depression and behavioral effects of antidepressants. We tested whether CUS and chronic JZL184 treatments affected adult neurogenesis and synaptic plasticity in the dentate gyrus (DG) of mouse hippocampus. We report that CUS induced depressive-like behaviors and decreased the number of bromodeoxyuridine (BrdU)-labeled neural progenitor cells and doublecortin-positive immature neurons in the DG, while chronic JZL184 treatments prevented these behavioral and cellular deficits. We also investigated the effects of CUS and chronic JZL184 on a form long-term potentiation (LTP) in the DG known to be neurogenesis-dependent. CUS impaired LTP induction, whereas chronic JZL184 treatments restored LTP in CUS-exposed mice. These results suggest that enhanced adult neurogenesis and long-term synaptic plasticity in the DG of the hippocampus might contribute to antidepressant- and anxiolytic-like behavioral effects of JZL184. ?? 2014 Wiley Periodicals, Inc.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Wiley Periodicals, Inc., a Wiley company.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Zhen</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Department of Pharmacology and Toxicology, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA; Department of Geriatrics, Qi-Lu Hospital of Shandong University, Key Laboratory of Proteomics of Shandong Province, Jinan Shandong, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                </Author>
                <Author>
                    <LastName>Zhong</LastName>
                    <ForeName>Peng</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Sarah J</ForeName>
                    <Initials>SJ</Initials>
                </Author>
                <Author>
                    <LastName>Long</LastName>
                    <ForeName>Jonathan Z</ForeName>
                    <Initials>JZ</Initials>
                </Author>
                <Author>
                    <LastName>Cravatt</LastName>
                    <ForeName>Benjamin F</ForeName>
                    <Initials>BF</Initials>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Qing-Song</ForeName>
                    <Initials>QS</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Hippocampus</MedlineTA>
            <NlmUniqueID>9108167</NlmUniqueID>
            <ISSNLinking>1050-9631</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">CB1 receptor</Keyword>
            <Keyword MajorTopicYN="N">chronic unpredictable stress</Keyword>
            <Keyword MajorTopicYN="N">depression</Keyword>
            <Keyword MajorTopicYN="N">endocannabinoid</Keyword>
            <Keyword MajorTopicYN="N">neurogenesis</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>5</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hipo.22344</ArticleId>
            <ArticleId IdType="pubmed">25131612</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131582</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-2744</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>17</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Molecular carcinogenesis</Title>
                <ISOAbbreviation>Mol. Carcinog.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Genetic analysis of colon tumors induced by a dietary carcinogen PhIP in CYP1A humanized mice: Identification of mutation of ??-catenin/Ctnnb1 as the driver gene for the carcinogenesis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/mc.22199</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Replacing mouse Cyp1a with human CYP1A enables the humanized CYP1A mice to mimic human metabolism of the dietary carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), by N(2) -hydroxylation to a proximate carcinogen. Our previous study demonstrated that PhIP, combined with the dextrin sulfate sodium (DSS)-induced colitis, induces colon carcinogenesis in hCYP1A mice. Here, we employed whole exome sequencing and found multiple gene mutations in PhIP/DSS-induced colon tumors. Mutations in the exon 3 of Ctnnb1/??-catenin, however, were the predominant events. We further sequenced the key fragments of Apc, Ctnnb1, and Kras, because mutations of these genes in the humans are commonly found as the drivers of colorectal cancer. Mutations on either codon 32 or 34 in the exon 3 of Ctnnb1 were found in 39 out of 42 tumors, but no mutation was found in either Apc or Kras. The sequence context of codons 32 and 34 suggests that PhIP targets +3G in a TGGA motif of Ctnnb1. Since mutations that activate Wnt signal is a major driving force for human colorectal cancers, we conclude that the mutated ??-catenin is the driver in PhIP/DSS-induced colon carcinogenesis. This result suggests that the colon tumors in hCYP1A mice mimic human colorectal carcinogenesis not only in the dietary etiology involving PhIP, but also in the aberrant activation of the Wnt signaling pathway as the driving force. ?? 2014 Wiley Periodicals, Inc.</AbstractText>
                <CopyrightInformation>?? 2014 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Hong</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Susan L. Cullman Laboratory for Cancer Research, Department of Chemical Biology and Center for Cancer Prevention Research, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, New Jersey.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhou</LastName>
                    <ForeName>Hong</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Guo</LastName>
                    <ForeName>Xiangyi</ForeName>
                    <Initials>X</Initials>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Chung S</ForeName>
                    <Initials>CS</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <GrantList>
                <Grant>
                    <GrantID>R01 CA120915</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 CA122474</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 CA133021</GrantID>
                    <Acronym>CA</Acronym>
                    <Agency>NCI NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Mol Carcinog</MedlineTA>
            <NlmUniqueID>8811105</NlmUniqueID>
            <ISSNLinking>0899-1987</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">carcinogenesis</Keyword>
            <Keyword MajorTopicYN="N">colorectal cancer</Keyword>
            <Keyword MajorTopicYN="N">driver mutation</Keyword>
            <Keyword MajorTopicYN="N">exon sequencing</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mc.22199</ArticleId>
            <ArticleId IdType="pubmed">25131582</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131562</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1460-9568</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The European journal of neuroscience</Title>
                <ISOAbbreviation>Eur. J. Neurosci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Cannabinoid modulation of alpha2 adrenergic receptor function in rodent medial prefrontal cortex.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/ejn.12690</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Endocannabinoids acting at the cannabinoid type 1 receptor (CB1R) are known to regulate attention, cognition and mood. Previous studies have shown that, in the rat medial prefrontal cortex (mPFC), CB1R agonists increase norepinephrine release, an effect that may be attributed, in part, to CB1Rs localised to noradrenergic axon terminals. The present study was aimed at further characterising functional interactions between CB1R and adrenergic receptor (AR) systems in the mPFC using in vitro intracellular electrophysiology and high-resolution neuroanatomical techniques. Whole-cell patch-clamp recordings of layer V/VI cortical pyramidal neurons in rats revealed that both acute and chronic treatment with the synthetic CB1R agonist WIN 55,212-2 blocked elevations in cortical pyramidal cell excitability and increases in input resistance evoked by the ??2-adrenergic receptor (??2-AR) agonist clonidine, suggesting a desensitisation of ??2-ARs. These CB1R-??2-AR interactions were further shown to be both action potential- and gamma-aminobutyric acid-independent. To better define sites of cannabinoid-AR interactions, we localised ??2A-adrenergic receptors (??2A-ARs) in a genetically modified mouse that expressed a hemoagglutinin (HA) tag downstream of the ??2A-AR promoter. Light and electron microscopy indicated that HA-??2A-AR was distributed in axon terminals and somatodendritic processes especially in layer V of the mPFC. Triple-labeling immunocytochemistry revealed that ??2A-AR and CB1R were localised to processes that contained dopamine-??-hydroxylase, a marker of norepinephrine. Furthermore, HA-??2A-AR was localised to processes that were directly apposed to CB1R. These findings suggest multiple sites of interaction between cortical cannabinoid-adrenergic systems that may contribute to understanding the effect of cannabinoids on executive functions and mood.</AbstractText>
                <CopyrightInformation>?? 2014 Federation of European Neuroscience Societies and John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Cathel</LastName>
                    <ForeName>Alessandra M</ForeName>
                    <Initials>AM</Initials>
                    <Affiliation>Department of Anatomy and Cell Biology, Center for Substance Abuse Research, Temple University School of Medicine, 3500??N. Broad Street, Philadelphia, PA, 19140, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Reyes</LastName>
                    <ForeName>Beverly A S</ForeName>
                    <Initials>BA</Initials>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Qin</ForeName>
                    <Initials>Q</Initials>
                </Author>
                <Author>
                    <LastName>Palma</LastName>
                    <ForeName>Jonathan</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Mackie</LastName>
                    <ForeName>Kenneth</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Van Bockstaele</LastName>
                    <ForeName>Elisabeth J</ForeName>
                    <Initials>EJ</Initials>
                </Author>
                <Author>
                    <LastName>Kirby</LastName>
                    <ForeName>Lynn G</ForeName>
                    <Initials>LG</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Eur J Neurosci</MedlineTA>
            <NlmUniqueID>8918110</NlmUniqueID>
            <ISSNLinking>0953-816X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">electron microscopy</Keyword>
            <Keyword MajorTopicYN="N">electrophysiology</Keyword>
            <Keyword MajorTopicYN="N">immunohistochemistry</Keyword>
            <Keyword MajorTopicYN="N">mouse</Keyword>
            <Keyword MajorTopicYN="N">rat</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ejn.12690</ArticleId>
            <ArticleId IdType="pubmed">25131562</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131522</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2042-7158</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of pharmacy and pharmacology</Title>
                <ISOAbbreviation>J. Pharm. Pharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Novel tricyclic[2,1-f]theophylline derivatives of LCAP with activity in mouse models of affective disorders.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/jphp.12305</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The purpose of this study was to investigate the central activity of the two new imidazo[2,1-f]purine-2,4-dione derivatives behaved as presynaptic 5HT1A receptor agonists and postsynaptic 5HT1A , 5HT2A and D2 receptors antagonists. The compounds were examined using animal tests towards antipsychotic, antidepressant- and anxiolytic-like properties and then compared with effects evoked by an atypical antipsychotic drug ziprasidone.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">D-amphetamine-induced hyperactivity test was used to determine antipsychotic-like activity of compounds 7 and 9. The forced swim test (FST) and the four-plate test were conducted to investigate antidepressant- and antianxiety-like activity, respectively, of studied agents. The investigated compounds 7, 9 and ziprasidone were administered intraperitoneally 60???min before the tests. Diazepam and imipramine were used as standard anxiolytic and antidepressant drugs, respectively.</AbstractText>
                <AbstractText Label="KEY FINDINGS" NlmCategory="RESULTS">The obtained results demonstrate that new synthesized compound 9 evokes antipsychotic-like activity alike ziprasidone and, in contrary to the antipsychotic drug, shows antidepressant- and anxiolytic-like properties in behavioural tests in mice.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The present preclinical results indicate that one of the two investigated imidazo[2,1-f]purine-2,4-dione derivatives, compound 9, with methyl group at 7 position of imidazo[2,1-f]purine-2,4-dione fragment and the ortho-OCH3 substituent in the aryl moiety, acts as an antipsychotic drug with additional antidepressant and anxiolytic properties.</AbstractText>
                <CopyrightInformation>?? 2014 Royal Pharmaceutical Society.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Partyka</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Clinical Pharmacy, Jagiellonian University Medical College, Krak??w, Poland.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jarosz</LastName>
                    <ForeName>Jakub</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Wasik</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Jastrz??bska-Wi??sek</LastName>
                    <ForeName>Magdalena</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Zag??rska</LastName>
                    <ForeName>Agnieszka</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Paw??owski</LastName>
                    <ForeName>Maciej</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Weso??owska</LastName>
                    <ForeName>Anna</ForeName>
                    <Initials>A</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Pharm Pharmacol</MedlineTA>
            <NlmUniqueID>0376363</NlmUniqueID>
            <ISSNLinking>0022-3573</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">antidepressant-like activity</Keyword>
            <Keyword MajorTopicYN="N">axiolytic-like activity</Keyword>
            <Keyword MajorTopicYN="N">imidazo[2,1-f]theophylline</Keyword>
            <Keyword MajorTopicYN="N">ziprasidone</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jphp.12305</ArticleId>
            <ArticleId IdType="pubmed">25131522</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131507</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-7549</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Behavioural brain research</Title>
                <ISOAbbreviation>Behav. Brain Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Regulation of object recognition and object placement by ovarian sex steroid hormones.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0166-4328(14)00512-9</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.bbr.2014.08.001</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The ovarian hormones 17??-estradiol (E2) and progesterone (P4) are potent modulators of hippocampal memory formation. Both hormones have been demonstrated to enhance hippocampal memory by regulating the cellular and molecular mechanisms thought to underlie memory formation. Behavioral neuroendocrinologists have increasingly used the object recognition and object placement (object location) tasks to investigate the role of E2 and P4 in regulating hippocampal memory formation in rodents. These one-trial learning tasks are ideal for studying acute effects of hormone treatments on different phases of memory because they can be administered during acquisition (pre-training), consolidation (post-training), or retrieval (pre-testing). This review synthesizes the rodent literature testing the effects of E2 and P4 on object recognition (OR) and object placement (OP), and the molecular mechanisms in the hippocampus supporting memory formation in these tasks. Some general trends emerge from the data. Among gonadally intact females, object memory tends to be best when E2 and P4 levels are elevated during the estrous cycle, pregnancy, and in middle age. In ovariectomized females, E2 given before or immediately after testing generally enhances OR and OP in young and middle-aged rats and mice, although effects are mixed in aged rodents. Effects of E2 treatment on OR and OP memory consolidation can be mediated by both classical estrogen receptors (ER?? and ER??), and depend on glutamate receptors (NMDA, mGluR1) and activation of numerous cell signaling cascades (e.g., ERK, PI3K/Akt, mTOR) and epigenetic processes (e.g., histone H3 acetylation, DNA methylation). Acute P4 treatment given immediately after training also enhances OR and OP in young and middle-aged ovariectomized females by activating similar cell signaling pathways as E2 (e.g., ERK, mTOR). The few studies that have administered both hormones in combination suggest that treatment can enhance OR and OP, but that effects are highly dependent on factors such as dose and timing of administration. In addition to providing more detail on these general conclusions, this review will discuss directions for future avenues of research into the hormonal regulation of object memory.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Tuscher</LastName>
                    <ForeName>Jennifer J</ForeName>
                    <Initials>JJ</Initials>
                    <Affiliation>Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Fortress</LastName>
                    <ForeName>Ashley M</ForeName>
                    <Initials>AM</Initials>
                    <Affiliation>Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kim</LastName>
                    <ForeName>Jaekyoon</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Frick</LastName>
                    <ForeName>Karyn M</ForeName>
                    <Initials>KM</Initials>
                    <Affiliation>Department of Psychology, University of Wisconsin-Milwaukee, Milwaukee, WI 53211, United States. Electronic address: frickk@uwm.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Behav Brain Res</MedlineTA>
            <NlmUniqueID>8004872</NlmUniqueID>
            <ISSNLinking>0166-4328</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Estradiol</Keyword>
            <Keyword MajorTopicYN="N">Hippocampus</Keyword>
            <Keyword MajorTopicYN="N">Mouse</Keyword>
            <Keyword MajorTopicYN="N">Object location</Keyword>
            <Keyword MajorTopicYN="N">Progesterone</Keyword>
            <Keyword MajorTopicYN="N">Rat</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25131507</ArticleId>
            <ArticleId IdType="pii">S0166-4328(14)00512-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbr.2014.08.001</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131506</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-7549</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Behavioural brain research</Title>
                <ISOAbbreviation>Behav. Brain Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The effects of curcumin on depressive-like behavior in mice after lipopolysaccharide administration.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0166-4328(14)00530-0</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.bbr.2014.08.018</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Current evidence supports that inflammation and increased cytokine levels are associated with depression-like symptoms and neuropsychological disturbances in humans. Curcumin has anti-inflammatory, antioxidant and anti-depressant-like properties. Here, we examined the effects of curcumin on lipopolysaccharide (LPS)-induced depressive-like behavior and inflammation in male mice. A single administration of LPS (0.83mg/kg, i.p.) increased the immobility time in the forced swimming test (FST) and tail suspension test (TST), reduced sucrose consumption without affecting spontaneous locomotor activity. Pretreatment with curcumin (50mg/kg, i.p.) for 7 consecutive days reversed LPS-induced alterations in the FST, TST, and sucrose preference test. Moreover, pre-treatment with curcumin attenuated LPS-induced microglial activation and overproduction of pro-inflammatory cytokine (interleukin-1?? and tumor necrosis factor-??), as well as the levels of inducible nitric oxide synthase and cyclooxygenase-2 mRNA in the hippocampus and prefrontal cortex (PFC). In addition, curcumin ameliorated LPS-induced NF-??B activation in the hippocampus and PFC. The results demonstrate that curcumin may be an effective therapeutic agent for LPS-induced depressive-like behavior, partially due to its anti-inflammatory aptitude.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Zhen</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Department of Physiology, Shandong University School of Medicine, 44#, Wenhua Xi Road, Jinan, Shandong 250012, PR China; Key Laboratory of the Ministry of Education for Experimental Teratology, Shandong Provincial Key Laboratory of Mental Disorders, Department of Histology and Embryology, Shandong University School of Medicine, 44#, Wenhua Xi Road, Jinan, Shandong 250012, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Qingrui</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>Department of Physiology, Shandong University School of Medicine, 44#, Wenhua Xi Road, Jinan, Shandong 250012, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yuan</LastName>
                    <ForeName>Lin</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Physiology, Shandong University School of Medicine, 44#, Wenhua Xi Road, Jinan, Shandong 250012, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Shuanglian</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of Physiology, Shandong University School of Medicine, 44#, Wenhua Xi Road, Jinan, Shandong 250012, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Liwei</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Key Laboratory of the Ministry of Education for Experimental Teratology, Shandong Provincial Key Laboratory of Mental Disorders, Department of Histology and Embryology, Shandong University School of Medicine, 44#, Wenhua Xi Road, Jinan, Shandong 250012, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Xudong</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Physiology, Shandong University School of Medicine, 44#, Wenhua Xi Road, Jinan, Shandong 250012, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Li</LastName>
                    <ForeName>Gang</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Neurosurgery Department, Qilu Hospital, Shandong University, Wenhua Xi Road, Jinan, Shandong Province 250012, PR China. Electronic address: doctorligang@126.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Dexiang</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Medical Psychology, Shandong University School of Medicine, 44#, Wenhua Xi Road, Jinan, Shandong 250012, PR China. Electronic address: liudexiang@sdu.edu.cn.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Behav Brain Res</MedlineTA>
            <NlmUniqueID>8004872</NlmUniqueID>
            <ISSNLinking>0166-4328</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Curcumin</Keyword>
            <Keyword MajorTopicYN="N">Depression</Keyword>
            <Keyword MajorTopicYN="N">Lipopolysaccharide</Keyword>
            <Keyword MajorTopicYN="N">NF-??B</Keyword>
            <Keyword MajorTopicYN="N">Pro-inflammatory cytokines</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25131506</ArticleId>
            <ArticleId IdType="pii">S0166-4328(14)00530-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.bbr.2014.08.018</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131439</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1552-4965</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>7</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of biomedical materials research. Part A</Title>
                <ISOAbbreviation>J Biomed Mater Res A</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The effect of calcium phosphate composite scaffolds on the osteogenic differentiation of rabbit dental pulp stem cells.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/jbm.a.35303</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The objective of this study is to compare the effects of the two calcium phosphate composite scaffolds on the attachment, proliferation and osteogenic differentiation of rabbit dental pulp stem cells (DPSCs). One nano-hydroxyapatite/collagen/poly (L-lactide) (nHAC/PLA), imitating the composition and the micro-structure characteristics of the natural bone, was made by Beijing Allgens Medical Science &amp; Technology Co., Ltd. (China). The other beta-tricalcium phosphate (??-TCP), being fully interoperability globular pore structure, was provided by Shanghai Bio-lu Biomaterials Co, Ltd. (China). We compared the absorption water rate and the protein adsorption rate of two scaffolds and the characterization of DPSCs cultured on the culture plate and both scaffolds under osteogenic differentiation media (ODM) treatment. The constructs were then implanted subcutaneously into the back of severely combined immunodeficient (SCID) mice for 8 and 12 weeks to compare their bone formation capacity. The results showed that the ODM-treated DPSCs expressed osteocalcin (OCN), bone sialoprotein (BSP), type I collagen (COLI) and osteopontin (OPN) by immunofluorescence staining. Positive alkaline phosphatase (ALP) staining, calcium deposition and calcium nodules were also observed on the ODM-treated DPSCs. The absorption water rate and protein adsorption rate of nHAC/PLA was significantly higher than ??-TCP. The initial attachment of DPSCs seeded onto nHAC/PLA was significantly higher than that onto ??-TCP; and the proliferation rate of the cells was also significantly higher than that of ??-TCP on 1, 3 and 7 days of cell culture. The ALP activity, calcium/phosphorus content and mineral formation of DPSCs+??-TCP were significantly higher than DPSCs+nHAC/PLA. When implanted into the back of SCID mice, nHAC/PLA alone had no new bone formation, newly formed mature bone and osteoid were only observed in ??-TCP alone, DPSCs+nHAC/PLA and DPSCs+??-TCP, and this three groups displayed increased bone formation over the 12-week period. The percentage of total bone formation area had no difference between DPSCs+??-TCP and DPSCs+nHAC/PLA at each time point , but the percentage of mature bone formation area of DPSCs+??-TCP was significantly higher than that of DPSCs+nHAC/PLA. Our results demonstrated that the DPSCs on nHAC/PLA had a better proliferation, and that the DPSCs on ??-TCP had a more mineralization in vitro, much more newly formed mature bones in vivo were presented in DPSCs+??-TCP group. These findings have provided a further knowledge that scaffold architecture has different influence on the attachment, proliferation and differentiation of cells. This study may provide insight into the clinical periodontal bone tissue repair with DPSCs+??-TCP construct.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Wiley Periodicals, Inc., A Wiley Company.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>E</LastName>
                    <ForeName>Ling-Ling</ForeName>
                    <Initials>LL</Initials>
                    <Affiliation>Institute of Stomatology, Chinese PLA General Hospital, Fuxing Lu 28#, Beijing, 100853, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Feng</LastName>
                    <ForeName>Lin</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Hong-Chen</ForeName>
                    <Initials>HC</Initials>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Dong-Sheng</ForeName>
                    <Initials>DS</Initials>
                </Author>
                <Author>
                    <LastName>Shi</LastName>
                    <ForeName>Zhan-Ping</ForeName>
                    <Initials>ZP</Initials>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Jun-Cheng</ForeName>
                    <Initials>JC</Initials>
                </Author>
                <Author>
                    <LastName>Luo</LastName>
                    <ForeName>Wei</ForeName>
                    <Initials>W</Initials>
                </Author>
                <Author>
                    <LastName>Yan</LastName>
                    <ForeName>Lv</ForeName>
                    <Initials>L</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Biomed Mater Res A</MedlineTA>
            <NlmUniqueID>101234237</NlmUniqueID>
            <ISSNLinking>1549-3296</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">beta-tricalcium phosphate</Keyword>
            <Keyword MajorTopicYN="N">bone regeneration</Keyword>
            <Keyword MajorTopicYN="N">dental pulp stem cells</Keyword>
            <Keyword MajorTopicYN="N">nano-hydroxyapatite/collagen/poly(L-lactide)</Keyword>
            <Keyword MajorTopicYN="N">periodontal tissue engineering</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jbm.a.35303</ArticleId>
            <ArticleId IdType="pubmed">25131439</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131412</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1460-9568</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The European journal of neuroscience</Title>
                <ISOAbbreviation>Eur. J. Neurosci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Lesions to the CA2 region of the hippocampus impair social memory in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/ejn.12689</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The function of the CA2 region of the hippocampus is poorly understood. Although the CA1 and CA3 regions have been extensively studied, for years the CA2 region has primarily been viewed as a linking area between the two. However, the CA2 region is known to have distinct neurochemical and structural features that are different from the other parts of the hippocampus and in recent years it has been suggested that the CA2 region may play a role in the formation and/or recall of olfactory-based memories needed for normal social behavior. Although this hypothesis has been supported by hippocampal lesion studies that have included the CA2 region, no studies have attempted to specifically lesion the CA2 region of the hippocampus in mice to determine the effects on social recognition memory and olfaction. To fill this knowledge gap, we sought to perform excitotoxic N-methyl-D-aspartate lesions of the CA2 region and determine the effects on social recognition memory. We predicted that lesions of the CA2 region would impair social recognition memory. We then went on to test olfaction in CA2-lesioned mice, as social memory requires a functional olfactory system. Consistent with our prediction, we found that CA2-lesioned animals had impaired social recognition. These findings are significant because they confirmed that the CA2 region of the hippocampus is a part of the neural circuitry that regulates social recognition memory, which may have implications for our understanding of the neural regulation of social behavior across species.</AbstractText>
                <CopyrightInformation>?? 2014 Federation of European Neuroscience Societies and John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Stevenson</LastName>
                    <ForeName>Erica L</ForeName>
                    <Initials>EL</Initials>
                    <Affiliation>Laboratory of Neuroendocrinology and Behavior, Department of Biological Sciences and the School of Biomedical Sciences, Kent State University, 121 Cunningham Hall, Kent, OH, 44242, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Caldwell</LastName>
                    <ForeName>Heather K</ForeName>
                    <Initials>HK</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <GrantList>
                <Grant>
                    <GrantID>R21 MH083963</GrantID>
                    <Acronym>MH</Acronym>
                    <Agency>NIMH NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Eur J Neurosci</MedlineTA>
            <NlmUniqueID>8918110</NlmUniqueID>
            <ISSNLinking>0953-816X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">behavior</Keyword>
            <Keyword MajorTopicYN="N">excitotoxic</Keyword>
            <Keyword MajorTopicYN="N">olfaction</Keyword>
            <Keyword MajorTopicYN="N">social recognition</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ejn.12689</ArticleId>
            <ArticleId IdType="pubmed">25131412</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131394</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1542-0760</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>8</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Birth defects research. Part A, Clinical and molecular teratology</Title>
                <ISOAbbreviation>Birth Defects Res. Part A Clin. Mol. Teratol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Heterozygous FGF8 mutations in patients presenting cryptorchidism and multiple VATER/VACTERL features without limb anomalies.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/bdra.23278</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The acronym VATER/VACTERL association describes the combination of at least three of the following cardinal features: vertebral defects, anorectal malformations, cardiac defects, tracheoesophageal fistula with or without esophageal atresia, renal malformations, and limb defects. Although fibroblast growth factor-8 (FGF8) mutations have mainly found in patients with Kallmann syndrome, mice with a hypomorphic Fgf8 allele or complete gene invalidation display, aside from gonadotropin-releasing hormone deficiency, parts or even the entire spectrum of human VATER/VACTERL association.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">We performed FGF8 gene analysis in 49 patients with VATER/VACTERL association and 27 patients presenting with a VATER/VACTERL-like phenotype (two cardinal features).</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified two heterozygous FGF8 mutations in patients displaying either VATER/VACTERL association (p.Gly29_Arg34dup) or a VATER/VACTERL-like phenotype (p.Pro26Leu) without limb anomalies. Whereas the duplication mutation has not been reported before, p.Pro26Leu was once observed in a Kallmann syndrome patient. Both our patients had additional bilateral cryptorchidism, a key phenotypic feature in males with FGF8 associated Kallmann syndrome. Each mutation was paternally inherited. Besides delayed puberty in both and additional unilateral cryptorchidism in one of the fathers, they were otherwise healthy. Serum hormone levels downstream the gonadotropin-releasing hormone in both patients and their fathers were within normal range.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Our results suggest FGF8 mutations to contribute to the formation of the VATER/VACTERL association. Further studies are needed to support this observation. Birth Defects Research (Part A), 2014. ?? 2014 Wiley Periodicals, Inc.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Zeidler</LastName>
                    <ForeName>Claudia</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Clinical Chemistry and Clinical Pharmacology, University of Bonn, Bonn, Germany.</Affiliation>
                </Author>
                <Author>
                    <LastName>Woelfle</LastName>
                    <ForeName>Joachim</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Draaken</LastName>
                    <ForeName>Markus</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Mughal</LastName>
                    <ForeName>Sadaf S</ForeName>
                    <Initials>SS</Initials>
                </Author>
                <Author>
                    <LastName>Gro??e</LastName>
                    <ForeName>Greta</ForeName>
                    <Initials>G</Initials>
                </Author>
                <Author>
                    <LastName>Hilger</LastName>
                    <ForeName>Alina C</ForeName>
                    <Initials>AC</Initials>
                </Author>
                <Author>
                    <LastName>Dworschak</LastName>
                    <ForeName>Gabriel C</ForeName>
                    <Initials>GC</Initials>
                </Author>
                <Author>
                    <LastName>Boemers</LastName>
                    <ForeName>Thomas M</ForeName>
                    <Initials>TM</Initials>
                </Author>
                <Author>
                    <LastName>Jenetzky</LastName>
                    <ForeName>Ekkehart</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Zwink</LastName>
                    <ForeName>Nadine</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author>
                    <LastName>Lacher</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Schmidt</LastName>
                    <ForeName>Dominik</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Schmiedeke</LastName>
                    <ForeName>Eberhard</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Grasshoff-Derr</LastName>
                    <ForeName>Sabine</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>M??rzheuser</LastName>
                    <ForeName>Stefanie</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Holland-Cunz</LastName>
                    <ForeName>Stefan</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Sch??fer</LastName>
                    <ForeName>Mattias</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Bartels</LastName>
                    <ForeName>Enrika</ForeName>
                    <Initials>E</Initials>
                </Author>
                <Author>
                    <LastName>Keppler</LastName>
                    <ForeName>Kathleen</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Palta</LastName>
                    <ForeName>Markus</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Leonhardt</LastName>
                    <ForeName>Johannes</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Kujath</LastName>
                    <ForeName>Christina</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Ri??mann</LastName>
                    <ForeName>Anke</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>N??then</LastName>
                    <ForeName>Markus M</ForeName>
                    <Initials>MM</Initials>
                </Author>
                <Author>
                    <LastName>Reutter</LastName>
                    <ForeName>Heiko</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Ludwig</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>8</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Birth Defects Res A Clin Mol Teratol</MedlineTA>
            <NlmUniqueID>101155107</NlmUniqueID>
            <ISSNLinking>1542-0752</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">FGF8</Keyword>
            <Keyword MajorTopicYN="N">Kallmann syndrome</Keyword>
            <Keyword MajorTopicYN="N">VACTERL/VATER association</Keyword>
            <Keyword MajorTopicYN="N">anorectal malformation</Keyword>
            <Keyword MajorTopicYN="N">cryptorchidism</Keyword>
            <Keyword MajorTopicYN="N">fibroblast growth factor</Keyword>
            <Keyword MajorTopicYN="N">hypergonadotropic hypogonadism</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/bdra.23278</ArticleId>
            <ArticleId IdType="pubmed">25131394</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131393</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1651-2251</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Acta oto-laryngologica</Title>
                <ISOAbbreviation>Acta Otolaryngol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Long-term administration of vasopressin can cause M??ni??re's disease in mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1-15</MedlinePgn>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Abstract Conclusion: A new murine model of M??ni??re's disease has been developed, based on long-term administration of vasopressin. Induction of vestibular dysfunction in the present animal model can cause additional stress, by reducing inner ear blood flow. Latanoprost, a selective agonist for the FP prostanoid receptor, may become a new remedy for M??ni??re's disease. Objective: The purpose of this study was to develop a more suitable animal model, with a closer resemblance to the pathophysiological process in M??ni??re's disease. Methods: Adult CBA/J or ICR mice were treated by subcutaneous injection of vasopressin for 5 days up to 8 weeks. Morphological analyses were performed of the cochlea, vestibular end organs and endolymphatic sac. The effect of latanoprost on the development of endolymphatic hydrops was also examined. Results: All experimental animals showed mild to moderate endolymphatic hydrops, increasing in severity as the vasopressin treatment was prolonged. Animals treated with vasopressin for 8 weeks showed severe endolymphatic hydrops with partial loss of outer hair cells and spiral ganglion cells. These animals also had a reversible vestibular dysfunction following intratympanic injection of epinephrine. Latanoprost inhibited the development of endolymphatic hydrops caused by vasopressin.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Katagiri</LastName>
                    <ForeName>Yoshiaki</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Otolaryngology, Hiroshima University Faculty of Medicine , Hiroshima , Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Takumida</LastName>
                    <ForeName>Masaya</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Hirakawa</LastName>
                    <ForeName>Katsuhiro</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Anniko</LastName>
                    <ForeName>Matti</ForeName>
                    <Initials>M</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Acta Otolaryngol</MedlineTA>
            <NlmUniqueID>0370354</NlmUniqueID>
            <ISSNLinking>0001-6489</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Endolymphatic hydrops</Keyword>
            <Keyword MajorTopicYN="N">latanoprost</Keyword>
            <Keyword MajorTopicYN="N">vestibular dysfunction</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.3109/00016489.2014.902989</ArticleId>
            <ArticleId IdType="pubmed">25131393</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131386</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2042-7158</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of pharmacy and pharmacology</Title>
                <ISOAbbreviation>J. Pharm. Pharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Protective effect of ((4-tert-butylcyclohexylidene) methyl) (4-methoxystyryl) sulfide, a novel unsymmetrical divinyl sulfide, on an oxidative stress model induced by sodium nitroprusside in mouse brain: involvement of glutathione peroxidase activity.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/jphp.12300</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">In this study, the antioxidant action of ((4-tert-butylcyclohexylidene) methyl) (4-methoxystyryl) sulfide, a novel unsymmetrical divinyl sulfide, against oxidative damage induced by sodium nitroprusside (SNP) in brains of mice was investigated.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Mice received SNP (0.335?????mol/site, intracerebroventricular) 30???min after administration of sulfide (10???mg/kg, intragastrically). After 1???h, animals were sacrificed and the brains were removed to biochemistry analysis. Thiobarbituric acid reactive species (TBARS), protein carbonyl (PC) and non-protein thiol (NPSH) levels, as well as catalase (CAT), superoxide dismutase (SOD), glutathione peroxidase (GPx), glutathione reductase (GR) and glutathione S-transferase (GST) activities were determined.</AbstractText>
                <AbstractText Label="KEY FINDINGS" NlmCategory="RESULTS">SNP increased TBARS and PC levels, CAT, GPx, GR and GST activities and reduced NPSH levels. Administration of the sulfide attenuated the changes produced by SNP and increased per se GPx activity in brains of mice. Toxicological parameters revealed that this compound did not cause acute renal or hepatic damage.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In conclusion, ((4-tert-butylcyclohexylidene) methyl) (4-methoxystyryl) sulfide protected against oxidative damage caused by SNP in mouse brain. GPx activity is involved, at least in part, in the cerebral antioxidant action of this compound.</AbstractText>
                <CopyrightInformation>?? 2014 Royal Pharmaceutical Society.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ianiski</LastName>
                    <ForeName>Francine R</ForeName>
                    <Initials>FR</Initials>
                    <Affiliation>Programa de P??s-Gradua????o em Nanoci??ncias, Centro Universit??rio Franciscano, Santa Maria, RS, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Alves</LastName>
                    <ForeName>Catiane B</ForeName>
                    <Initials>CB</Initials>
                </Author>
                <Author>
                    <LastName>Bassaco</LastName>
                    <ForeName>Mariana M</ForeName>
                    <Initials>MM</Initials>
                </Author>
                <Author>
                    <LastName>Silveira</LastName>
                    <ForeName>Claudio C</ForeName>
                    <Initials>CC</Initials>
                </Author>
                <Author>
                    <LastName>Luchese</LastName>
                    <ForeName>Cristiane</ForeName>
                    <Initials>C</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Pharm Pharmacol</MedlineTA>
            <NlmUniqueID>0376363</NlmUniqueID>
            <ISSNLinking>0022-3573</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">antioxidant</Keyword>
            <Keyword MajorTopicYN="N">brain</Keyword>
            <Keyword MajorTopicYN="N">glutathione peroxidase activity</Keyword>
            <Keyword MajorTopicYN="N">oxidative stress</Keyword>
            <Keyword MajorTopicYN="N">sulfur</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>11</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jphp.12300</ArticleId>
            <ArticleId IdType="pubmed">25131386</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131380</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1868-6982</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of hepato-biliary-pancreatic sciences</Title>
                <ISOAbbreviation>J Hepatobiliary Pancreat Sci</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Homing effect of adipose-derived stem cells to the injured liver: the shift of stromal cell-derived factor 1 expressions.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/jhbp.147</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Whether systemically transplanted human adipose-derived stem cells (ADSCs) homed to the injured liver in nude mice under stress with subsequent hepatectomy (Hx) and ischemia-reperfusion (I/R) was investigated in the present study. The types of cells in the liver that were involved in the homing of ADSCs were clarified, with focus on the stromal-derived factor-1 (SDF-1)/C-X-C chemokine receptor type 4 (CXCR-4) axis.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Adipose-derived stem cells were transplanted intravenously immediately after 70% Hx and I/R. ADSCs were traced by in vivo imaging for 24???h after transplantation and ADSCs were histologically detected in the liver. SDF-1 and CXCR-4 expressions in the liver were evaluated by real time RT-PCR. The immunohistochemical analysis of SDF-1 was also performed to identify SDF-1 expressing cells in the liver.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Adipose-derived stem cells were found in various organs immediately following transplantation and almost accumulated in remnant liver or spleen at 6???h after transplantation. ADSCs were also histologically revealed in the harvested liver. Hx and I/R injury significantly enhanced SDF-1 expressions regardless of ADSCs transplantation, and only ADSC transplantation increased CXCR-4 expressions. The predominant SDF-1 positive cells in the liver were equally identified in parenchymal and non-parenchymal cells at 6???h, but shifted to non-parenchymal cells at 24???h after transplantation.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Systemically transplanted ADSCs homed to the injured liver after transplantation, possibly based on the mechanisms of SDF-1/CXCR-4 axis. Therefore, systemic transplantation might be an effective and practical route for the transplantation of ADSCs.</AbstractText>
                <CopyrightInformation>?? 2014 Japanese Society of Hepato-Biliary-Pancreatic Surgery.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Saito</LastName>
                    <ForeName>Yu</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Surgery, Institute of Health Biosciences, The University of Tokushima Graduate School, 3-18-15 Kuramoto-cho, Tokushima, 770-8503, Japan. saito@clin.med.tokushima-u.ac.jp.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shimada</LastName>
                    <ForeName>Mitsuo</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Utsunomiya</LastName>
                    <ForeName>Tohru</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Ikemoto</LastName>
                    <ForeName>Tetsuya</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Yamada</LastName>
                    <ForeName>Shinichiro</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Morine</LastName>
                    <ForeName>Yuji</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Imura</LastName>
                    <ForeName>Satoru</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Mori</LastName>
                    <ForeName>Hiroki</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Arakawa</LastName>
                    <ForeName>Yusuke</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Kanamoto</LastName>
                    <ForeName>Mami</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Iwahashi</LastName>
                    <ForeName>Shuichi</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Takasu</LastName>
                    <ForeName>Chie</ForeName>
                    <Initials>C</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Hepatobiliary Pancreat Sci</MedlineTA>
            <NlmUniqueID>101528587</NlmUniqueID>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Adipose derived stem cells</Keyword>
            <Keyword MajorTopicYN="N">C-X-C chemokine receptor type 4</Keyword>
            <Keyword MajorTopicYN="N">Hepatic ischemia-reperfusion</Keyword>
            <Keyword MajorTopicYN="N">Homing</Keyword>
            <Keyword MajorTopicYN="N">Stromal derived factor-1</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jhbp.147</ArticleId>
            <ArticleId IdType="pubmed">25131380</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131378</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-9096</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Antiviral research</Title>
                <ISOAbbreviation>Antiviral Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Modulation of inflammation and pathology during dengue virus infection by p38 MAPK inhibitor SB203580.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0166-3542(14)00241-1</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.antiviral.2014.08.004</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Dengue virus (DENV) infection could lead to dengue fever (DF), dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS). The disease outcome is controlled by both viral and host factors. Inflammation mediators from DENV-infected cells could contribute to increased vascular permeability, leading to severe DHF/DSS. Therefore, suppression of inflammation could be a potential therapeutic approach for treatment of dengue patients. In this context, p38 MAPK (mitogen-activated protein kinase) is a key enzyme that modulates the initiation of stress and inflammatory responses. Here we show that SB203580, a p38 MAPK inhibitor, suppressed the over production of DENV-induced pro-inflammatory mediators such as TNF-??, IL-8, and RANTES from human PBMCs, monocytic THP-1, and granulocyte KU812 cell lines. Oral administration of SB203580 in DENV-infected AG129 mice prevented hematocrit rise and lymphopenia, limited the development of inflammation and pathology (including intestine leakage), and significantly improved survival. These results, for the first time, have provided experimental evidence to imply that a short term inhibition of p38 MAPK may be beneficial to reduce disease symptoms in dengue patients.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Fu</LastName>
                    <ForeName>Yilong</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Novartis Institute for Tropical Diseases, Singapore 138670, Singapore.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yip</LastName>
                    <ForeName>Andy</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Novartis Institute for Tropical Diseases, Singapore 138670, Singapore.</Affiliation>
                </Author>
                <Author>
                    <LastName>Seah</LastName>
                    <ForeName>Peck Gee</ForeName>
                    <Initials>PG</Initials>
                    <Affiliation>Novartis Institute for Tropical Diseases, Singapore 138670, Singapore.</Affiliation>
                </Author>
                <Author>
                    <LastName>Blasco</LastName>
                    <ForeName>Francesca</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Novartis Institute for Tropical Diseases, Singapore 138670, Singapore.</Affiliation>
                </Author>
                <Author>
                    <LastName>Shi</LastName>
                    <ForeName>Pei-Yong</ForeName>
                    <Initials>PY</Initials>
                    <Affiliation>Novartis Institute for Tropical Diseases, Singapore 138670, Singapore. Electronic address: pei_yong.shi@novartis.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Herve</LastName>
                    <ForeName>Maxime</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Novartis Institute for Tropical Diseases, Singapore 138670, Singapore. Electronic address: maxime.herve@novartis.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Antiviral Res</MedlineTA>
            <NlmUniqueID>8109699</NlmUniqueID>
            <ISSNLinking>0166-3542</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antiviral drug discovery</Keyword>
            <Keyword MajorTopicYN="N">Dengue therapeutics</Keyword>
            <Keyword MajorTopicYN="N">Dengue virus</Keyword>
            <Keyword MajorTopicYN="N">p38 MAPK</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>19</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25131378</ArticleId>
            <ArticleId IdType="pii">S0166-3542(14)00241-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.antiviral.2014.08.004</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131377</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-9096</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Antiviral research</Title>
                <ISOAbbreviation>Antiviral Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Alleviation of respiratory syncytial virus replication and inflammation by fungal immunomodulatory protein FIP-fve from Flammulina velutipes.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0166-3542(14)00243-5</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.antiviral.2014.08.006</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Respiratory syncytial virus (RSV) causes bronchiolitis in children followed by inflammation and asthma-like symptoms. The development of preventive therapy for this virus continues to pose a challenge. Fungal immunomodulatory proteins (FIPs) exhibit anti-inflammatory function. FIP-fve is an immunomodulatory protein isolated from Flammulina velutipes. To determine whether FIP-fve affects the infection or consequence of immunity of RSV, we investigated viral titers of RSV and inflammatory cytokine levels in vivo and in vitro. Oral FIP-fve decreased RSV-induced airway hyperresponsiveness (AHR), airway inflammation, and IL-6 expression in bronchoalveolar lavage fluid (BALF) of BALB/c mice. RSV replication and interleukin 6 (IL-6) levels in RSV-infected HEp-2 cells were compared before and after FIP-fve treatment. FIP-fve inhibited viral titers on plaque assay and Western blot, as well as inhibited RSV-stimulated expression of IL-6 on ELISA and RT-PCR. The results of this study suggested that FIP-fve decreases RSV replication, RSV-induced inflammation and respiratory pathogenesis. FIP-fve is a widely used, natural compound from F.velutipes that may be a safe agent for viral prevention and even therapy.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Chang</LastName>
                    <ForeName>Yu-Chi</ForeName>
                    <Initials>YC</Initials>
                    <Affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Chow</LastName>
                    <ForeName>Yen-Hung</ForeName>
                    <Initials>YH</Initials>
                    <Affiliation>Vaccine Research and Development Center, Miaoli County, National Health Research Institutes, Miaoli, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sun</LastName>
                    <ForeName>Hai-Lun</ForeName>
                    <Initials>HL</Initials>
                    <Affiliation>Division of Allergy, Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Yu-Fan</ForeName>
                    <Initials>YF</Initials>
                    <Affiliation>Department of Biomedical Sciences, Chung Shan Medical University, Taichung, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Yu-Tzu</ForeName>
                    <Initials>YT</Initials>
                    <Affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lue</LastName>
                    <ForeName>Ko-Huang</ForeName>
                    <Initials>KH</Initials>
                    <Affiliation>Division of Allergy, Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan; School of Medicine, Chung Shan Medical University, Taichung, Taiwan. Electronic address: cshy095@csh.org.tw.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ko</LastName>
                    <ForeName>Jiunn-Liang</ForeName>
                    <Initials>JL</Initials>
                    <Affiliation>Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan; Division of Allergy, Department of Pediatrics, Chung Shan Medical University Hospital, Taichung, Taiwan. Electronic address: jlko@csmu.edu.tw.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Antiviral Res</MedlineTA>
            <NlmUniqueID>8109699</NlmUniqueID>
            <ISSNLinking>0166-3542</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antiviral agent</Keyword>
            <Keyword MajorTopicYN="N">FIP-fve</Keyword>
            <Keyword MajorTopicYN="N">Immunomodulatory protein</Keyword>
            <Keyword MajorTopicYN="N">Inflammatory</Keyword>
            <Keyword MajorTopicYN="N">NF-??B</Keyword>
            <Keyword MajorTopicYN="N">Respiratory syncytial virus</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25131377</ArticleId>
            <ArticleId IdType="pii">S0166-3542(14)00243-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.antiviral.2014.08.006</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131345</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1538-7836</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>16</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Journal of thrombosis and haemostasis : JTH</Title>
                <ISOAbbreviation>J. Thromb. Haemost.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Influence of genetic background on bleeding phenotype in the tail-tip bleeding model and recommendations for standardization: communication from the SSC of the ISTH.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/jth.12700</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The murine tail-tip bleeding model is widely used to measure bleeding time, blood loss, and survival after treatment [1-4]. Due to the considerable variation in data from these studies and thus the need for large sample sizes per group, and the incomparability of results from different laboratories, research groups have tried to standardize the model. In 2010, the Standardization Subcommittee for Animal, Cellular and Molecular Models of the International Society of Thrombosis and Haemostasis proposed standardized methods for tail bleeding time in mice. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Schiviz</LastName>
                    <ForeName>Alexandra</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Baxter Innovations GmbH, 1221, Vienna, Austria.</Affiliation>
                </Author>
                <Author>
                    <LastName>Magirr</LastName>
                    <ForeName>Dominic</ForeName>
                    <Initials>D</Initials>
                </Author>
                <Author>
                    <LastName>Leidenm??hler</LastName>
                    <ForeName>Peter</ForeName>
                    <Initials>P</Initials>
                </Author>
                <Author>
                    <LastName>Schuster</LastName>
                    <ForeName>Maria</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Muchitsch</LastName>
                    <ForeName>Eva-Maria</ForeName>
                    <Initials>EM</Initials>
                </Author>
                <Author>
                    <LastName>H??llriegl</LastName>
                    <ForeName>Werner</ForeName>
                    <Initials>W</Initials>
                </Author>
                <Author>
                    <CollectiveName>The Subcommittee on Animal Models</CollectiveName>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>16</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Thromb Haemost</MedlineTA>
            <NlmUniqueID>101170508</NlmUniqueID>
            <ISSNLinking>1538-7836</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">animal models</Keyword>
            <Keyword MajorTopicYN="N">genetic diversity</Keyword>
            <Keyword MajorTopicYN="N">hemophilia A</Keyword>
            <Keyword MajorTopicYN="N">knockout mice</Keyword>
            <Keyword MajorTopicYN="N">phenotype</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>10</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jth.12700</ArticleId>
            <ArticleId IdType="pubmed">25131345</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131333</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2042-650X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Food &amp; function</Title>
                <ISOAbbreviation>Food Funct</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Dietary squid ink polysaccharides ameliorated the intestinal microflora dysfunction in mice undergoing chemotherapy.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Gastrointestinal mucositis and infection by chemotherapy treatment are associated with alteration of intestinal microflora and bacterial translocation due to the potential damage induced by anti-cancer drugs on the intestinal barrier and microbiota homeostasis. This study aimed to investigate the protective effect of dietary polysaccharides on chemotherapy induced intestinal microflora dysfunction. In the current contribution, with a mouse model intraperitoneally injected with 50 mg kg(-1) of cyclophosphamide (Cy) for 2 days, we revealed that polysaccharides from the ink of Ommastrephes bartrami (OBP) altered the intestinal microflora composition. OBP retarded the excessive growth of intestinal bacteria induced by cyclophosphamide, based on 16S rRNA gene (16S rDNA) quantification. The clone libraries of intestinal bacteria 16S rDNA were used to decipher the difference in bacterial community structures in different groups of mice. Followed by RFLP evaluation and OTU abundance analysis, they imply that OBP changed the intestinal microflora composition, in which the quantity of probiotic Bifidobacterium got up-regulated but Bacteroidetes decreased in mice undergoing chemotherapy. Our results may have important implications for OBP as a functional food component or nutrient against chemotherapy induced intestinal injury and potential pathogenic intestinal disorders involving inflammation and infection.</AbstractText>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Tang</LastName>
                    <ForeName>Qingjuan</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>College of Food Science and Engineering, Ocean University of China, Yushan Road 5th, Qingdao, Shandong province, P.R. China266003. tangqingjuan@ouc.edu.cn xuech@ouc.edu.cn.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zuo</LastName>
                    <ForeName>Tao</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Lu</LastName>
                    <ForeName>Shangyun</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Wu</LastName>
                    <ForeName>Juan</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Jianghua</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Zheng</LastName>
                    <ForeName>Rong</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Shiguo</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Xue</LastName>
                    <ForeName>Changhu</ForeName>
                    <Initials>C</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Food Funct</MedlineTA>
            <NlmUniqueID>101549033</NlmUniqueID>
            <ISSNLinking>2042-6496</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1039/c4fo00408f</ArticleId>
            <ArticleId IdType="pubmed">25131333</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131306</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1439-0531</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Reproduction in domestic animals = Zuchthygiene</Title>
                <ISOAbbreviation>Reprod. Domest. Anim.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The Expression and Localization of Crb3 in Developmental Stages of the Mice Embryos and in Different Organs of 1-week-old Female Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/rda.12374</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Crumbs homolog 3 (Crb3) is a member of the Crumbs family of proteins. This protein may play a role in epithelial cell polarity and is associated with tight junctions at the apical surface of epithelial cells. Alternative transcriptional splice variants that encode different Crb3 isoforms have been characterized. The expression of Crb3 mRNA and protein was observed in the pre-implantation mouse embryos and different organs of 1-week-old mouse, and Crb3 expression was primarily observed in the cytoplasm. Crb3 was expressed in a unique temporal pattern in pre-implantation embryos. The main characteristic of Crb3 expression was that the positive signals were stronger in the mature oocytes and zygotes than in the 2-cell, 4-cell, and 8-cell stages and the morula, but a similar level of high expression was observed in blastocysts. Therefore, the Crb3 expression signal during the course of development process grew gradually stronger from the 2-cell stage to blastocyst. In addition, Crb3 protein was widely distributed in each stage of the post-implantation embryos. Crb3 expression was observed in the inner cell mass, trophoblast cells and endoderm of E4.5d embryos; in the chorion, amnion, trophoblast cells, yolk sac endoderm and embryo ectoderm of E7.5d embryos; in the amnion and limb bud of E8.0d embryos; and in the semicircular canal epithelium, retina, lens vesicle and liver tissue of E13.5d embryos. Crb3 was expressed at different levels in different organs of 1-week-old mouse with the strengths in the following order: kidney &gt; small intestine &gt; stomach &gt; uterus &gt; liver &gt; skeletal muscle &gt; cerebellum &gt; brain. The presence of Crb3 in many organs and the regularity of Crb3 distribution in the process of mouse embryonic development indicate that Crb3 protein plays an important role in establishing and maintaining the polarity of mouse embryos.</AbstractText>
                <CopyrightInformation>?? 2014 Blackwell Verlag GmbH.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Yin</LastName>
                    <ForeName>Y</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>College of Veterinary Medicine, Northwest A &amp; F University, Yangling, Shaanxi, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sheng</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Hu</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Y</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Qing</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Reprod Domest Anim</MedlineTA>
            <NlmUniqueID>9015668</NlmUniqueID>
            <ISSNLinking>0936-6768</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/rda.12374</ArticleId>
            <ArticleId IdType="pubmed">25131306</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131300</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1460-9568</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>8</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The European journal of neuroscience</Title>
                <ISOAbbreviation>Eur. J. Neurosci.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>The glutamate receptor GluN2 subunit regulates synaptic trafficking of AMPA receptors in the neonatal mouse brain.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/ejn.12682</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The N-methyl-d-aspartate receptor (NMDAR) plays various physiological and pathological roles in neural development, synaptic plasticity and neuronal cell death. It is composed of two GluN1 and two GluN2 subunits and, in the neonatal hippocampus, most synaptic NMDARs are GluN2B-containing receptors, which are gradually replaced with GluN2A-containing receptors during development. Here, we examined whether GluN2A could be substituted for GluN2B in neural development and functions by analysing knock-in (KI) mice in which GluN2B is replaced with GluN2A. The KI mutation was neonatally lethal, although GluN2A-containing receptors were transported to the postsynaptic membrane even without GluN2B and functional at synapses of acute hippocampal slices of postnatal day 0, indicating that GluN2A-containing NMDARs could not be substituted for GluN2B-containing NMDARs. Importantly, the synaptic ??-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptor (AMPAR) subunit GluA1 was increased, and the transmembrane AMPAR regulatory protein, which is involved in AMPAR synaptic trafficking, was increased in KI mice. Although the regulation of AMPARs by GluN2B has been reported in cultured neurons, we showed here that AMPAR-mediated synaptic responses were increased in acute KI slices, suggesting differential roles of GluN2A and GluN2B in AMPAR expression and trafficking in vivo. Taken together, our results suggest that GluN2B is essential for the survival of animals, and that the GluN2B-GluN2A switching plays a critical role in synaptic integration of AMPARs through regulation of GluA1 in the whole animal.</AbstractText>
                <CopyrightInformation>?? 2014 Federation of European Neuroscience Societies and John Wiley &amp; Sons Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Hamada</LastName>
                    <ForeName>Shun</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Division of Neuronal Network, Institute of Medical Science, University of Tokyo, Tokyo, 108-8639, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ogawa</LastName>
                    <ForeName>Itone</ForeName>
                    <Initials>I</Initials>
                </Author>
                <Author>
                    <LastName>Yamasaki</LastName>
                    <ForeName>Miwako</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Kiyama</LastName>
                    <ForeName>Yuji</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Kassai</LastName>
                    <ForeName>Hidetoshi</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author>
                    <LastName>Watabe</LastName>
                    <ForeName>Ayako M</ForeName>
                    <Initials>AM</Initials>
                </Author>
                <Author>
                    <LastName>Nakao</LastName>
                    <ForeName>Kazuki</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Aiba</LastName>
                    <ForeName>Atsu</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Watanabe</LastName>
                    <ForeName>Masahiko</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Manabe</LastName>
                    <ForeName>Toshiya</ForeName>
                    <Initials>T</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>8</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Eur J Neurosci</MedlineTA>
            <NlmUniqueID>8918110</NlmUniqueID>
            <ISSNLinking>0953-816X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">TARP</Keyword>
            <Keyword MajorTopicYN="N">NMDA receptor</Keyword>
            <Keyword MajorTopicYN="N">hippocampus</Keyword>
            <Keyword MajorTopicYN="N">miniature EPSC</Keyword>
            <Keyword MajorTopicYN="N">postsynaptic density</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/ejn.12682</ArticleId>
            <ArticleId IdType="pubmed">25131300</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131262</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2042-7158</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>17</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of pharmacy and pharmacology</Title>
                <ISOAbbreviation>J. Pharm. Pharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Association of daunorubicin to a lipid nanoemulsion that binds to low-density lipoprotein receptors enhances the antitumour action and decreases the toxicity of the drug in melanoma-bearing mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/jphp.12296</ELocationID>
            <Abstract>
                <AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To test the toxicity and antitumoral activity of the compound N-oleyl-daunorubicin (oDNR) with a cholesterol-rich nanoemulsion (LDE) formulation.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">LDE-oDNR was prepared by high-pressure homogenisation of lipid mixtures. B16F10 melanoma cells and NIH/3T3 fibroblasts were used for cytotoxicity tests. The maximum tolerated dose (MTD) of both commercial and LDE-oDNR was determined in mice, and melanoma-bearing mice were used for the antitumoral activity tests.</AbstractText>
                <AbstractText Label="KEY FINDINGS" NlmCategory="RESULTS">CC50 for LDE-oDNR and DNR in melanoma cells were 200?????m and 15?????m, respectively, but LDE-oDNR was less toxic against fibroblasts than DNR. MTD for LDE-oDNR was 65-fold higher than commercial DNR. In tumour-bearing mice, LDE-oDNR (7.5?????mol/kg) reduced tumour growth by 59????????2%, whereas the reduction by DNR was only 23????????2%. LDE-oDNR increased survival rates (P???&lt;???0.05), which was not achieved by DNR treatment. The number of mice with metastasis was only 30% in LDE-oDNR-treated mice, compared with 82% under DNR treatment. By flow cytometry, there were 9% viable cells in tumours of animals treated with LDE-oDNR compared with 27% in DNR-treated animals. Less haematological toxicity was observed in LDE-oDNR-treated mice.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Compared with DNR, LDE-oDNR improved tumour growth inhibition and survival rates with pronouncedly less toxicity, and thus may become a new tool for cancer treatment.</AbstractText>
                <CopyrightInformation>?? 2014 Royal Pharmaceutical Society.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Contente</LastName>
                    <ForeName>Tha??s C</ForeName>
                    <Initials>TC</Initials>
                    <Affiliation>Lipid Metabolism Laboratory, Heart Institute of the Medical School Hospital, University of S??o Paulo, S??o Paulo, Brazil.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kretzer</LastName>
                    <ForeName>Iara F</ForeName>
                    <Initials>IF</Initials>
                </Author>
                <Author>
                    <LastName>Filippin-Monteiro</LastName>
                    <ForeName>Fabiola B</ForeName>
                    <Initials>FB</Initials>
                </Author>
                <Author>
                    <LastName>Maria</LastName>
                    <ForeName>Durvanei A</ForeName>
                    <Initials>DA</Initials>
                </Author>
                <Author>
                    <LastName>Maranh??o</LastName>
                    <ForeName>Raul C</ForeName>
                    <Initials>RC</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Pharm Pharmacol</MedlineTA>
            <NlmUniqueID>0376363</NlmUniqueID>
            <ISSNLinking>0022-3573</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">cancer treatment</Keyword>
            <Keyword MajorTopicYN="N">daunorubicin</Keyword>
            <Keyword MajorTopicYN="N">drug delivery</Keyword>
            <Keyword MajorTopicYN="N">low-density lipoprotein receptors</Keyword>
            <Keyword MajorTopicYN="N">nanoparticles</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/jphp.12296</ArticleId>
            <ArticleId IdType="pubmed">25131262</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25131210</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2211-1247</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell reports</Title>
                <ISOAbbreviation>Cell Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Dysregulated expression of neuregulin-1 by cortical pyramidal neurons disrupts synaptic plasticity.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1130-45</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2014.07.026</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S2211-1247(14)00610-X</ELocationID>
            <Abstract>
                <AbstractText>Neuregulin-1 (NRG1) gene variants are associated with increased genetic risk for schizophrenia. It is unclear whether risk haplotypes cause elevated or??decreased expression of NRG1 in the brains of schizophrenia patients, given that both findings have been reported from autopsy studies. To study NRG1 functions in??vivo, we generated mouse mutants with reduced and elevated NRG1 levels and analyzed the impact on cortical functions. Loss of NRG1 from cortical projection neurons resulted in increased inhibitory neurotransmission, reduced synaptic plasticity, and hypoactivity. Neuronal overexpression of cysteine-rich domain (CRD)-NRG1, the major brain isoform, caused unbalanced excitatory-inhibitory neurotransmission, reduced synaptic plasticity, abnormal spine growth, altered steady-state levels of synaptic plasticity-related proteins, and impaired sensorimotor gating. We conclude that an &quot;optimal&quot; level of NRG1 signaling balances excitatory and inhibitory neurotransmission in the cortex. Our data provide a potential pathomechanism for impaired synaptic plasticity and suggest that human NRG1 risk haplotypes exert a gain-of-function effect.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Agarwal</LastName>
                    <ForeName>Amit</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Neurogenetics, Max Planck Institute of Experimental Medicine, 37075 G??ttingen, Germany; Solomon H. Snyder Department of Neuroscience, Johns Hopkins University, Baltimore, MD 21025, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Mingyue</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Laboratory of Molecular Psychiatry, Department of Psychiatry, University of M??nster, 48149 Muenster Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Trembak-Duff</LastName>
                    <ForeName>Irina</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Laboratory of Molecular Psychiatry, Department of Psychiatry, University of M??nster, 48149 Muenster Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Unterbarnscheidt</LastName>
                    <ForeName>Tilmann</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Neurogenetics, Max Planck Institute of Experimental Medicine, 37075 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Radyushkin</LastName>
                    <ForeName>Konstantin</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Clinical Neuroscience, Max Planck Institute of Experimental Medicine, 37075 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Dibaj</LastName>
                    <ForeName>Payam</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Department of Neurogenetics, Max Planck Institute of Experimental Medicine, 37075 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Martins de Souza</LastName>
                    <ForeName>Daniel</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Institute of Biotechnology, University of Cambridge, Cambridge CB2 1QT, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boretius</LastName>
                    <ForeName>Susann</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Biomedizinische NMR Forschungs GmbH, Max Planck Institute of Biophysical Chemistry, 37077 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Brz??zka</LastName>
                    <ForeName>Magdalena M</ForeName>
                    <Initials>MM</Initials>
                    <Affiliation>Department of Neurogenetics, Max Planck Institute of Experimental Medicine, 37075 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Steffens</LastName>
                    <ForeName>Heinz</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of NanoBiophotonics, Max Planck Institute for Biophysical Chemistry, 37077 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Berning</LastName>
                    <ForeName>Sebastian</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Department of NanoBiophotonics, Max Planck Institute for Biophysical Chemistry, 37077 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Teng</LastName>
                    <ForeName>Zenghui</ForeName>
                    <Initials>Z</Initials>
                    <Affiliation>Laboratory of Molecular Psychiatry, Department of Psychiatry, University of M??nster, 48149 Muenster Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gummert</LastName>
                    <ForeName>Maike N</ForeName>
                    <Initials>MN</Initials>
                    <Affiliation>Department of Neurogenetics, Max Planck Institute of Experimental Medicine, 37075 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tantra</LastName>
                    <ForeName>Martesa</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Clinical Neuroscience, Max Planck Institute of Experimental Medicine, 37075 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Guest</LastName>
                    <ForeName>Peter C</ForeName>
                    <Initials>PC</Initials>
                    <Affiliation>Institute of Biotechnology, University of Cambridge, Cambridge CB2 1QT, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Willig</LastName>
                    <ForeName>Katrin I</ForeName>
                    <Initials>KI</Initials>
                    <Affiliation>Department of NanoBiophotonics, Max Planck Institute for Biophysical Chemistry, 37077 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Frahm</LastName>
                    <ForeName>Jens</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Biomedizinische NMR Forschungs GmbH, Max Planck Institute of Biophysical Chemistry, 37077 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hell</LastName>
                    <ForeName>Stefan W</ForeName>
                    <Initials>SW</Initials>
                    <Affiliation>Department of NanoBiophotonics, Max Planck Institute for Biophysical Chemistry, 37077 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bahn</LastName>
                    <ForeName>Sabine</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Institute of Biotechnology, University of Cambridge, Cambridge CB2 1QT, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Rossner</LastName>
                    <ForeName>Moritz J</ForeName>
                    <Initials>MJ</Initials>
                    <Affiliation>Department of Neurogenetics, Max Planck Institute of Experimental Medicine, 37075 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nave</LastName>
                    <ForeName>Klaus-Armin</ForeName>
                    <Initials>KA</Initials>
                    <Affiliation>Department of Neurogenetics, Max Planck Institute of Experimental Medicine, 37075 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ehrenreich</LastName>
                    <ForeName>Hannelore</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Clinical Neuroscience, Max Planck Institute of Experimental Medicine, 37075 G??ttingen, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Weiqi</ForeName>
                    <Initials>W</Initials>
                    <Affiliation>Laboratory of Molecular Psychiatry, Department of Psychiatry, University of M??nster, 48149 Muenster Germany. Electronic address: wzhang@uni-muenster.de.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schwab</LastName>
                    <ForeName>Markus H</ForeName>
                    <Initials>MH</Initials>
                    <Affiliation>Department of Neurogenetics, Max Planck Institute of Experimental Medicine, 37075 G??ttingen, Germany. Electronic address: schwab@em.mpg.de.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Cell Rep</MedlineTA>
            <NlmUniqueID>101573691</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>11</Month>
                <Day>25</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S2211-1247(14)00610-X</ArticleId>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.07.026</ArticleId>
            <ArticleId IdType="pubmed">25131210</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25131204</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2211-1247</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell reports</Title>
                <ISOAbbreviation>Cell Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Evidence against a Stem Cell Origin of New Hepatocytes in a Common Mouse Model of Chronic Liver Injury.</ArticleTitle>
            <Pagination>
                <MedlinePgn>933-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2014.07.003</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S2211-1247(14)00570-1</ELocationID>
            <Abstract>
                <AbstractText>Hepatocytes provide most liver functions, but they can also proliferate and regenerate the liver after injury. However, under some liver injury conditions, particularly chronic liver injury where hepatocyte proliferation is impaired, liver stem cells (LSCs) are thought to replenish lost hepatocytes. Conflicting results have been reported about the identity of LSCs and their contribution to liver regeneration. To??address this uncertainty, we followed candidate LSC populations by genetic fate tracing in adult mice with chronic liver injury due to a choline-deficient, ethionine-supplemented diet. In contrast to previous studies, we failed to detect hepatocytes derived from biliary epithelial cells or mesenchymal liver cells beyond a negligible frequency. In fact, we failed to detect hepatocytes that were not derived from pre-existing hepatocytes. In conclusion, our findings argue against LSCs, or other nonhepatocyte cell types, providing a backup system for hepatocyte??regeneration in this common mouse model of chronic liver injury.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Schaub</LastName>
                    <ForeName>Johanna R</ForeName>
                    <Initials>JR</Initials>
                    <Affiliation>Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, 35 Medical Center Way, San Francisco, CA 94143, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Malato</LastName>
                    <ForeName>Yann</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, 35 Medical Center Way, San Francisco, CA 94143, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gormond</LastName>
                    <ForeName>Coralie</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, 35 Medical Center Way, San Francisco, CA 94143, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Willenbring</LastName>
                    <ForeName>Holger</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, 35 Medical Center Way, San Francisco, CA 94143, USA; Department of Surgery, Division of Transplantation, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA; Liver Center, University of California, San Francisco, 1001 Potrero Avenue, San Francisco, CA 94110, USA. Electronic address: willenbringh@stemcell.ucsf.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Cell Rep</MedlineTA>
            <NlmUniqueID>101573691</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S2211-1247(14)00570-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.07.003</ArticleId>
            <ArticleId IdType="pubmed">25131204</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25131203</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2211-1247</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell reports</Title>
                <ISOAbbreviation>Cell Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Perturbation of NCOA6 Leads to Dilated Cardiomyopathy.</ArticleTitle>
            <Pagination>
                <MedlinePgn>991-8</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2014.07.027</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S2211-1247(14)00611-1</ELocationID>
            <Abstract>
                <AbstractText>Dilated cardiomyopathy (DCM) is a progressive heart disease characterized by left ventricular dilation and contractile dysfunction. Although many candidate genes have been identified with mouse models, few of them have been shown to be associated with DCM in humans. Germline depletion of Ncoa6, a nuclear hormone receptor coactivator, leads to embryonic lethality and heart defects. However, it is unclear whether Ncoa6 mutations cause heart diseases in adults. Here, we report that two independent mouse models of NCOA6 dysfunction develop severe DCM with impaired mitochondrial function and reduced activity of peroxisome proliferator-activated receptor ?? (PPAR??), an NCOA6 target critical for normal heart function. Sequencing of NCOA6-coding regions revealed three independent nonsynonymous mutations present in 5 of 50 (10%) patients with idiopathic DCM (iDCM). These data suggest that malfunction of NCOA6 can cause DCM in humans.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Roh</LastName>
                    <ForeName>Jae-Il</ForeName>
                    <Initials>JI</Initials>
                    <Affiliation>Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, South Korea; Yonsei Laboratory Animal Research Center, Yonsei University, Seoul 120-749, South Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Cheong</LastName>
                    <ForeName>Cheolho</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Laboratory of Cellular Physiology and Immunology, Institut de Recherches Cliniques de Montr??al, Montr??al QC H2W 1R7, Canada; Department of Microbiology, Infectiology and Immunology, Universit?? de Montr??al, Montreal QC H3T 1J4, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sung</LastName>
                    <ForeName>Young Hoon</ForeName>
                    <Initials>YH</Initials>
                    <Affiliation>Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, South Korea; Yonsei Laboratory Animal Research Center, Yonsei University, Seoul 120-749, South Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Jeehyun</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, South Korea; Yonsei Laboratory Animal Research Center, Yonsei University, Seoul 120-749, South Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oh</LastName>
                    <ForeName>Jaewon</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Cardiology Division, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul 120-752, South Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Beom Seob</ForeName>
                    <Initials>BS</Initials>
                    <Affiliation>Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul 120-752, South Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Jong-Eun</ForeName>
                    <Initials>JE</Initials>
                    <Affiliation>DNA Link, Inc., Songpa-Gu, Seoul 138-736, South Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gho</LastName>
                    <ForeName>Yong Song</ForeName>
                    <Initials>YS</Initials>
                    <Affiliation>Department of Life Sciences, Pohang University of Science and Technology, Gyeongbuk 790-784, South Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Duk-Kyung</ForeName>
                    <Initials>DK</Initials>
                    <Affiliation>Cardiac and Vascular Center, Samsung Medical Center, Sungkyunkwan University School of Medicine, Suwon, Gyeonggi-do 440-746, South Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Park</LastName>
                    <ForeName>Chan Bae</ForeName>
                    <Initials>CB</Initials>
                    <Affiliation>Department of Physiology, Ajou University School of Medicine, Suwon 443-380, South Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Ji Hyun</ForeName>
                    <Initials>JH</Initials>
                    <Affiliation>Department of Oral Biology, College of Dentistry, Yonsei University, Seoul 120-752, South Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Jae Woon</ForeName>
                    <Initials>JW</Initials>
                    <Affiliation>Department of Pediatrics, Oregon Health &amp; Science University, Portland, OR 97239-3098, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kang</LastName>
                    <ForeName>Seok-Min</ForeName>
                    <Initials>SM</Initials>
                    <Affiliation>Cardiology Division, Severance Cardiovascular Hospital, Yonsei University College of Medicine, Seoul 120-752, South Korea; Cardiovascular Research Institute, Yonsei University College of Medicine, Seoul 120-752, South Korea. Electronic address: smkang@yuhs.ac.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>Han-Woong</ForeName>
                    <Initials>HW</Initials>
                    <Affiliation>Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, South Korea; Yonsei Laboratory Animal Research Center, Yonsei University, Seoul 120-749, South Korea. Electronic address: hwl@yonsei.ac.kr.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Cell Rep</MedlineTA>
            <NlmUniqueID>101573691</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>31</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S2211-1247(14)00611-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.07.027</ArticleId>
            <ArticleId IdType="pubmed">25131203</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25131201</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2211-1247</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell reports</Title>
                <ISOAbbreviation>Cell Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A Macrohistone Variant Links Dynamic Chromatin Compaction to BRCA1-Dependent Genome Maintenance.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1049-62</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2014.07.024</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S2211-1247(14)00608-1</ELocationID>
            <Abstract>
                <AbstractText>Appropriate DNA double-strand break (DSB) repair factor choice is essential for ensuring accurate repair outcome and genomic integrity. The factors that regulate this process remain poorly understood. Here, we identify two repressive chromatin components, the macrohistone variant macroH2A1 and the H3K9 methyltransferase and tumor suppressor PRDM2, which together direct the choice between the antagonistic DSB repair mediators BRCA1 and 53BP1. The macroH2A1/PRDM2 module mediates an unexpected shift from accessible to condensed chromatin that requires the ataxia telangiectasia mutated (ATM)-dependent accumulation of both proteins at DSBs in order to promote DSB-flanking H3K9 dimethylation. Remarkably, loss of macroH2A1 or PRDM2, as well as experimentally induced chromatin decondensation, impairs the retention of BRCA1, but not 53BP1, at DSBs. As a result, macroH2A1 and/or PRDM2 depletion causes epistatic defects in DSB end resection, homology-directed repair, and the resistance to poly(ADP-ribose) polymerase (PARP) inhibition-all hallmarks of BRCA1-deficient tumors. Together, these findings identify dynamic, DSB-associated chromatin reorganization as a critical modulator of BRCA1-dependent genome maintenance.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Khurana</LastName>
                    <ForeName>Simran</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Laboratory of Receptor Biology and Gene Expression, NCI/NIH, Bethesda, MD 20892, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kruhlak</LastName>
                    <ForeName>Michael J</ForeName>
                    <Initials>MJ</Initials>
                    <Affiliation>Experimental Immunology Branch, NCI/NIH, Bethesda, MD 20892, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kim</LastName>
                    <ForeName>Jeongkyu</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Laboratory of Receptor Biology and Gene Expression, NCI/NIH, Bethesda, MD 20892, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tran</LastName>
                    <ForeName>Andy D</ForeName>
                    <Initials>AD</Initials>
                    <Affiliation>Laboratory of Receptor Biology and Gene Expression, NCI/NIH, Bethesda, MD 20892, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Jinping</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Laboratory of Receptor Biology and Gene Expression, NCI/NIH, Bethesda, MD 20892, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nyswaner</LastName>
                    <ForeName>Katherine</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Mouse Cancer Genetics Program, NCI/NIH, Frederick, MD 21702, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shi</LastName>
                    <ForeName>Lei</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Department of Biochemistry and Molecular Biology, Tianjin Medical University, Tianjin 300070, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jailwala</LastName>
                    <ForeName>Parthav</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Advanced Biomedical Computing Center, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research, Inc., Frederick, MD 21702, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sung</LastName>
                    <ForeName>Myong-Hee</ForeName>
                    <Initials>MH</Initials>
                    <Affiliation>Laboratory of Receptor Biology and Gene Expression, NCI/NIH, Bethesda, MD 20892, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hakim</LastName>
                    <ForeName>Ofir</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>The Mina and Everard Goodman Faculty of Life Sciences, Bar-Ilan University, Ramat Gan 5290002, Israel.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Oberdoerffer</LastName>
                    <ForeName>Philipp</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Laboratory of Receptor Biology and Gene Expression, NCI/NIH, Bethesda, MD 20892, USA. Electronic address: philipp.oberdoerffer@nih.gov.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Cell Rep</MedlineTA>
            <NlmUniqueID>101573691</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>8</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>28</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>16</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S2211-1247(14)00608-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.07.024</ArticleId>
            <ArticleId IdType="pubmed">25131201</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25131200</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2211-1247</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell reports</Title>
                <ISOAbbreviation>Cell Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>A Polymorphic Enhancer near GREM1 Influences Bowel Cancer Risk through Differential CDX2 and TCF7L2 Binding.</ArticleTitle>
            <Pagination>
                <MedlinePgn>983-90</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2014.07.020</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S2211-1247(14)00589-0</ELocationID>
            <Abstract>
                <AbstractText>A rare germline duplication upstream of the bone morphogenetic protein antagonist GREM1 causes a??Mendelian-dominant predisposition to colorectal cancer (CRC). The underlying disease mechanism is strong, ectopic GREM1 overexpression in the intestinal epithelium. Here, we confirm that a common GREM1 polymorphism, rs16969681, is also associated with CRC susceptibility, conferring ???20% differential risk in the general population. We hypothesized the underlying cause to be moderate differences in??GREM1 expression. We showed that rs16969681 lies in a region of active chromatin with allele- and tissue-specific enhancer activity. The CRC high-risk allele was associated with stronger gene expression, and higher Grem1 mRNA levels increased the intestinal tumor burden in Apc(Min) mice. The intestine-specific transcription factor CDX2 and Wnt effector TCF7L2 bound near rs16969681, with significantly higher affinity for the risk allele, and CDX2 overexpression in CDX2/GREM1-negative cells caused re-expression of GREM1. rs16969681 influences CRC risk through effects on Wnt-driven GREM1 expression in colorectal tumors.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lewis</LastName>
                    <ForeName>Annabelle</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford??OX3 7BN, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Freeman-Mills</LastName>
                    <ForeName>Luke</ForeName>
                    <Initials>L</Initials>
                    <Affiliation>Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford??OX3 7BN, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>de la Calle-Mustienes</LastName>
                    <ForeName>Elisa</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Centro Andaluz de Biolog??a del Desarrollo, CSIC-Universidad Pablo de Olavide-Junta de Andaluc??a, Carretera de Utrera Km1, 41013 Sevilla, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gir??ldez-P??rez</LastName>
                    <ForeName>Rosa Mar??a</ForeName>
                    <Initials>RM</Initials>
                    <Affiliation>Centro Andaluz de Biolog??a del Desarrollo, CSIC-Universidad Pablo de Olavide-Junta de Andaluc??a, Carretera de Utrera Km1, 41013 Sevilla, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Davis</LastName>
                    <ForeName>Hayley</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford??OX3 7BN, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Jaeger</LastName>
                    <ForeName>Emma</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford??OX3 7BN, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Becker</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Max Planck Institute for Psycholinguistics, Wundtlaan 1, 6525 XD Nijmegen, the Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hubner</LastName>
                    <ForeName>Nina C</ForeName>
                    <Initials>NC</Initials>
                    <Affiliation>Department of Molecular Biology, Radboud Institute for Molecular Life Science, Geert Grooteplein 26/28, 6525 GA Nijmegen, the??Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nguyen</LastName>
                    <ForeName>Luan N</ForeName>
                    <Initials>LN</Initials>
                    <Affiliation>Department of Molecular Biology, Radboud Institute for Molecular Life Science, Geert Grooteplein 26/28, 6525 GA Nijmegen, the??Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zeron-Medina</LastName>
                    <ForeName>Jorge</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Ludwig Institute for Cancer Research, Ltd., Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bond</LastName>
                    <ForeName>Gareth</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Ludwig Institute for Cancer Research, Ltd., Nuffield Department of Clinical Medicine, University of Oxford, Old Road Campus Research Building, Roosevelt Drive, Oxford OX3 7DQ, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stunnenberg</LastName>
                    <ForeName>Hendrik G</ForeName>
                    <Initials>HG</Initials>
                    <Affiliation>Department of Molecular Biology, Radboud Institute for Molecular Life Science, Geert Grooteplein 26/28, 6525 GA Nijmegen, the??Netherlands.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Carvajal</LastName>
                    <ForeName>Jaime J</ForeName>
                    <Initials>JJ</Initials>
                    <Affiliation>Centro Andaluz de Biolog??a del Desarrollo, CSIC-Universidad Pablo de Olavide-Junta de Andaluc??a, Carretera de Utrera Km1, 41013 Sevilla, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gomez-Skarmeta</LastName>
                    <ForeName>Jose Luis</ForeName>
                    <Initials>JL</Initials>
                    <Affiliation>Centro Andaluz de Biolog??a del Desarrollo, CSIC-Universidad Pablo de Olavide-Junta de Andaluc??a, Carretera de Utrera Km1, 41013 Sevilla, Spain.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Leedham</LastName>
                    <ForeName>Simon</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford??OX3 7BN, UK.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tomlinson</LastName>
                    <ForeName>Ian</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Molecular and Population Genetics Laboratory, Wellcome Trust Centre for Human Genetics, University of Oxford, Roosevelt Drive, Oxford??OX3 7BN, UK. Electronic address: iant@well.ox.ac.uk.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Cell Rep</MedlineTA>
            <NlmUniqueID>101573691</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>15</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S2211-1247(14)00589-0</ArticleId>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.07.020</ArticleId>
            <ArticleId IdType="pubmed">25131200</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25131198</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">2211-1247</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>8</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>21</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Cell reports</Title>
                <ISOAbbreviation>Cell Rep</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Conversion of the thymus into a bipotent lymphoid organ by replacement of foxn1 with its paralog, foxn4.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1184-97</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.celrep.2014.07.017</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S2211-1247(14)00584-1</ELocationID>
            <Abstract>
                <AbstractText>The thymus is a lymphoid organ unique to vertebrates, and it provides a unique microenvironment that facilitates the differentiation of immature hematopoietic precursors into mature T??cells. We subjected the evolutionary trajectory of the thymic microenvironment to experimental analysis. A hypothetical primordial form of the thymus was established in mice by replacing FOXN1, the vertebrate-specific master regulator of thymic epithelial cell function, with its metazoan ancestor, FOXN4, thereby resetting the regulatory and coding changes that have occurred since the divergence of these two paralogs. FOXN4 exhibited substantial thymopoietic activity. Unexpectedly, histological changes and a functional imbalance between the lymphopoietic cytokine IL7 and the T??cell specification factor DLL4 within the reconstructed thymus resulted in coincident but spatially segregated T and B cell development. Our results identify an evolutionary mechanism underlying the conversion of a general lymphopoietic organ to a site of exclusive T??cell generation.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 The Authors. Published by Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Swann</LastName>
                    <ForeName>Jeremy B</ForeName>
                    <Initials>JB</Initials>
                    <Affiliation>Department of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Stuebeweg 51, 79108 Freiburg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Weyn</LastName>
                    <ForeName>Annelies</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Stuebeweg 51, 79108 Freiburg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nagakubo</LastName>
                    <ForeName>Daisuke</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Stuebeweg 51, 79108 Freiburg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Bleul</LastName>
                    <ForeName>Conrad C</ForeName>
                    <Initials>CC</Initials>
                    <Affiliation>Department of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Stuebeweg 51, 79108 Freiburg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Toyoda</LastName>
                    <ForeName>Atsushi</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Comparative Genomics Laboratory, Center for Genetic Resource Information, National Institute of Genetics, Mishima, Shizuoka 411-8540, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Happe</LastName>
                    <ForeName>Christiane</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>Department of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Stuebeweg 51, 79108 Freiburg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Netuschil</LastName>
                    <ForeName>Nikolai</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Stuebeweg 51, 79108 Freiburg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hess</LastName>
                    <ForeName>Isabell</ForeName>
                    <Initials>I</Initials>
                    <Affiliation>Department of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Stuebeweg 51, 79108 Freiburg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Haas-Assenbaum</LastName>
                    <ForeName>Annette</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Stuebeweg 51, 79108 Freiburg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Taniguchi</LastName>
                    <ForeName>Yoshihito</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Radiation Genetics, Graduate School of Medicine, Kyoto University, Yoshida Konoe, Sakyo-ku, Kyoto 606-8501, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schorpp</LastName>
                    <ForeName>Michael</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Stuebeweg 51, 79108 Freiburg, Germany.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Boehm</LastName>
                    <ForeName>Thomas</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Developmental Immunology, Max Planck Institute of Immunobiology and Epigenetics, Stuebeweg 51, 79108 Freiburg, Germany. Electronic address: boehm@immunbio.mpg.de.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Cell Rep</MedlineTA>
            <NlmUniqueID>101573691</NlmUniqueID>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S2211-1247(14)00584-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.celrep.2014.07.017</ArticleId>
            <ArticleId IdType="pubmed">25131198</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131136</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>24</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1521-7035</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Clinical immunology (Orlando, Fla.)</Title>
                <ISOAbbreviation>Clin. Immunol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Lessons learned from mice and man: Mimicking human allergy through mouse models.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1521-6616(14)00193-4</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.clim.2014.08.002</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">The relevance of using mouse models to represent human allergic pathologies is still unclear. Recent studies suggest the limitations of using models as a standard for assessing immune response and tolerance mechanisms, as mouse models often do not sufficiently depict human atopic conditions. Allergy is a combination of aberrant responses to innocuous environmental agents and the subsequent TH2-mediated inflammatory responses. In this review, we will discuss current paradigms of allergy - specifically, TH2-mediated and IgE-associated immune responses - and current mouse models used to recreate these TH2-mediated pathologies. Our overall goal is to highlight discrepancies that exist between mice and men by examining the advantages and disadvantages of allergic mouse models with respect to the human allergic condition.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Graham</LastName>
                    <ForeName>Michelle T</ForeName>
                    <Initials>MT</Initials>
                    <Affiliation>Division of Pediatric Immunology, Allergy, and Rheumatology, Department of Pediatrics, Stanford University School of Medicine, 1291 Welch Rd, Grant S303, Stanford, CA 94305, USA. Electronic address: mgraham2@stanford.edu.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nadeau</LastName>
                    <ForeName>Kari C</ForeName>
                    <Initials>KC</Initials>
                    <Affiliation>Division of Pediatric Immunology, Allergy, and Rheumatology, Department of Pediatrics, Stanford University School of Medicine, 1291 Welch Rd, Grant S303, Stanford, CA 94305, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>REVIEW</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Clin Immunol</MedlineTA>
            <NlmUniqueID>100883537</NlmUniqueID>
            <ISSNLinking>1521-6616</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Allergic rhinitis</Keyword>
            <Keyword MajorTopicYN="N">Allergy</Keyword>
            <Keyword MajorTopicYN="N">Asthma</Keyword>
            <Keyword MajorTopicYN="N">Atopic dermatitis</Keyword>
            <Keyword MajorTopicYN="N">Food allergy</Keyword>
            <Keyword MajorTopicYN="N">Mouse models</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25131136</ArticleId>
            <ArticleId IdType="pii">S1521-6616(14)00193-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.clim.2014.08.002</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25131095</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1873-2623</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>46</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <MedlineDate>2014 Jul-Aug</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>Transplantation proceedings</Title>
                <ISOAbbreviation>Transplant. Proc.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Resistance of Spontaneously Diabetic Ins2(akita) Mice to Allograft Tolerance Induced by Anti-CD154 Therapy.</ArticleTitle>
            <Pagination>
                <MedlinePgn>2007-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.transproceed.2014.06.012</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0041-1345(14)00442-4</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Despite ongoing advances in the clinical islet transplant field, progressive decline in graft function continues to reduce the long-term success of islet transplantation for restoring euglycemia in type 1 diabetic recipients. To preserve graft function and avoid the use of chronic immunosuppressive drug therapy, a key goal is to induce donor-specific immune tolerance to islet transplants. Preclinical rodent studies of islet transplantation largely utilize models of diabetes either induced experimentally with beta cell toxins or spontaneously occurring in strains genetically prone to autoimmune diabetes. In this study, we sought to determine if chronic, severe hyperglycemia itself, independent of both beta cell toxins and host autoimmunity, influenced acute allograft rejection and/or the capacity to induce allograft tolerance.</AbstractText>
                <AbstractText Label="METHOD" NlmCategory="METHODS">To this end, we studied the response to islet??allografts in severely diabetic, non-autoimmune C57Bl/6 Ins2(akita) recipients.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Results indicate that diabetic Ins2(akita) mice display higher levels of blood glucose, show more rapid acute islet??allograft rejection, and are resistant to allograft prolongation induced with anti-CD154 therapy relative to wild-type littermates rendered diabetic with streptozotocin. As such, results suggest that severe hyperglycemia may be an independent risk factor impacting the capacity to induce tolerance to islet??allografts. Thus, Ins2(akita) mice represent a stringent model for evaluating anti-rejection strategies in the setting of severe metabolic demand on islet transplants.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Bishop</LastName>
                    <ForeName>N H</ForeName>
                    <Initials>NH</Initials>
                    <Affiliation>Integrated Department of Immunology, University of Colorado Denver, Aurora, Colorado.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Beard</LastName>
                    <ForeName>K S</ForeName>
                    <Initials>KS</Initials>
                    <Affiliation>Department of Surgery, University of Colorado Denver, Aurora, Colorado.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gill</LastName>
                    <ForeName>R G</ForeName>
                    <Initials>RG</Initials>
                    <Affiliation>Integrated Department of Immunology, University of Colorado Denver, Aurora, Colorado; Department of Surgery, University of Colorado Denver, Aurora, Colorado. Electronic address: ronald.gill@ucdenver.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Transplant Proc</MedlineTA>
            <NlmUniqueID>0243532</NlmUniqueID>
            <ISSNLinking>0041-1345</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0041-1345(14)00442-4</ArticleId>
            <ArticleId IdType="doi">10.1016/j.transproceed.2014.06.012</ArticleId>
            <ArticleId IdType="pubmed">25131095</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25131094</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1873-2623</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>46</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <MedlineDate>2014 Jul-Aug</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>Transplantation proceedings</Title>
                <ISOAbbreviation>Transplant. Proc.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Failure to Achieve Normal Metabolic Response in Non-Obese Diabetic Mice and Streptozotocin-Induced Diabetic Mice After Transplantation of Primary Murine Hepatocytes Electroporated With the Human Proinsulin Gene (p3MTChins).</ArticleTitle>
            <Pagination>
                <MedlinePgn>2002-6</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.transproceed.2014.05.068</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0041-1345(14)00416-3</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A recent study by Chen et??al described a therapy for diabetes that involved electroporation of primary hepatocytes with human proinsulin cDNA, p3MTChins. Intrahepatic transplantation of treated hepatocytes into streptozotocin (STZ) murine and porcine models led to euglycemia, weight maintenance, and normal insulin production. We tested the repeatability of their basic experiments and transplantation technique and expanded the study to include an autoimmune model.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Hepatocytes were isolated from B6 mice, electroporated with p3MTChins, and glucose-challenged or were injected into hepatic or spleen parenchyma of STZ-diabetic B6 and non-obese diabetic mice. Outcomes included survival, serum glucose levels, insulin, and c-peptide release. Untransfected primary hepatocytes and mice transplanted with these cells served as controls.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">p3MTChins-hepatocytes secreted insulin during glucose challenge, but glucose levels did not change with increasing glucose concentrations. Direct hepatic injection led to high mortality rates. Mice that underwent intrasplenic injection survived for &gt;50 days (control??= 4 days) and had a mild but stable improvement in hyperglycemia. C-peptide in both mouse models was detectable but eventually declined to baseline in the non-obese diabetic mice.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Hepatocytes can be transfected with p3MTChins to produce human insulin but may lack the proper glucose-sensing or complex storage and secretion capabilities that allow for a finely tuned dynamic insulin response. Treatment is subtherapeutic, and p3MTChins-hepatocyte function may not endure in an autoimmune model. Without successful preliminary findings, cell therapy involving electroporation of p3MTChins does not appear to be practical as a therapy for diabetes and may not be a strategy to pursue at this time.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Lee</LastName>
                    <ForeName>R H</ForeName>
                    <Initials>RH</Initials>
                    <Affiliation>Department of Surgery, University of California-San Francisco, San Francisco, California, USA. Electronic address: ryalee@alamedahealthsystem.org.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Roll</LastName>
                    <ForeName>G</ForeName>
                    <Initials>G</Initials>
                    <Affiliation>Department of Surgery, University of California-San Francisco, San Francisco, California, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nguyen</LastName>
                    <ForeName>V</ForeName>
                    <Initials>V</Initials>
                    <Affiliation>Department of Surgery, University of California-San Francisco, San Francisco, California, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Willenbring</LastName>
                    <ForeName>H</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Surgery, University of California-San Francisco, San Francisco, California, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tang</LastName>
                    <ForeName>Q</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>Department of Surgery, University of California-San Francisco, San Francisco, California, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kang</LastName>
                    <ForeName>S-M</ForeName>
                    <Initials>SM</Initials>
                    <Affiliation>Department of Surgery, University of California-San Francisco, San Francisco, California, USA.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stock</LastName>
                    <ForeName>P G</ForeName>
                    <Initials>PG</Initials>
                    <Affiliation>Department of Surgery, University of California-San Francisco, San Francisco, California, USA.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Transplant Proc</MedlineTA>
            <NlmUniqueID>0243532</NlmUniqueID>
            <ISSNLinking>0041-1345</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0041-1345(14)00416-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.transproceed.2014.05.068</ArticleId>
            <ArticleId IdType="pubmed">25131094</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25131091</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1873-2623</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>46</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <MedlineDate>2014 Jul-Aug</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>Transplantation proceedings</Title>
                <ISOAbbreviation>Transplant. Proc.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Clinical porcine islet xenotransplantation under comprehensive regulation.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1992-5</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.transproceed.2014.06.008</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0041-1345(14)00438-2</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Xenotransplantation with porcine islets is a promising approach to overcome the shortage of human donors. This is the first report of phase 1/2a xenotransplantation study of encapsulated neonatal porcine islets under the current framework of regulations for xenotransplantation in New Zealand.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Newborn piglets were anesthetized and bled, and the pancreata were removed with the use of sterile technique and processed. Encapsulated neonatal porcine islets were implanted with the use of laparoscopy into the peritoneal cavity of 14 patients with unstable type 1 diabetes without any immunosuppressive drugs. The patients received encapsulated islets of 5,000 (n??= 4; group 1), 10,000 (n??= 4; group 2), 15,000 (n??= 4; group 3), or 20,000 (n??= 2; group 4) islet equivalents per kg body weight. Outcome was determined from adverse event reports, HbA1c, total daily insulin dose, and frequency of unaware hypoglycemic events. To assess graft function, transplant estimated function (TEF) scores were calculated. Sufficient or marginal numbers of encapsulated neonatal porcine islets were transplanted into streptozotocin-induced diabetic B6 mice as an in??vivo functional assay.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 4 serious adverse events, of which 3 were considered to be possibly related to the procedure. Tests for porcine endogenous retrovirus DNA and RNA were all negative. The numbers of unaware hypoglycemia events were reduced after transplantation in all groups. Four of 14 patients attained HbA1c??&lt;7% compared with 1 at baseline. The average TEF scores were 0.17, 0.02,??-0.01, and 0.08 in groups 1, 2, 3, and 4 respectively. The in??vivo study demonstrated that a sufficient number of the transplanted group reversed diabetes with positive porcine C-peptide.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Transplantation of encapsulated neonatal porcine islets was safe and was followed by a reduction in unaware hypoglycemia events in unstable type 1 diabetic patients. The mouse in??vivo assessment data demonstrated certain graft function.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Matsumoto</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Otsuka Pharmaceutical Factory, Naruto, Japan. Electronic address: matsumoto.shinichi@otsuka.jp.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tan</LastName>
                    <ForeName>P</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Living Cell Technologies, Auckland, New Zealand.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Baker</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Centre for Clinical Research and Effective Practice, Middlemore Hospital, Auckland, New Zealand.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Durbin</LastName>
                    <ForeName>K</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Living Cell Technologies, Auckland, New Zealand.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tomiya</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Otsuka Pharmaceutical Factory, Naruto, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Azuma</LastName>
                    <ForeName>K</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Otsuka Pharmaceutical Factory, Naruto, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Doi</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Otsuka Pharmaceutical Factory, Naruto, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Elliott</LastName>
                    <ForeName>R B</ForeName>
                    <Initials>RB</Initials>
                    <Affiliation>Living Cell Technologies, Auckland, New Zealand.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Transplant Proc</MedlineTA>
            <NlmUniqueID>0243532</NlmUniqueID>
            <ISSNLinking>0041-1345</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0041-1345(14)00438-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.transproceed.2014.06.008</ArticleId>
            <ArticleId IdType="pubmed">25131091</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25131090</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1873-2623</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>46</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <MedlineDate>2014 Jul-Aug</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>Transplantation proceedings</Title>
                <ISOAbbreviation>Transplant. Proc.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Human Islet Viability and Function Is Maintained During High-density Shipment in Silicone Rubber Membrane Vessels.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1989-91</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.transproceed.2014.06.002</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0041-1345(14)00432-1</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The shipment of human islets (IE) from processing centers to distant laboratories is beneficial for both research and clinical applications. The maintenance of islet viability and function in transit is critically important. Gas-permeable silicone rubber membrane (SRM) vessels reduce the risk of hypoxia-induced death or dysfunction during high-density islet culture or shipment. SRM vessels may offer additional advantages: they are cost-effective (fewer flasks, less labor needed), safer (lower contamination risk), and simpler (culture vessel can also be used for shipment).</AbstractText>
                <AbstractText Label="METHOD" NlmCategory="METHODS">IE were isolated from two manufacturing centers and shipped in 10-cm(2) surface area SRM vessels in temperature- and pressure-controlled containers to a distant center after at least 2 days of culture (n??= 6). Three conditions were examined: low density (LD), high density (HD), and a microcentrifuge tube negative control (NC). LD was designed to mimic the standard culture density for IE preparations (200 IE/cm(2)), while HD was designed to have a 20-fold higher tissue density, which would enable the culture of an entire human isolation in 1-3 vessels. Upon receipt, islets were assessed for viability (measured by oxygen consumption rate normalized to DNA content [OCR/DNA)]), quantity (measured by DNA), and, when possible, potency and function (measured by dynamic glucose-stimulated insulin secretion measurements and transplants in immunodeficient B6 Rag(+/-) mice). Postshipment OCR/DNA was not reduced in HD vs LD and was substantially reduced in the NC condition. HD islets exhibited normal function postshipment. Based on the data, we conclude that entire islet isolations (up to 400,000 IE) may be shipped using a single, larger SRM vessel with no negative effect on viability and ex??vivo and in??vivo function.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kitzmann</LastName>
                    <ForeName>J P</ForeName>
                    <Initials>JP</Initials>
                    <Affiliation>Department of Surgery, University of Arizona, Tucson, Arizona, United States.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pepper</LastName>
                    <ForeName>A R</ForeName>
                    <Initials>AR</Initials>
                    <Affiliation>Clinical Islet Transplant Program, University of Alberta, Edmonton, Alberta, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gala-Lopez</LastName>
                    <ForeName>B</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Clinical Islet Transplant Program, University of Alberta, Edmonton, Alberta, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pawlick</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                    <Affiliation>Clinical Islet Transplant Program, University of Alberta, Edmonton, Alberta, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kin</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Clinical Islet Transplant Program, University of Alberta, Edmonton, Alberta, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>O'Gorman</LastName>
                    <ForeName>D</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Clinical Islet Transplant Program, University of Alberta, Edmonton, Alberta, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Mueller</LastName>
                    <ForeName>K R</ForeName>
                    <Initials>KR</Initials>
                    <Affiliation>Department of Surgery, University of Arizona, Tucson, Arizona, United States.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gruessner</LastName>
                    <ForeName>A C</ForeName>
                    <Initials>AC</Initials>
                    <Affiliation>Department of Surgery, University of Arizona, Tucson, Arizona, United States.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Avgoustiniatos</LastName>
                    <ForeName>E S</ForeName>
                    <Initials>ES</Initials>
                    <Affiliation>Department of Surgery, University of Arizona, Tucson, Arizona, United States.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Karatzas</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Department of Surgery, University of Arizona, Tucson, Arizona, United States; Second Department of Propedeutic Surgery University of Athens, School of Medicine, Athens, Greece.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Szot</LastName>
                    <ForeName>G L</ForeName>
                    <Initials>GL</Initials>
                    <Affiliation>Diabetes Center, University of California, San Francisco, Calif, United States.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Posselt</LastName>
                    <ForeName>A M</ForeName>
                    <Initials>AM</Initials>
                    <Affiliation>Diabetes Center, University of California, San Francisco, Calif, United States.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Stock</LastName>
                    <ForeName>P G</ForeName>
                    <Initials>PG</Initials>
                    <Affiliation>Diabetes Center, University of California, San Francisco, Calif, United States.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Wilson</LastName>
                    <ForeName>J R</ForeName>
                    <Initials>JR</Initials>
                    <Affiliation>Wilson Wolf Manufacturing Corporation, New Brighton, Minn, United States.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shapiro</LastName>
                    <ForeName>A M</ForeName>
                    <Initials>AM</Initials>
                    <Affiliation>Clinical Islet Transplant Program, University of Alberta, Edmonton, Alberta, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Papas</LastName>
                    <ForeName>K K</ForeName>
                    <Initials>KK</Initials>
                    <Affiliation>Department of Surgery, University of Arizona, Tucson, Arizona, United States. Electronic address: kkpapas@surgery.arizona.edu.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <GrantList CompleteYN="Y">
                <Grant>
                    <GrantID>R44 DK069865</GrantID>
                    <Acronym>DK</Acronym>
                    <Agency>NIDDK NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Transplant Proc</MedlineTA>
            <NlmUniqueID>0243532</NlmUniqueID>
            <ISSNLinking>0041-1345</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0041-1345(14)00432-1</ArticleId>
            <ArticleId IdType="doi">10.1016/j.transproceed.2014.06.002</ArticleId>
            <ArticleId IdType="pubmed">25131090</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25131081</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1873-2623</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>46</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <MedlineDate>2014 Jul-Aug</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>Transplantation proceedings</Title>
                <ISOAbbreviation>Transplant. Proc.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Assessment of Human Islet Grafts in Frozen Sections of CD-1 Athymic nu/nu Mouse Liver for Molecular Analysis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1956-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.transproceed.2014.06.013</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0041-1345(14)00443-6</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Post-transplantation islet graft monitoring is hampered by a lack of efficient methods to locate and analyze islets in situ. We evaluated histologic methods to rapidly locate islets within the liver parenchyma post-transplantation, using several staining strategies, prior to analysis using laser capture microdissection.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Human islets were isolated (n??= 8) from brain dead, multiorgan donor pancreases at the McGill University Health Centre Islet Transplant Laboratory. Mean yield was 247,609 ?? 195,272 IE and 3172 ?? 1645 IE/g (purity and viability, respectively, 84.5 ?? 8.6% and 95 ?? 5% average; mean ?? SD). Diabetic athymic CD-1 nu/nu mice (streptozotocin intraperitoneal injection, 200??mg/kg) were maintained with sustained release insulin pellets until a suitable islet preparation was available for transplant. Intraportal islet transplantation of 2000 IE/mouse was performed via the ileocecal vein, as previously described. Frozen sections of liver containing human islets were prepared from specimens collected on days 0, 4, and 30 post-transplant. Every twentieth slide from serial sectioned liver was stained using a rapid protocol to determine if islets were present. Sections were fixed and stained for 5 minutes with either an anti-human insulin fluorescein isothiocyanate (FITC)-conjugated primary antibody (Ins-FITC), Newport Green (NG), or diphenylthiocarbazone (dithizone, DZ).</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Islets were readily localized using each technique, mostly toward the liver periphery. However, DZ had a faint appearance in 10-??m-thick sections and was best utilized to locate sections containing islets during sectioning.</AbstractText>
                <AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Ins-FITC, NG, and DZ are all good candidates for a rapid islet staining protocol to evaluate human islet grafts in situ, with DZ being best for sectioning and Ins-FITC and NG being equal in locating islets during processing for laser capture microdissection.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Hasilo</LastName>
                    <ForeName>C P</ForeName>
                    <Initials>CP</Initials>
                    <Affiliation>Human Islet Transplant Laboratory, McGill University Health Centre, Montr??al, Qu??bec, Canada; Department of Surgery, McGill University, Montr??al, Qu??bec, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Negi</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Human Islet Transplant Laboratory, McGill University Health Centre, Montr??al, Qu??bec, Canada; Department of Surgery, McGill University, Montr??al, Qu??bec, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Gasparrini</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Human Islet Transplant Laboratory, McGill University Health Centre, Montr??al, Qu??bec, Canada.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Paraskevas</LastName>
                    <ForeName>S</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Human Islet Transplant Laboratory, McGill University Health Centre, Montr??al, Qu??bec, Canada; Department of Surgery, McGill University, Montr??al, Qu??bec, Canada. Electronic address: steven.paraskevas@mcgill.ca.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Transplant Proc</MedlineTA>
            <NlmUniqueID>0243532</NlmUniqueID>
            <ISSNLinking>0041-1345</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0041-1345(14)00443-6</ArticleId>
            <ArticleId IdType="doi">10.1016/j.transproceed.2014.06.013</ArticleId>
            <ArticleId IdType="pubmed">25131081</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25131079</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Electronic">1873-2623</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>46</Volume>
                    <Issue>6</Issue>
                    <PubDate>
                        <MedlineDate>2014 Jul-Aug</MedlineDate>
                    </PubDate>
                </JournalIssue>
                <Title>Transplantation proceedings</Title>
                <ISOAbbreviation>Transplant. Proc.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Effects of All-Trans Retinoid Acid and Exendin-4 on Islet Transplantation in NOD Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1950-2</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.transproceed.2014.05.072</ELocationID>
            <ELocationID EIdType="pii" ValidYN="Y">S0041-1345(14)00420-5</ELocationID>
            <Abstract>
                <AbstractText>Type 1 diabetes usually develops due to autoimmune destruction of ??-cells in the pancreas. It has been shown that all-trans retinoid acid (ATRA), a potent derivative of vitamin A, hinders the development of autoimmune diabetes by inducing immune tolerance status. In addition, exendin-4, a glucagon-like peptide-1 receptor agonist, stimulates growth and differentiation of ??-cells and exerts anti-apoptotic effect on ??-cells. Thus, we hypothesized that the ATRA and exendin-4 therapy may improve the outcome of islet transplantation in non-obese diabetic (NOD) mice. After the onset of diabetes, each NOD mouse was transplanted with 300 or 600 islets isolated from NOD/severe combined immunodeficient (SCID) mice with or without treatment of ATRA (0.5 mg intraperitoneally every other day) and/or exendin-4 (3 ??g/kg subcutaneously twice daily) for 6 weeks. After 300 or 600 NOD/SCID islet transplantation without any other treatment, all NOD recipients remained diabetic. However, the lowest blood glucose level in mice transplanted with 600 but not 300 islets was significantly lower than those without islet transplantation (P??&lt; .05), although their survival time was comparable. Among recipients treated with ATRA, exendin-4, ATRA and exendin-4, and without treatment, their lowest blood glucose levels and survival time were not different. However, one recipient treated with ATRA survived for 223 days with intermittent hyperglycemia and the other who was treated with ATRA and exendin-4 achieved normoglycemia. In conclusion, islet transplantation lowered blood glucose levels in diabetic NOD mice. With a few exceptions, treatment with ATRA and exendin-4 alone or in combination in islet recipients could not reverse diabetes or prolong survival.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Juang</LastName>
                    <ForeName>J-H</ForeName>
                    <Initials>JH</Initials>
                    <Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung University and Chang Gung Memorial Hospital, Taoyuan, Taiwan. Electronic address: jjuang@cgmh.org.tw.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kuo</LastName>
                    <ForeName>C-H</ForeName>
                    <Initials>CH</Initials>
                    <Affiliation>Industrial Technology Research Institute of Taiwan, Hsinchu, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Y-H</ForeName>
                    <Initials>YH</Initials>
                    <Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung University and Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chang</LastName>
                    <ForeName>H-Y</ForeName>
                    <Initials>HY</Initials>
                    <Affiliation>Division of Endocrinology and Metabolism, Department of Internal Medicine, Chang Gung University and Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Van</LastName>
                    <ForeName>Y-H</ForeName>
                    <Initials>YH</Initials>
                    <Affiliation>Division of Pediatric Endocrinology, Department of Pediatrics, Chang Gung Memorial Hospital, Taoyuan, Taiwan.</Affiliation>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>United States</Country>
            <MedlineTA>Transplant Proc</MedlineTA>
            <NlmUniqueID>0243532</NlmUniqueID>
            <ISSNLinking>0041-1345</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0041-1345(14)00420-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.transproceed.2014.05.072</ArticleId>
            <ArticleId IdType="pubmed">25131079</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25131002</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1558-1497</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jul</Month>
                        <Day>18</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neurobiology of aging</Title>
                <ISOAbbreviation>Neurobiol. Aging</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Age-associated evolution of plasmatic amyloid in mouse lemur primates: relationship with intracellular amyloid deposition.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0197-4580(14)00486-2</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.neurobiolaging.2014.07.017</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Alzheimer's disease (AD) is the most common age-related neurodegenerative disorder. Amyloid-?? peptide (A??) deposition in the brain is one of its hallmarks, and the measure of plasma A?? is considered to be a biomarker for anti-amyloid drug efficacy in animal models of AD. However, age-associated plasmatic A?? modulation in animal models is practically never addressed in the literature. Mouse lemur primates are used as a model of normal and AD-like cerebral aging. Here, we studied the effect of age on plasmatic A?? in 58 mouse lemurs aged from 1 to 10??years. A subset of animals presented high plasmatic A??, and the proportion of animals with high plasmatic A?? was higher in aged animals as compared with young ones. Histologic evaluation of the brain of some of these animals was carried out to assess extracellular and intracellular amyloid load. In aged lemurs, plasmatic A?? was negatively correlated with the density of neurons accumulating deposits of A??.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Inc. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Roy</LastName>
                    <ForeName>Maggie</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>CEA, DSV, I2BM, MIRCen, URA CEA CNRS 2210, Fontenay aux Roses, France; CNRS, URA 2210, Fontenay aux Roses, France; Research Center on Aging, Universit?? de Sherbrooke, Sherbrooke, Quebec, Canada.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cardoso</LastName>
                    <ForeName>C??cile</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>CEA, DSV, I2BM, MIRCen, URA CEA CNRS 2210, Fontenay aux Roses, France; CNRS, URA 2210, Fontenay aux Roses, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dorieux</LastName>
                    <ForeName>Ol??ne</ForeName>
                    <Initials>O</Initials>
                    <Affiliation>CEA, DSV, I2BM, MIRCen, URA CEA CNRS 2210, Fontenay aux Roses, France; CNRS, URA 2210, Fontenay aux Roses, France; CNRS UMR 7179, MNHN, Brunoy, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Malgorn</LastName>
                    <ForeName>Carole</ForeName>
                    <Initials>C</Initials>
                    <Affiliation>CEA, DSV, I2BM, MIRCen, URA CEA CNRS 2210, Fontenay aux Roses, France; CNRS, URA 2210, Fontenay aux Roses, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Epelbaum</LastName>
                    <ForeName>St??phane</ForeName>
                    <Initials>S</Initials>
                    <Affiliation>Sorbonne Universit??s, Paris, France; UPMC Univ Paris 06 UMR S 1127, Paris, France; Inserm, U 1127, Paris, France; CNRS UMR 7225, Paris, France; ICM, Paris, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Petit</LastName>
                    <ForeName>Fanny</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>CEA, DSV, I2BM, MIRCen, URA CEA CNRS 2210, Fontenay aux Roses, France; CNRS, URA 2210, Fontenay aux Roses, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kraska</LastName>
                    <ForeName>Audrey</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>CEA, DSV, I2BM, MIRCen, URA CEA CNRS 2210, Fontenay aux Roses, France; CNRS, URA 2210, Fontenay aux Roses, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Brouillet</LastName>
                    <ForeName>Emmanuel</ForeName>
                    <Initials>E</Initials>
                    <Affiliation>CEA, DSV, I2BM, MIRCen, URA CEA CNRS 2210, Fontenay aux Roses, France; CNRS, URA 2210, Fontenay aux Roses, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Delatour</LastName>
                    <ForeName>Beno??t</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Sorbonne Universit??s, Paris, France; UPMC Univ Paris 06 UMR S 1127, Paris, France; Inserm, U 1127, Paris, France; CNRS UMR 7225, Paris, France; ICM, Paris, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Perret</LastName>
                    <ForeName>Martine</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>CNRS UMR 7179, MNHN, Brunoy, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Aujard</LastName>
                    <ForeName>Fabienne</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>CNRS UMR 7179, MNHN, Brunoy, France.</Affiliation>
                </Author>
                <Author>
                    <LastName>Dhenain</LastName>
                    <ForeName>Marc</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>CEA, DSV, I2BM, MIRCen, URA CEA CNRS 2210, Fontenay aux Roses, France; CNRS, URA 2210, Fontenay aux Roses, France. Electronic address: Marc.Dhenain@cea.fr.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>18</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neurobiol Aging</MedlineTA>
            <NlmUniqueID>8100437</NlmUniqueID>
            <ISSNLinking>0197-4580</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Alzheimer</Keyword>
            <Keyword MajorTopicYN="N">Amyloid</Keyword>
            <Keyword MajorTopicYN="N">Cerebral aging</Keyword>
            <Keyword MajorTopicYN="N">Intracellular amyloid</Keyword>
            <Keyword MajorTopicYN="N">Lemur</Keyword>
            <Keyword MajorTopicYN="N">Microcebus murinus</Keyword>
            <Keyword MajorTopicYN="N">Plasma</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2012</Year>
                <Month>11</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>2</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0197-4580(14)00486-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neurobiolaging.2014.07.017</ArticleId>
            <ArticleId IdType="pubmed">25131002</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130912</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1879-2472</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>6</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Thrombosis research</Title>
                <ISOAbbreviation>Thromb. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Platelet activation biomarkers in Berkeley sickle cell mice and the response to prasugrel.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0049-3848(14)00412-5</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.thromres.2014.07.035</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Vaso-occlusive crisis (VOC) is a common complication that occurs in sickle cell disease (SCD) patients. Although underlying mechanisms of VOC remain unclear, platelet activation has been associated with VOC. In the present study, plasma adenine nucleotide measurements using LC-ESI-MS/MS showed that plasma ADP in the Berkeley murine model of SCD was significantly higher (applox. 2.7-fold increase) compared with control mice. Assessment of platelet activation markers using flow cytometry indicated that in SCD mice at steady state (8weeks old), circulating platelets were partially activated and this tended to increase with age (15weeks old). The administration of prasugrel, a thienopiridyl P2Y12 antagonist, did not affect the activation state of circulating platelets suggesting P2Y12 independent mechanism of activation. In this murine SCD model, ex vivo addition of ADP or PAR4 TRAP resulted in further platelet activation as assessed by expression of activated GPIIb/IIIa and P-selectin both at 8 and 15weeks. In 15weeks old SCD mice, agonist-induced increases in activation markers were enhanced compared to control mice. Oral administration of prasugrel effectively inhibited ex vivo platelet activation consistent with clinical data in patients with SCD. In conclusion, in the Berkeley murine model of SCD, we found evidence of basal and agonist-stimulated platelet activation which could in part be attenuated by prasugrel. These data are consistent with observations made in patients with SCD and suggest possible utility of this murine model and prasugrel therapy in exploring treatment options for patients with SCD.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier Ltd. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Ohno</LastName>
                    <ForeName>Kousaku</ForeName>
                    <Initials>K</Initials>
                    <Affiliation>Biological Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tanaka</LastName>
                    <ForeName>Hisako</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Center for Pharmaceutical and Biomedical Analysis, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Samata</LastName>
                    <ForeName>Naozumi</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Center for Pharmaceutical and Biomedical Analysis, Daiichi Sankyo RD Novare Co., Ltd., Tokyo, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Jakubowski</LastName>
                    <ForeName>Joseph A</ForeName>
                    <Initials>JA</Initials>
                    <Affiliation>Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.</Affiliation>
                </Author>
                <Author>
                    <LastName>Tomizawa</LastName>
                    <ForeName>Atsuyuki</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Biological Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Mizuno</LastName>
                    <ForeName>Makoto</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Biological Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sugidachi</LastName>
                    <ForeName>Atsuhiro</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Biological Research Laboratories, Daiichi Sankyo Co., Ltd., Tokyo, Japan. Electronic address: sugidachi.atsuhiro.r7@daiichisankyo.co.jp.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Thromb Res</MedlineTA>
            <NlmUniqueID>0326377</NlmUniqueID>
            <ISSNLinking>0049-3848</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Adenine nucleotide</Keyword>
            <Keyword MajorTopicYN="N">P2Y(12) antagonist</Keyword>
            <Keyword MajorTopicYN="N">Platelet</Keyword>
            <Keyword MajorTopicYN="N">Prasugrel</Keyword>
            <Keyword MajorTopicYN="N">Sickle cell disease</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>22</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S0049-3848(14)00412-5</ArticleId>
            <ArticleId IdType="doi">10.1016/j.thromres.2014.07.035</ArticleId>
            <ArticleId IdType="pubmed">25130912</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25130839</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1009-2137</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>22</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology</Title>
                <ISOAbbreviation>Zhongguo Shi Yan Xue Ye Xue Za Zhi</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Effect of Different Irradiation Doses on the Establishment of Murine cGVHD Model after MHC Matched Spleen Stem Cell Transplantation].</ArticleTitle>
            <Pagination>
                <MedlinePgn>1115-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.7534/j.issn.1009-2137.2014.04.043</ELocationID>
            <Abstract>
                <AbstractText>This study was aimed to investigate the effect of different irradiation doses on the establishment of murine cGVHD model after MHC matched spleen stem cell transplantation. The male mouse BALB/c(H)-2d was totally irradiated with different radiation dose of (60)Co (TBI), then was infused with the same number of spleenocytes from MHC matched DBA/2 male mice. After transplantation, the bodyweight, general appearance, hair changes, survival time and pathological damage were observed. The results indicated that compared to the control group (0 Gy) and the 7.0 Gy group, the mice irradiated with 7.5 Gy and 8.0 Gy showed cGVHD symptoms and obvious pathological damage. At the end of experiments (60 d after transplantation), all mice irradiated by 7.5 Gy survived while only 60% animals survived in the 8.0 Gy group. It is concluded that under infusion of 10(8) MHC matched splenocytes per mouse, 7.5 Gy irradiation is appropriate to efficiently establish cGVHD model. This study laid an important foundation for further studying the pathogenesis, biological characteristics, and intervention factors of cGVHD.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Li</LastName>
                    <ForeName>Xi-Mei</ForeName>
                    <Initials>XM</Initials>
                    <Affiliation>Training Base for Postgraduater, Shengyang Military Command General Hospital, Liaoning Medical College, Shenyang 110016, Liaoning Province, China; Department of Cell Biology, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing 100850, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhu</LastName>
                    <ForeName>Heng</ForeName>
                    <Initials>H</Initials>
                    <Affiliation>Department of Cell Biology, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing 100850, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tang</LastName>
                    <ForeName>Bo</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Training Base for Postgraduater, Shengyang Military Command General Hospital, Liaoning Medical College, Shenyang 110016, Liaoning Province, China; Department of Cell Biology, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing 100850, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Chu</LastName>
                    <ForeName>Ya-Nan</ForeName>
                    <Initials>YN</Initials>
                    <Affiliation>Department of Cell Biology, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing 100850, China; Department of Pediatrics, General Hospital of Tianjing Medical Universisty, Tianjing 300052, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Liu</LastName>
                    <ForeName>Yuan-Lin</ForeName>
                    <Initials>YL</Initials>
                    <Affiliation>Department of Cell Biology, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing 100850, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhou</LastName>
                    <ForeName>Fan</ForeName>
                    <Initials>F</Initials>
                    <Affiliation>Training Base for Postgraduater, Shengyang Military Command General Hospital, Liaoning Medical College, Shenyang 110016, Liaoning Province, China. E-mail: zhoufan611@sina.com.cn.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Yi</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Cell Biology, Institute of Basic Medical Sciences, Academy of Military Medical Sciences, Beijing 100850, China. E-mail: zhangyi612@hotmail.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>chi</Language>
            <PublicationTypeList>
                <PublicationType>English Abstract</PublicationType>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Zhongguo Shi Yan Xue Ye Xue Za Zhi</MedlineTA>
            <NlmUniqueID>101084424</NlmUniqueID>
            <ISSNLinking>1009-2137</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">1009-2137(2014)04-1115-05</ArticleId>
            <ArticleId IdType="pubmed">25130839</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25130797</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print">
            <Journal>
                <ISSN IssnType="Print">1009-2137</ISSN>
                <JournalIssue CitedMedium="Print">
                    <Volume>22</Volume>
                    <Issue>4</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jul</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology</Title>
                <ISOAbbreviation>Zhongguo Shi Yan Xue Ye Xue Za Zhi</ISOAbbreviation>
            </Journal>
            <ArticleTitle>[Progress and potential applications of induced pluripotent stem cell technology].</ArticleTitle>
            <Pagination>
                <MedlinePgn>883-8</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.7534/j.issn.1009-2137.2014.04.001</ELocationID>
            <Abstract>
                <AbstractText>Differentiated somatic cells can be reprogrammed to a pluripotent state through ectopic expression of specific transcription factors. These reprogrammed cells, which were designated as induced pluripotent stem (iPS) cells, are detected to exhibit unlimited self-renewal capacity and pluripotency. This breakthrough in stem cell research provides a powerful and novel tool for the studies on pathogenesis of diseases, reprogramming mechanism and development of new therapies. For this reason, the iPSC technology has currently become one of the hot topics in stem cells research. Recently, major progress in this field has been achieved: initially, researchers succeeded in inducing the reprogramming of mouse fibroblasts by retroviral transduction of four specific transcription factors; in succession, the accelerated development of iPSC technology by employing non-integrating viral vectors, non-viral vectors or removing the introduced foreign genes via gene knock-out has ensured the yields of much safer iPSC; meanwhile, some researches discoversed the proofs that a number of micromolecular compounds were potent in accelerating the cellular reprogramming. For a prospect, iPSC are highly promising for regenerative medicine, disease modeling and drug screening. In this review, the recent progress in the generation of iPSC, prospects of their possible clinical applications and problems in the iPSC research are summarized and discussed.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Wu</LastName>
                    <ForeName>Cui-Ling</ForeName>
                    <Initials>CL</Initials>
                    <Affiliation>Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Zhang</LastName>
                    <ForeName>Yu-Ming</ForeName>
                    <Initials>YM</Initials>
                    <Affiliation>Department of Pediatrics, Nanfang Hospital, Southern Medical University, Guangzhou 510515, Guangdong Province, China. E-mail:yumingzhang1966@hotmail.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>chi</Language>
            <PublicationTypeList>
                <PublicationType>English Abstract</PublicationType>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
        </Article>
        <MedlineJournalInfo>
            <Country>China</Country>
            <MedlineTA>Zhongguo Shi Yan Xue Ye Xue Za Zhi</MedlineTA>
            <NlmUniqueID>101084424</NlmUniqueID>
            <ISSNLinking>1009-2137</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">1009-2137(2014)04-0883-06</ArticleId>
            <ArticleId IdType="pubmed">25130797</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130770</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-9896</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of pathology</Title>
                <ISOAbbreviation>J. Pathol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Heparin Cofactor II Enhances Cell Motility and Promotes Metastasis in Non-Small-Cell Lung Cancer.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/path.4421</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">By using Serial Analysis of Gene Expression (SAGE) database from the Cancer Genome Anatomy Project, we identified heparin cofactor II (HCII) that is overexpressed in non-small cell lung cancer (NSCLC). Here, we investigate the clinical significance of HCII and provide molecular evidence to support that HCII could enhance cancer metastasis in NSCLC. We found that high HCII expression in tumor tissue is associated with increased cancer recurrence and shorter overall survival times in 75 clinically operable NSCLC patients. High pre-treatment plasma concentration of HCII is associated with reduced overall survival in 57 consecutive NSCLC patients. We overexpress and knockdown HCII expressions in lung cancer cell lines and confirm that HCII can promote cell motility, invasion ability and filopodium dynamics in NSCLC cells in vitro and increased metastatic colonization in an in vivo mouse model. Exogenous treatment of HCII promotes cancer cell migration, and this promigratory effect of HCII is independent of thrombin. We further show that HCII can upregulate cancer cell migration through activation of PI3K, which acts upstream of Rac1 and Cdc42, and this effect can be blocked by heparin. We suggest that HCII is a novel metastasis enhancer and may be used as a prognostic predictor for heparin treatment in NSCLC.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Liao</LastName>
                    <ForeName>Wei-Yu</ForeName>
                    <Initials>WY</Initials>
                    <Affiliation>Graduate Institute of Clinical Medicine, National Taiwan University College of Medicine, Taipei, 10002, Taiwan; Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, 10002, Taiwan.</Affiliation>
                </Author>
                <Author>
                    <LastName>Ho</LastName>
                    <ForeName>Chao-Chi</ForeName>
                    <Initials>CC</Initials>
                </Author>
                <Author>
                    <LastName>Hou</LastName>
                    <ForeName>Hsin-Han</ForeName>
                    <Initials>HH</Initials>
                </Author>
                <Author>
                    <LastName>Hsu</LastName>
                    <ForeName>Tsi-Hsuan</ForeName>
                    <Initials>TH</Initials>
                </Author>
                <Author>
                    <LastName>Tsai</LastName>
                    <ForeName>Meng-Feng</ForeName>
                    <Initials>MF</Initials>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Kuan-Yu</ForeName>
                    <Initials>KY</Initials>
                </Author>
                <Author>
                    <LastName>Chen</LastName>
                    <ForeName>Hsuan-Yu</ForeName>
                    <Initials>HY</Initials>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Yung-Chie</ForeName>
                    <Initials>YC</Initials>
                </Author>
                <Author>
                    <LastName>Yu</LastName>
                    <ForeName>Chong-Jen</ForeName>
                    <Initials>CJ</Initials>
                </Author>
                <Author>
                    <LastName>Lee</LastName>
                    <ForeName>Chau-Hwang</ForeName>
                    <Initials>CH</Initials>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Pan-Chyr</ForeName>
                    <Initials>PC</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Pathol</MedlineTA>
            <NlmUniqueID>0204634</NlmUniqueID>
            <ISSNLinking>0022-3417</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Cell motility</Keyword>
            <Keyword MajorTopicYN="N">Heparin cofactor II</Keyword>
            <Keyword MajorTopicYN="N">Metastasis</Keyword>
            <Keyword MajorTopicYN="N">Non-small-cell lung cancer</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>8</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.4421</ArticleId>
            <ArticleId IdType="pubmed">25130770</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25130743</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1347-6947</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>78</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Bioscience, biotechnology, and biochemistry</Title>
                <ISOAbbreviation>Biosci. Biotechnol. Biochem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Anti-diabetic properties of Daphniphyllum macropodum fruit and its active compound.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1392-401</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/09168451.2014.923289</ELocationID>
            <Abstract>
                <AbstractText>We evaluated in vitro anti-diabetic activities of 497 native plants of Jeju Island (South Korea) by measuring the induction of adipocyte differentiation. Among the plants, Daphniphyllum macropodum fruit extract (DME) had the highest peroxisome proliferator-activated receptor ?? (PPAR??) agonist activity and was therefore selected as a potential source of anti-diabetic agents. To elucidate the active components of DME, constituent compounds were purified and their effects on the adipocyte differentiation were studied. Using activity-guided fractionation, four compounds were isolated from DME and their adipogenic effects were evaluated. Among the compounds isolated, 5,7-dihydroxychromone potently induced the differentiation of mouse 3T3-L1 preadipocytes. DME and 5,7-dihydroxychromone increased PPAR?? and liver X receptor ?? (LXR??) mRNA expression levels. To determine whether the adipogenic effects we observed might affect serum glucose levels, we undertook in vivo experiment using streptozotocin-/high-fat diet-induced type 2 diabetes mouse model. DME supplementation reduced serum glucose, total cholesterol, and triacylglycerol levels in diabetes mice. These results suggest that DME may be useful for the prevention and treatment of type 2 diabetes mellitus. Moreover, it was proposed that 5,7-dihydroxychromone isolated from DME is one of the active compounds that may contribute to regulate blood glucose levels.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Koo</LastName>
                    <ForeName>Hyun Jung</ForeName>
                    <Initials>HJ</Initials>
                    <Affiliation>a Department of Life Science , Gachon University , Seongnam , Republic of Korea.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kwak</LastName>
                    <ForeName>Jong Hwan</ForeName>
                    <Initials>JH</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kang</LastName>
                    <ForeName>Se Chan</ForeName>
                    <Initials>SC</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>06</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Biosci Biotechnol Biochem</MedlineTA>
            <NlmUniqueID>9205717</NlmUniqueID>
            <ISSNLinking>0916-8451</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">5,7-dihydroxychromone</Keyword>
            <Keyword MajorTopicYN="N">Daphniphyllum macropodum</Keyword>
            <Keyword MajorTopicYN="N">adipocyte differentiation</Keyword>
            <Keyword MajorTopicYN="N">peroxisome proliferator-activated receptor gamma</Keyword>
            <Keyword MajorTopicYN="N">type 2 diabetes mellitus</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>12</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09168451.2014.923289</ArticleId>
            <ArticleId IdType="pubmed">25130743</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25130737</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1347-6947</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>78</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Bioscience, biotechnology, and biochemistry</Title>
                <ISOAbbreviation>Biosci. Biotechnol. Biochem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>I??B kinase epsilon expression in adipocytes is upregulated by interaction with macrophages.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1357-62</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/09168451.2014.925776</ELocationID>
            <Abstract>
                <AbstractText>Macrophage infiltration in the adipose tissue, and the interaction with adipocytes, is well documented to be involved in fat inflammation and obesity-associated complications. In this study, we isolated I??B kinase ?? (IKK??) as a key adipocyte factor that is potentially affected by interaction with macrophages in adipose tissue in vivo. We showed that IKK?? mRNA expression levels in white adipose tissue were increased in both genetic and diet-induced obese mouse. Furthermore, IKK?? mRNA expression was decreased by the administration of vitamin B6, an anti-inflammatory vitamin, and that IKK?? expression levels in adipose tissue were closely correlated with the numbers of infiltrating macrophages. In a co-culture system, we showed that IKK?? expression in adipocytes was upregulated by interaction with activated macrophages. This study provides novel insight into IKK??, which is involved in adipose tissue inflammation during the development of obesity.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Sanada</LastName>
                    <ForeName>Yohei</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>a Department of Molecular and Applied Bioscience , Graduate School of Biosphere Science, Hiroshima University , Higashi-Hiroshima , Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kumoto</LastName>
                    <ForeName>Takahiro</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Suehiro</LastName>
                    <ForeName>Haruna</ForeName>
                    <Initials>H</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yamamoto</LastName>
                    <ForeName>Takafumi</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Nishimura</LastName>
                    <ForeName>Fusanori</ForeName>
                    <Initials>F</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Kato</LastName>
                    <ForeName>Norihisa</ForeName>
                    <Initials>N</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yanaka</LastName>
                    <ForeName>Noriyuki</ForeName>
                    <Initials>N</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>07</Month>
                <Day>10</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Biosci Biotechnol Biochem</MedlineTA>
            <NlmUniqueID>9205717</NlmUniqueID>
            <ISSNLinking>0916-8451</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">IKK epsilon</Keyword>
            <Keyword MajorTopicYN="N">chronic low-grade inflammation</Keyword>
            <Keyword MajorTopicYN="N">macrophage</Keyword>
            <Keyword MajorTopicYN="N">obesity</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>10</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09168451.2014.925776</ArticleId>
            <ArticleId IdType="pubmed">25130737</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25130730</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1347-6947</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>78</Volume>
                    <Issue>8</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Bioscience, biotechnology, and biochemistry</Title>
                <ISOAbbreviation>Biosci. Biotechnol. Biochem.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Simultaneous measurement of nicotinamide and its catabolites, nicotinamide N-oxide, N(1)-methyl-2-pyridone-5-carboxamide, and N(1)-methyl-4-pyridone-3-carboxamide, in mice urine.</ArticleTitle>
            <Pagination>
                <MedlinePgn>1306-9</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1080/09168451.2014.918495</ELocationID>
            <Abstract>
                <AbstractText>Nicotinamide N-oxide is a major nicotinamide catabolite in mice but not in humans and rats. A high-performance liquid chromatographic method for the simultaneous measurement of nicotinamide, nicotinamide N-oxide, N(1)-methyl-2-pyridone-5-carboxamide, and N(1)-methyl-4-pyridone-3-carboxamide in mice urine was developed by modifying the mobile phase of a reported method for measurement of nicotinamide N-oxide.</AbstractText>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Maeta</LastName>
                    <ForeName>Akihiro</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>a Department of Nutrition , School of Human Cultures, The University of Shiga Prefecture , Hikone , Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sano</LastName>
                    <ForeName>Mitsue</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Fukuwatari</LastName>
                    <ForeName>Tsutomu</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Shibata</LastName>
                    <ForeName>Katsumi</ForeName>
                    <Initials>K</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>06</Month>
                <Day>17</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Biosci Biotechnol Biochem</MedlineTA>
            <NlmUniqueID>9205717</NlmUniqueID>
            <ISSNLinking>0916-8451</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">HPLC</Keyword>
            <Keyword MajorTopicYN="N">mouse</Keyword>
            <Keyword MajorTopicYN="N">nicotinamide N-oxide</Keyword>
            <Keyword MajorTopicYN="N">urine</Keyword>
            <Keyword MajorTopicYN="N">vitamin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>17</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1080/09168451.2014.918495</ArticleId>
            <ArticleId IdType="pubmed">25130730</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130652</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1096-9896</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The Journal of pathology</Title>
                <ISOAbbreviation>J. Pathol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Klotho suppresses renal tubulointerstitial fibrosis by controlling basic fibroblast growth factor-2 signaling.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/path.4420</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Increased basic fibroblast growth factor-2 (FGF2) and reduced Klotho have both been reported to be closely associated with renal fibrosis. However, the relationship between Klotho and FGF2 remains unclear. We demonstrate that FGF2 induced tubuloepithelial plasticity in cultured HK-2 cells, accompanied by a reduction in Klotho expression, whereas recombinant Klotho protein could inhibit the action of FGF2. The FGF2 effects required extracellular signal-regulated protein kinase 1/2 activation which was suppressed by Klotho. Moreover, Klotho also restrained FGF2-induced fibroblast proliferation and activation. The inhibitory effect of Klotho on the activity of FGF2 was likely due to its potent ability to compete with FGF2 binding to FGF receptor 1. Unilateral ureteral obstruction (UUO)-induced renal fibrosis was associated with an increase in FGF2 and a reduction in Klotho expression in wild type mice, whereas FGF2(-/-) mice largely preserved Klotho expression and developed only mild renal fibrosis after obstructive injury. Furthermore, administration of Klotho protein in UUO mice significantly reduced renal fibrosis, concomitant with a marked suppression of FGF2 production and signaling. These studies demonstrate a feedback loop between Klotho depletion and FGF2 activation in renal fibrosis. Our results also suggest that Klotho treatment reduces renal fibrosis, at least in part, by inhibiting FGF2 signaling.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Guan</LastName>
                    <ForeName>Xu</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Nephrology, Institute of Nephrology of Chongqing and Kidney Center of PLA, Xinqiao Hospital, Third Military Medical University, Chongqing, 400037, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nie</LastName>
                    <ForeName>Ling</ForeName>
                    <Initials>L</Initials>
                </Author>
                <Author>
                    <LastName>He</LastName>
                    <ForeName>Ting</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Yang</LastName>
                    <ForeName>Ke</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Xiao</LastName>
                    <ForeName>Tangli</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Song</ForeName>
                    <Initials>S</Initials>
                </Author>
                <Author>
                    <LastName>Huang</LastName>
                    <ForeName>Yunjian</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Jingbo</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Junping</ForeName>
                    <Initials>J</Initials>
                </Author>
                <Author>
                    <LastName>Sharma</LastName>
                    <ForeName>Kumar</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author>
                    <LastName>Liu</LastName>
                    <ForeName>Youhua</ForeName>
                    <Initials>Y</Initials>
                </Author>
                <Author>
                    <LastName>Zhao</LastName>
                    <ForeName>Jinghong</ForeName>
                    <Initials>J</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Pathol</MedlineTA>
            <NlmUniqueID>0204634</NlmUniqueID>
            <ISSNLinking>0022-3417</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">FGF2</Keyword>
            <Keyword MajorTopicYN="N">Klotho</Keyword>
            <Keyword MajorTopicYN="N">renal fibrosis</Keyword>
            <Keyword MajorTopicYN="N">tubuloepithelial plasticity</Keyword>
            <Keyword MajorTopicYN="N">unilateral ureteral obstruction</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>9</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/path.4420</ArticleId>
            <ArticleId IdType="pubmed">25130652</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130650</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1521-2254</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>12</Day>
                    </PubDate>
                </JournalIssue>
                <Title>The journal of gene medicine</Title>
                <ISOAbbreviation>J Gene Med</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Long term therapeutic and reporter gene expression in lentiviral vector treated cystic fibrosis mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/jgm.2778</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Persistent reporter gene and cystic fibrosis transmembrane conductance regulator (CFTR) nasal airway gene expression can be achieved with a single lentiviral (LV) gene vector dosing when coupled with a preparatory lysophosphatidylcholine (LPC) airway pre-treatment. In this study we characterised the duration of gene expression in individual cystic fibrosis (CF) knockout mice (cftr(tm1unc) ) over their lifetimes.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">CF mouse nasal airways were treated with LV-Rx, a mixture of a therapeutic LV-CFTR gene vector and a LV-Luciferase reporter gene vector, after pre-treatment with LPC. Control groups received either PBS sham pre-treatment followed by LV-Rx, or LPC prior to delivery of a LV vector containing no transgene (LV-MT). Airway reporter gene expression was monitored by bioluminescence, and functional CFTR expression was assessed via nasal transepithelial potential difference (TPD) measurements at regular intervals up to 21???months. The presence of the CFTR transgene in the nasal septa, liver and spleen tissues were assessed by qPCR. Circulating antibodies to the vector glycoprotein envelope (VSV-G) and to the Luciferase protein were also measured.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">The combined use of LPC and LV gene vectors in the nasal airway produced enhanced and sustained luciferase and CFTR gene expression lasting at least 12???months. Improved survival was also observed in CF knockout mice treated with the LV vector mixture when compared to all control CF mouse groups.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study showed that our airway pre-treatment and gene delivery technique resulted in sustained functional CFTR expression and improved survival in CF mice. This article is protected by copyright. All rights reserved.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Cmielewski</LastName>
                    <ForeName>Patricia</ForeName>
                    <Initials>P</Initials>
                    <Affiliation>Respiratory and Sleep Medicine, Women's and Children's Hospital Network, North Adelaide, SA, Australia; School of Paediatrics and Reproductive Health, University of Adelaide, Adelaide, SA, Australia; Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.</Affiliation>
                </Author>
                <Author>
                    <LastName>Donnelley</LastName>
                    <ForeName>Martin</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Parsons</LastName>
                    <ForeName>David W</ForeName>
                    <Initials>DW</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>12</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>J Gene Med</MedlineTA>
            <NlmUniqueID>9815764</NlmUniqueID>
            <ISSNLinking>1099-498X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">cystic fibrosis</Keyword>
            <Keyword MajorTopicYN="N">gene expression</Keyword>
            <Keyword MajorTopicYN="N">lentivirus</Keyword>
            <Keyword MajorTopicYN="N">long-term</Keyword>
            <Keyword MajorTopicYN="N">mouse</Keyword>
            <Keyword MajorTopicYN="N">survival</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>3</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>1</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>5</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/jgm.2778</ArticleId>
            <ArticleId IdType="pubmed">25130650</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130621</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1098-1136</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>8</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Glia</Title>
                <ISOAbbreviation>Glia</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Blockade of monoacylglycerol lipase inhibits oligodendrocyte excitotoxicity and prevents demyelination in vivo.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1002/glia.22742</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">MAGL blockade attenuates AMPA receptor-mediated excitotoxicity to oligodendrocytes in vitro. MAGL inhibition reduces clinical severity, demyelination, and white matter inflammation in EAE mice. MAGL inhibition prevents demyelination and microglial activation by cuprizone feeding.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Wiley Periodicals, Inc.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Bernal-Chico</LastName>
                    <ForeName>Ana</ForeName>
                    <Initials>A</Initials>
                    <Affiliation>Department of Neurosciences, School of Medicine, University of the Basque Country-UPV/EHU, Leioa, Spain; Achucarro Basque Center for Neuroscience, Zamudio, Spain.</Affiliation>
                </Author>
                <Author>
                    <LastName>Canedo</LastName>
                    <ForeName>Manuel</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>Manterola</LastName>
                    <ForeName>Andrea</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Victoria S??nchez-G??mez</LastName>
                    <ForeName>Mar??a</ForeName>
                    <Initials>M</Initials>
                </Author>
                <Author>
                    <LastName>P??rez-Samart??n</LastName>
                    <ForeName>Alberto</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Rodr??guez-Puertas</LastName>
                    <ForeName>Rafael</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author>
                    <LastName>Matute</LastName>
                    <ForeName>Carlos</ForeName>
                    <Initials>C</Initials>
                </Author>
                <Author>
                    <LastName>Mato</LastName>
                    <ForeName>Susana</ForeName>
                    <Initials>S</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>8</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Glia</MedlineTA>
            <NlmUniqueID>8806785</NlmUniqueID>
            <ISSNLinking>0894-1491</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">2-AG</Keyword>
            <Keyword MajorTopicYN="N">AMPA receptors</Keyword>
            <Keyword MajorTopicYN="N">CB1 receptors</Keyword>
            <Keyword MajorTopicYN="N">multiple sclerosis</Keyword>
            <Keyword MajorTopicYN="N">myelin</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>29</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1002/glia.22742</ArticleId>
            <ArticleId IdType="pubmed">25130621</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130614</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1601-183X</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Genes, brain, and behavior</Title>
                <ISOAbbreviation>Genes Brain Behav.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Mutation of Dcdc2 in mice leads to impairments in auditory processing and memory ability.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/gbb.12170</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Dyslexia is a complex neurodevelopmental disorder characterized by impaired reading ability despite normal intellect, and is associated with specific difficulties in phonological and rapid auditory processing, visual attention, and working memory. Genetic variants in DCDC2 have been associated with dyslexia, impairments in phonological processing, and in short term/working memory. The purpose of this study was to determine whether sensory and behavioral impairments can result directly from mutation of the Dcdc2 gene in mice. Several behavioral tasks, including a modified pre-pulse inhibition paradigm (to examine auditory processing), a 4/8 radial arm maze (to assess/dissociate working versus reference memory), and rotarod (to examine sensorimotor ability and motor learning) were used to assess the effects of Dcdc2 mutation. Behavioral results revealed deficits in rapid auditory processing, working memory, and reference memory in Dcdc2(del2/del2) mice as compared to matched wild types. Current findings parallel clinical research linking genetic variants of DCDC2 with specific impairments of phonological processing and memory ability.</AbstractText>
                <CopyrightInformation>This article is protected by copyright. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Truong</LastName>
                    <ForeName>Dongnhu T</ForeName>
                    <Initials>DT</Initials>
                    <Affiliation>Department of Psychology/Behavioral Neuroscience, University of Connecticut, 406 Babbidge Road, Unit 1020, Storrs, CT, 06269.</Affiliation>
                </Author>
                <Author>
                    <LastName>Che</LastName>
                    <ForeName>Alicia</ForeName>
                    <Initials>A</Initials>
                </Author>
                <Author>
                    <LastName>Rendall</LastName>
                    <ForeName>Amanda R</ForeName>
                    <Initials>AR</Initials>
                </Author>
                <Author>
                    <LastName>Szalkowski</LastName>
                    <ForeName>Caitlin E</ForeName>
                    <Initials>CE</Initials>
                </Author>
                <Author>
                    <LastName>LoTurco</LastName>
                    <ForeName>Joseph J</ForeName>
                    <Initials>JJ</Initials>
                </Author>
                <Author>
                    <LastName>Galaburda</LastName>
                    <ForeName>Albert M</ForeName>
                    <Initials>AM</Initials>
                </Author>
                <Author>
                    <LastName>Fitch</LastName>
                    <ForeName>R Holly</ForeName>
                    <Initials>RH</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Genes Brain Behav</MedlineTA>
            <NlmUniqueID>101129617</NlmUniqueID>
            <ISSNLinking>1601-183X</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Dcdc2</Keyword>
            <Keyword MajorTopicYN="N">Dyslexia</Keyword>
            <Keyword MajorTopicYN="N">Language impairment</Keyword>
            <Keyword MajorTopicYN="N">Rapid auditory processing</Keyword>
            <Keyword MajorTopicYN="N">working memory</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>14</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>7</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/gbb.12170</ArticleId>
            <ArticleId IdType="pubmed">25130614</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130607</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1878-1705</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>14</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International immunopharmacology</Title>
                <ISOAbbreviation>Int. Immunopharmacol.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Prolonged pretreatment of mice with cholera toxin, but not isoproterenol, alleviates acute lethal systemic inflammatory response.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S1567-5769(14)00312-9</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.intimp.2014.07.035</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Isoproterenol, a synthetic non-selective ??-adrenergic agonist, is often used during the immediate postoperative period after open heart surgery for its chronotropic and vasodilatory effects. It has been demonstrated that isoproterenol pretreatment followed by immediate LPS administration leads to reduced tumor necrosis factor-?? (TNF-??) response in vivo. However, sepsis never happens immediately after the surgery, but rather severe immune dysfunction occurs at least 24h later. It remains elusive what effects isoproterenol might exert to innate immunity during the period. In this scenario, we investigated the effects of 24-h isoproterenol pretreatment on septic shock induced by experimental endotoxemia and bacterial peritonitis, with cholera toxin as another cAMP elevator. Unexpectedly, we found that isoproterenol and cholera toxin exhibited distinct effects in acute lethal systemic inflammatory response. Isoproterenol worsened liver injury without enhancing NK/NKT activity. Meanwhile, cholera toxin but not isoproterenol showed dramatically reduced TNF-?? response in LPS induced septic shock. Our data provide a caution for the clinical use of isoproterenol and suggest that isoproterenol has cAMP-independent functions.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 Elsevier B.V. All rights reserved.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Jingyang</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Molecular Immunology, Institute of Basic Medical Sciences, 27 Taiping Road, Beijing 100850, PR China; Medical College, Nankai University, Tianjin 300071, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Guo</LastName>
                    <ForeName>Xiangrui</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Molecular Immunology, Institute of Basic Medical Sciences, 27 Taiping Road, Beijing 100850, PR China; Department of Biomedicine, Institute of Frontier Medical Sciences, Jilin University, Changchun 130021, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cao</LastName>
                    <ForeName>Junxia</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Molecular Immunology, Institute of Basic Medical Sciences, 27 Taiping Road, Beijing 100850, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Xueying</ForeName>
                    <Initials>X</Initials>
                    <Affiliation>Department of Molecular Immunology, Institute of Basic Medical Sciences, 27 Taiping Road, Beijing 100850, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Zhang</LastName>
                    <ForeName>Jiyan</ForeName>
                    <Initials>J</Initials>
                    <Affiliation>Department of Molecular Immunology, Institute of Basic Medical Sciences, 27 Taiping Road, Beijing 100850, PR China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sun</LastName>
                    <ForeName>Dejun</ForeName>
                    <Initials>D</Initials>
                    <Affiliation>Department of Biomedicine, Institute of Frontier Medical Sciences, Jilin University, Changchun 130021, PR China. Electronic address: sundjjl@yahoo.com.cn.</Affiliation>
                </Author>
                <Author>
                    <LastName>Wang</LastName>
                    <ForeName>Qingyang</ForeName>
                    <Initials>Q</Initials>
                    <Affiliation>Department of Molecular Immunology, Institute of Basic Medical Sciences, 27 Taiping Road, Beijing 100850, PR China. Electronic address: tansun0532@163.com.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>14</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Int Immunopharmacol</MedlineTA>
            <NlmUniqueID>100965259</NlmUniqueID>
            <ISSNLinking>1567-5769</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Inflammatory response</Keyword>
            <Keyword MajorTopicYN="N">Isoproterenol</Keyword>
            <Keyword MajorTopicYN="N">Liver injury</Keyword>
            <Keyword MajorTopicYN="N">TNF-??</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>2</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>30</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">S1567-5769(14)00312-9</ArticleId>
            <ArticleId IdType="doi">10.1016/j.intimp.2014.07.035</ArticleId>
            <ArticleId IdType="pubmed">25130607</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130590</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1530-0277</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>4</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Alcoholism, clinical and experimental research</Title>
                <ISOAbbreviation>Alcohol. Clin. Exp. Res.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Histone Acetylation in the Nucleus Accumbens Shell Modulates Ethanol-Induced Locomotor Activity in DBA/2J Mice.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.1111/acer.12502</ELocationID>
            <Abstract>
                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">A growing body of literature suggests that epigenetic mechanisms, including histone acetylation, may play key roles in drug abuse and the development of addiction. Experiments in this study were designed to investigate the role of histone acetylation in ethanol (EtOH)-induced locomotor sensitization.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">Immunohistochemical, Western blotting, and site-directed pharmacological techniques were used to explore the roles of histone acetylation at histone H3 (acH3K9) in both the expression of and acquisition of EtOH-induced locomotor sensitization. A commonly used sensitization protocol, in which animals were exposed to repeated injections of a low dose of EtOH while in their home cage, was used to examine this behavioral phenomenon. Additionally, site-directed administration of the histone deacetylase inhibitor (HDACi) Trichostatin A (TSA), in the absence of repeated EtOH injections, was used to examine the role of hyperacetylation in the nucleus accumbens (NAC) shell in EtOH-induced locomotor sensitization.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Sensitized mice displayed elevated acH3K9 immunoreactivity (IR) localized to the shell of the NAC. This augmentation in acH3K9 IR was confirmed, in a separate experiment, using Western blot analyses. Next, repeated intra-accumbal infusions of TSA, in the absence of repeated EtOH injections, were sufficient to induce an augmented locomotor response to a later injection of a low dose (2.0??g/kg, intraperitoneally) of EtOH, indicative of cross-sensitization to this locomotor stimulation between TSA and EtOH. Finally, a local infusion of TSA into the shell of the accumbens was also associated with a significant increase in acH3K9 IR within this region.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Together, the present observations suggest that histone acetylation, particularly within the shell of the NAC, is important for the development and expression of EtOH-induced locomotor sensitization.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014 by the Research Society on Alcoholism.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Sprow</LastName>
                    <ForeName>Gretchen M</ForeName>
                    <Initials>GM</Initials>
                    <Affiliation>Department of Psychology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.</Affiliation>
                </Author>
                <Author>
                    <LastName>Rinker</LastName>
                    <ForeName>Jennifer A</ForeName>
                    <Initials>JA</Initials>
                </Author>
                <Author>
                    <LastName>Thiele</LastName>
                    <ForeName>Todd E</ForeName>
                    <Initials>TE</Initials>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <GrantList>
                <Grant>
                    <GrantID>R01 AA013573</GrantID>
                    <Acronym>AA</Acronym>
                    <Agency>NIAAA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 AA015148</GrantID>
                    <Acronym>AA</Acronym>
                    <Agency>NIAAA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
                <Grant>
                    <GrantID>R01 AA022048</GrantID>
                    <Acronym>AA</Acronym>
                    <Agency>NIAAA NIH HHS</Agency>
                    <Country>United States</Country>
                </Grant>
            </GrantList>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>4</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Alcohol Clin Exp Res</MedlineTA>
            <NlmUniqueID>7707242</NlmUniqueID>
            <ISSNLinking>0145-6008</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Acetylation</Keyword>
            <Keyword MajorTopicYN="N">Ethanol</Keyword>
            <Keyword MajorTopicYN="N">Locomotor</Keyword>
            <Keyword MajorTopicYN="N">Sensitization</Keyword>
            <Keyword MajorTopicYN="N">Trichostatin A</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2013</Year>
                <Month>11</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/acer.12502</ArticleId>
            <ArticleId IdType="pubmed">25130590</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130579</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1745-7262</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jun</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Asian journal of andrology</Title>
                <ISOAbbreviation>Asian J. Androl.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Re: New insights into SET protein during mouse spermatogenesis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.4103/1008-682X.131708</ELocationID>
            <AuthorList>
                <Author>
                    <LastName>Cui</LastName>
                    <ForeName>Yu-Gui</ForeName>
                    <Initials>YG</Initials>
                    <Affiliation>The State Key Laboratory of Reproductive Medicine, Clinical Center of Reproductive Medicine, First Affiliated Hospital, Nanjing Medical University, Nanjing, China.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Asian J Androl</MedlineTA>
            <NlmUniqueID>100942132</NlmUniqueID>
            <ISSNLinking>1008-682X</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">131708</ArticleId>
            <ArticleId IdType="pubmed">25130579</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130578</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>18</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1745-7262</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Jun</Month>
                        <Day>13</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Asian journal of andrology</Title>
                <ISOAbbreviation>Asian J. Androl.</ISOAbbreviation>
            </Journal>
            <ArticleTitle>New insights into SET protein during mouse spermatogenesis.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="doi">10.4103/1008-682X.131065</ELocationID>
            <AuthorList>
                <Author>
                    <LastName>Yeste</LastName>
                    <ForeName>Marc</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Department of Animal Medicine and Surgery, Autonomous University of Barcelona, Bellaterra, Spain.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>13</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Asian J Androl</MedlineTA>
            <NlmUniqueID>100942132</NlmUniqueID>
            <ISSNLinking>1008-682X</ISSNLinking>
        </MedlineJournalInfo>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pii">131065</ArticleId>
            <ArticleId IdType="pubmed">25130578</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Owner="NLM" Status="In-Data-Review">
        <PMID Version="1">25130574</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>08</Month>
            <Day>22</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1365-2443</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <Volume>19</Volume>
                    <Issue>9</Issue>
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Sep</Month>
                    </PubDate>
                </JournalIssue>
                <Title>Genes to cells : devoted to molecular &amp; cellular mechanisms</Title>
                <ISOAbbreviation>Genes Cells</ISOAbbreviation>
            </Journal>
            <ArticleTitle>JSAP1 and JLP are required for ARF6 localization to the midbody in cytokinesis.</ArticleTitle>
            <Pagination>
                <MedlinePgn>692-703</MedlinePgn>
            </Pagination>
            <ELocationID EIdType="doi" ValidYN="Y">10.1111/gtc.12170</ELocationID>
            <Abstract>
                <AbstractText>The ADP-ribosylation factor 6 (ARF6) GTPase is important in cytokinesis and localizes to the midbody. However, the mechanism and regulation of ARF6's recruitment to the midbody are largely unknown. Here, we investigated the functions of two binding partners of active ARF6, c-Jun NH2 -terminal kinase (JNK)/stress-activated protein kinase-associated protein 1 (JSAP1) and JNK-associated leucine zipper protein (JLP), by gene knockout and rescue experiments in mouse embryonic fibroblasts. Depleting both JSAP1 and JLP impaired ARF6's localization to the midbody and delayed cytokinesis. These defects were almost completely rescued by wild-type JSAP1 or JLP, but not by JSAP1 or JLP mutants that were unable to interact with active ARF6 or with the kinesin heavy chain (KHC) of kinesin-1. In transfected cells, a constitutively active form of ARF6 associated with KHC only when co-expressed with wild-type JSAP1 or JLP and not with a JSAP1 or JLP mutant. These findings suggest that JSAP1 and JLP, which might be paralogous to each other, are critical and functionally redundant in cytokinesis and control ARF6 localization to the midbody by forming a tripartite complex of JSAP1/JLP, active ARF6, and kinesin-1.</AbstractText>
                <CopyrightInformation>?? 2014 The Authors Genes to Cells ?? 2014 by the Molecular Biology Society of Japan and Wiley Publishing Asia Pty Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Tuvshintugs</LastName>
                    <ForeName>Baljinnyam</ForeName>
                    <Initials>B</Initials>
                    <Affiliation>Division of Molecular Cell Signaling, Cancer Research Institute, Kanazawa University, Kanazawa, 920-1192, Japan.</Affiliation>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Sato</LastName>
                    <ForeName>Tokiharu</ForeName>
                    <Initials>T</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Enkhtuya</LastName>
                    <ForeName>Radnaa</ForeName>
                    <Initials>R</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yamashita</LastName>
                    <ForeName>Katsumi</ForeName>
                    <Initials>K</Initials>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Yoshioka</LastName>
                    <ForeName>Katsuji</ForeName>
                    <Initials>K</Initials>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType>Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>08</Month>
                <Day>06</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>England</Country>
            <MedlineTA>Genes Cells</MedlineTA>
            <NlmUniqueID>9607379</NlmUniqueID>
            <ISSNLinking>1356-9597</ISSNLinking>
        </MedlineJournalInfo>
        <CitationSubset>IM</CitationSubset>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>18</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>6</Month>
                <Day>23</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="aheadofprint">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>ppublish</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="doi">10.1111/gtc.12170</ArticleId>
            <ArticleId IdType="pubmed">25130574</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130560</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>24</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-7544</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neuroscience</Title>
                <ISOAbbreviation>Neuroscience</ISOAbbreviation>
            </Journal>
            <ArticleTitle>5-HT3A receptors are required in long-term depression and AMPA receptor internalization.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0306-4522(14)00647-2</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.neuroscience.2014.07.070</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">5-Hydroxytrytamine (serotonin) type 3A receptors (5-HT3ARs), as the only ligand-gated ion channels in the serotonin receptor family, are known to regulate neuronal excitation and release of GABA in hippocampal interneurons. However, their physiological role in glutamatergic synaptic plasticity remains unclear. Here, we show that deletion of the 5-HT3AR gene in mice abolished N-methyl-d-aspartate (NMDA) receptor (NMDAR)-dependent long-term depression (LTD) induced by low-frequency stimulation (LFS) in hippocampal CA1 synapses in slices, whereas the metabotropic glutamate receptor (mGluR)-dependent LTD did not change in the 5-HT3AR knockout mice. In addition, 5-HT3ARs disruption inhibited ??-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) internalization, without altering basal surface levels of AMPARs. However, the deletion of 5-HT3ARs did not lead to loss of synapses and structural alteration of dendritic spines. Furthermore, the concentrations of 5-HT and 5-hydroxyindoleacetic acid (5-HIAA) in the hippocampus were not affected by the deletion of 5-HT3ARs. These observations revealed an important role of 5-HT3ARs in NMDAR-dependent long-term depression, which is critical for learning behaviors.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Yu</LastName>
                    <ForeName>Y</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Cao</LastName>
                    <ForeName>D-Q</ForeName>
                    <Initials>DQ</Initials>
                    <Affiliation>Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Xu</LastName>
                    <ForeName>H-Y</ForeName>
                    <Initials>HY</Initials>
                    <Affiliation>Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Sun</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>R&amp;D China, GlaxoSmithKline, Pudong, Shanghai 201203, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Huang</LastName>
                    <ForeName>Z-L</ForeName>
                    <Initials>ZL</Initials>
                    <Affiliation>Department of Pharmacology, Shanghai Medical College, Fudan University, Shanghai, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yung</LastName>
                    <ForeName>W-H</ForeName>
                    <Initials>WH</Initials>
                    <Affiliation>School of Biomedical Sciences, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong, China.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lu</LastName>
                    <ForeName>N</ForeName>
                    <Initials>N</Initials>
                    <Affiliation>Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: luning7@shmu.edu.cn.</Affiliation>
                </Author>
                <Author>
                    <LastName>Huang</LastName>
                    <ForeName>Y</ForeName>
                    <Initials>Y</Initials>
                    <Affiliation>Department of Physiology and Pathophysiology, Shanghai Medical College, Fudan University, Shanghai, China. Electronic address: yinghuang@shmu.edu.cn.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neuroscience</MedlineTA>
            <NlmUniqueID>7605074</NlmUniqueID>
            <ISSNLinking>0306-4522</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">5-HT(3A) receptor</Keyword>
            <Keyword MajorTopicYN="N">AMPA receptor internalization</Keyword>
            <Keyword MajorTopicYN="N">dendritic spines</Keyword>
            <Keyword MajorTopicYN="N">long-term depression</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>5</Month>
                <Day>3</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>11</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>7</Month>
                <Day>24</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25130560</ArticleId>
            <ArticleId IdType="pii">S0306-4522(14)00647-2</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2014.07.070</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">25130559</PMID>
        <DateCreated>
            <Year>2014</Year>
            <Month>8</Month>
            <Day>23</Day>
        </DateCreated>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1873-7544</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2014</Year>
                        <Month>Aug</Month>
                        <Day>15</Day>
                    </PubDate>
                </JournalIssue>
                <Title>Neuroscience</Title>
                <ISOAbbreviation>Neuroscience</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Downstream effects of striatal-enriched protein tyrosine phosphatase reduction on RNA expression in vivo and in vitro.</ArticleTitle>
            <Pagination>
                <MedlinePgn/>
            </Pagination>
            <ELocationID EIdType="pii">S0306-4522(14)00642-3</ELocationID>
            <ELocationID EIdType="doi">10.1016/j.neuroscience.2014.08.002</ELocationID>
            <Abstract>
                <AbstractText NlmCategory="UNLABELLED">Striatal-enriched protein tyrosine phosphatase (STEP) is a brain-specific tyrosine phosphatase that has been shown to de-phosphorylate several key neuronal signaling proteins, including kinases (extracellular signal-regulated kinase (ERK1/2), FYN, PYK2) and glutamate receptor subunits (N-methyl-d-aspartate receptor subtype 2B (NR2B), glutamate receptor 2 (GLUR2)). Step knock-out mice have increased phosphorylation of these substrates in the brain, with potential functional consequences in synaptic plasticity and cognitive tasks. It is therefore of interest to identify the molecular pathways and downstream transcriptional targets that are impacted by Step knockdown. In the present study, striatal RNA samples from Step wild-type, knock-out and heterozygous mice were hybridized to Affymetrix microarray chips and evaluated for transcriptional changes between genotypes. Pathway analysis highlighted Erk signaling and multiple pathways related to neurotrophin signaling, neuronal development and synaptic transmission. Potential genes of interest identified by microarray were confirmed by quantitative real-time polymerase chain reaction (qRT-PCR) in the cortex and hippocampus, which shared several transcriptional alterations with the striatum. In order to evaluate Step knockdown in an in vitro system, a panel of genes were evaluated using qRT-PCR in rat cortical neurons that were transduced with lentivirus expressing short hairpin RNA against Step or a non-targeting control. Our data suggest that Step has a role in the expression of immediate early genes relevant to synaptic plasticity, in both in vitro and in vivo systems.</AbstractText>
                <CopyrightInformation>Copyright ?? 2014. Published by Elsevier Ltd.</CopyrightInformation>
            </Abstract>
            <AuthorList>
                <Author>
                    <LastName>Reinhart</LastName>
                    <ForeName>V L</ForeName>
                    <Initials>VL</Initials>
                    <Affiliation>Pfizer Research &amp; Development, Cambridge, MA, United States. Electronic address: Veronica.Reinhart@pfizer.com.</Affiliation>
                </Author>
                <Author>
                    <LastName>Nguyen</LastName>
                    <ForeName>T</ForeName>
                    <Initials>T</Initials>
                    <Affiliation>Pfizer Research &amp; Development, Cambridge, MA, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Gerwien</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                    <Suffix>Jr</Suffix>
                    <Affiliation>Quanticate, Durham, NC, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Kuhn</LastName>
                    <ForeName>M</ForeName>
                    <Initials>M</Initials>
                    <Affiliation>Pfizer Research &amp; Development, Groton, CT, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Yates</LastName>
                    <ForeName>P D</ForeName>
                    <Initials>PD</Initials>
                    <Affiliation>Pfizer Research &amp; Development, Groton, CT, United States.</Affiliation>
                </Author>
                <Author>
                    <LastName>Lanz</LastName>
                    <ForeName>T A</ForeName>
                    <Initials>TA</Initials>
                    <Affiliation>Pfizer Research &amp; Development, Cambridge, MA, United States.</Affiliation>
                </Author>
            </AuthorList>
            <Language>ENG</Language>
            <PublicationTypeList>
                <PublicationType>JOURNAL ARTICLE</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>15</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <MedlineTA>Neuroscience</MedlineTA>
            <NlmUniqueID>7605074</NlmUniqueID>
            <ISSNLinking>0306-4522</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">NMDA</Keyword>
            <Keyword MajorTopicYN="N">PTPN5</Keyword>
            <Keyword MajorTopicYN="N">STEP</Keyword>
            <Keyword MajorTopicYN="N">microarray</Keyword>
            <Keyword MajorTopicYN="N">qRT-PCR</Keyword>
            <Keyword MajorTopicYN="N">schizophrenia</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2014</Year>
                <Month>4</Month>
                <Day>21</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>4</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>6</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2014</Year>
                <Month>8</Month>
                <Day>19</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">25130559</ArticleId>
            <ArticleId IdType="pii">S0306-4522(14)00642-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.neuroscience.2014.08.002</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

</PubmedArticleSet>
